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Abstract 
 
Background 
The emergence of nanomedicine, involving the intravenous injection of tracking agents 
(such as dyes and nanoparticles) and drug-loaded nanoparticles (NPs) for diagnostic and 
therapeutic purposes may display a biosafety concern specifically to the circulating blood 
and the vascular system. Dye-encapsulated silica nanoparticles (SiNPs) are one of the most 
popular NPs recently being explored for medical intervention. However, there are limited 
studies investigating their biocompatibility and biosafety with regards to blood vessels. Our 
group’s previous findings suggest that SiNPs of 100 and 200 nm in size have no detrimental 
effect on conduit arterial function. However, their direct effect on small size arteries, which 
play an important role in controlling blood flow into tissues, has not been investigated 
previously.  
 
Aim  
To investigate the direct influence of SiNPs on small arterial function and contractility. 
 
Methodology  
Mono-dispersed dye-encapsulated SiNPs of defined diameters (98 nm) were fabricated 
using a modified Stöber method and characterised using the Malvern Zetasizer and 
transmission electron microscopy (TEM). NP characteristics (size and charge) were 
monitored over a 15-month period in various media. Small mesenteric arteries (MAs) (150-
300 µm in diameter) from male Wistar rats were isolated, mounted between two glass 
cannulae and superfused in gassed physiological salt solution (PSS) at 37℃. Vasoconstrictor 
(high potassium [KPSS], Phenylephrine [Phe]) and vasodilator (Acetylcholine [ACh], Sodium 
nitroprusside [SNP] and papaverine [PAPA]) responses were assessed using pressure 
myography before and 30 minutes after the intravascular infusion of SiNPs under static 
conditions at intravascular pressure of 60 mmHg. SiNPs were also injected intravenously 
and mesenteric vessels isolated after a 2-hour period, for assessment of vascular reactivity.  
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 Results and Conclusion 
Our findings show that SiNPs are rapidly taken up into ECs lining small mesenteric arteries 
and were freely localised in the cytoplasm, with no evidence of uptake into the nucleus or 
the smooth muscle cell layer. SiNPs (calculated at 5.32 x 1011 NP/mL) attenuated Phe 
contractile responses, but did not alter the responses to KPSS ex vivo, suggesting that the 
contractile machinery is unaffected by SiNP uptake. There was an attenuated endothelium 
dependent (ACh) dilator response following the incubation with SiNPs ex vivo. In contrast, 
the lower dose of SiNPs (at 1.01 x 1011 NP/mL) had no overall effect on ACh responses. The 
endothelium-independent (SNP) vasodilator responses were unaffected by the incubation 
in SiNPs. When injected intravenously in vivo, SiNPs only had a detrimental effect on 
constrictor (Phe) and endothelial dependent (ACh) dilator responses, at the lower agonist 
concentrations. At high agonist concentrations, however, the injected SiNPs did not seem 
to alter the constriction or dilation response, suggesting that possible corona formation 
may have been protective in vivo. SiNPs injected in vivo, significantly reduced SNP-induced 
dilator responses at a lower dosage. This may have clinical implications on the use of SNP 
drugs for patients with heart disease. A small fraction of the SiNPs administered in vivo (6%) 
were localised within various tissues including; lungs, heart, aorta, mesentery, liver, spleen 
and kidney, with the MA accounting for the majority of uptake (approximately 5% of total 
injected SiNPs). Inhibition studies (using L-NNA and potassium channel blockers), 
demonstrated that both nitric oxide (NO) and endothelial-derived hyperpolarising factors 
(EDHFs) contribute to the vasodilator component in MAs. The co-incubation of SiNPs in the 
presence of L-NNA completely abolished the dilator responses to ACh, suggesting the direct 
effect of SiNPs on the EDHF pathway. The co-incubation in SOD did not reverse the actions 
of the SiNPs, indicating that a reactive oxygen species (ROS)-independent mechanism may 
mediate SiNPs actions in small arteries. The reduction of ERK and Akt phosphorylation ex 
vivo may underpin the mechanisms of SiNPs effects on rat mesenteric arteries. Depending 
on their dosage, we demonstrate that SiNPs uptake and accumulation in ECs have 
detrimental effects on the function of small arteries. 
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1.1 Background   
 
The vascular system permits the transport and controls the flow of circulating blood 
enriched with oxygen and nutrients or waste to and from organs and tissues (Whittemore, 
1999). The preservation of vascular integrity and function is thus essential to ensure that 
blood flow is matched to demand. The emergence of nanomedicine, involving the 
intravenous (iv) injection of tracking agents (such as dyes and nanoparticles (NPs)) and drug 
loaded NPs for diagnostic and therapeutic purposes may potentially cause injury and 
compromise the function of blood vessels. Preventative and protective measures are thus 
essential to maintain vascular integrity and function through targeted NPs uptake into 
living systems, bypass their negative acute (short-term) and chronic (long-term) effects and 
ensure the safe administration and/or targeting of these agents in vivo. 
 
In the present report, the structure and function of the vascular system will initially be 
described, followed by an introduction to nanotechnology and the use of nanomaterials 
for diagnostic and therapeutic intervention. The influence that nanomaterials may have on 
vascular function will be highlighted, leading to the aims and objectives of the study.   
 
 
1.2 Vascular Anatomy and Physiology  
 
1.2.1 Blood Vessel Architecture 
In blood vessels, the arterial wall is composed of three layers, the tunica interna, tunica 
media and tunica externa (Figure 1). The innermost tunica interna contains a lining of 
simple endothelium, a basement membrane and a layer of elastic tissue. The tunica media 
however is the thickest layer of elastic fibre and smooth muscle cells (especially in small 
arteries), while the tunica externa only contains elastic and collagen fibres. Veins have 
thinner tunica interna and tunica media (with little smooth muscle and elastic fibres) with 
a bigger lumen and more intense tunica externa, consisting mainly of collagen and elastic 
fibres. Arterioles have tunica interna consisting of endothelium elastic and collagen fibres 
and tunica media composed of smooth muscle and few elastic fibres (Figure 2). Capillaries 
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in turn are composed of a single layer of endothelial cells (ECs) with a basement membrane 
and when several capillaries unite, they form small veins called venules. These consist of 
tunica interna of endothelium and tunica media with scattered smooth muscle fibres and 
fibroblasts (Tortora, 2003).   
 
 
Figure 1. Anatomy of an artery. Adapted from 
http://science.nhmccd.edu/biol/cardio/artery.htm, access date: 2006. 
 
 
Figure 2. Anatomy of arterioles, capillaries and venules. Adapted from 
http://apocketmerlin.tumblr.com/post/18660545870/the-hitchhikers-guide-to-the-
circulatory-system-basics, access date: 2013. 
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1.2.1.1 The Vascular Endothelium and Smooth Muscle Layers 
The vascular endothelial tissue acts as a secretory tissue and has critical roles in lining blood 
vessels, forming a barrier to blood flow into the vascular tissue, acting as a selective 
permeability barrier and maintaining tissue haemodynamics and homoeostasis. ECs are 
involved in coagulation and fibrinolysis, regulation of vascular tone, growth regulation of 
other cell types and blood cell activation and migration during physiological and 
pathological processes (Dora, 2001; Risau, 1995; Shireman and Pearce, 1996). Smooth 
muscle cells within vascular tissues form along, with elastin, collagen and other 
extracellular matrix (ECM), components of the vascular media. As vascular smooth muscle 
cells (VSMCs) grow they attach to ECM and become elongated (pulled or flattened) and 
spindle-shaped and become known as “differentiated contractile” (medial) cells (Schwartz, 
1997; Myit et al., 2003). These contractile VSMCs control blood flow through the 
maintenance of vascular tone (Fok et al., 2012). The contraction of VSMCs is calcium ion 
(Ca2+)-dependent and triggered by the activation of plasma membrane (PM) receptors 
(Somlyo and Somlyo, 1994). Thus, VSMCs provide the integrity of the vascular wall 
structure and have a major impact on the functional characteristics of blood vessels.  
 
ECs are in close proximity to VSMCs, where they communicate directly (Powell et al., 1997) 
via gap junctions and signalling molecules (Davies, 1986; Lyubimov and Gotlieb, 2004). 
There is a cross talk and continuous interaction between the endothelium and smooth 
muscle cell layer which influences blood vessel development and function (Bernanke and 
Velkey, 2002). These interactions are translated into the regulation of VSMC proliferation 
and EC migration (Shum-Tim et al., 1999), preventing excessive SMC proliferation into the 
lumen (Campbell and Campbell, 1986; Casscells, 1992) 
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1.2.2 The Maintenance of Vascular Tone 
Vascular tone is defined as the degree of constriction experienced by a blood vessel relative 
to its maximally dilated state. All arterial and venous vessels under basal conditions exhibit 
some degree of smooth muscle contraction that determines the diameter and hence tone, 
of the vessel (Shimoda et al., 2000). However, the endothelium plays an important role in 
the modulation of vascular tone (Busse et al., 1985) through the release of vasoconstrictor 
and vasodilator regulatory factors (Imig and Roman, 1992; Cines et al., 1998). The factors 
that descend from the endothelium ensure a low level of phosphorylation of the muscular 
cell kinases to maintain the VSMCs tone in the absence of external stimulation. Vascular 
tone is also determined by extrinsic factors (neurohumoral) that originate from outside of 
the organ or tissue in which the blood vessel is located such as sympathetic nerves and 
circulating hormones (Yamamoto et al., 1994) and intrinsic factors that originate from the 
vessel itself or the surrounding tissue e.g. metabolites. The primary function of extrinsic 
factors is to regulate arterial blood pressure by altering systemic vascular resistance, 
whereas intrinsic mechanisms are important for local blood flow regulation within an organ 
(Vicent et al., 2003). Vasodilator autacoids include endothelial-derived hyperpolarising 
factor (EDHF) (Cheung et al., 1999), nitric oxide (NO) (Okamura and Toda, 1992; Yamashita 
et al., 2001) and prostacyclin (PGI-2), but a substantial component of the vasodilator 
response observed is in response to receptor-dependent agonists or changes in the flow of 
blood. Generally, the factors that increase vascular tone cause vasoconstriction; however, 
those that decrease vascular tone cause vasodilation. Some intrinsic factors may initiate 
myogenic mechanisms (Davis et al., 2001), originating from vascular smooth muscle to 
increase tone. While other endothelial factors, such as NO (Van Camp et al., 1994) and 
endothelin (Gellai et al., 1997), can either decrease or increase tone, respectively.  
 
Myogenic mechanisms of diameter control are intrinsic to the smooth muscle of blood 
vessels, particularly in small arteries and arterioles. If the pressure within a vessel is 
suddenly increased, the vessel responds by constricting. In contrast, if the pressure is 
diminished within the vessel, it causes relaxation and vasodilation. This response is known 
as myogenic reactivity and is observed in vivo and in isolated, pressurised blood vessels 
(Azzawi and Austin, 2006). The myogenic behaviour may play a role in local autoregulation 
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of blood flow and in reactive hyperaemia, especially in small-resistant size arteries (<100 
µm diameter) that are able to regulate their own diameter, thus protecting dependent 
capillary beds from large increases in hydrostatic pressure (Davis and Hill, 1999). 
Electrophysiological studies have shown that VSMC depolarise when stretched, leading to 
contraction. Stretching also increases the rate of VSMCs that spontaneously undergo 
depolarisation and repolarisation (Hill and Davis, 2007). The mechanisms by which the 
above influences either constrict or relax blood vessels involve a variety of signal 
transduction mechanisms that ultimately influence the interaction between actin and 
myosin in the smooth muscle (Figure 3). Several signal transduction mechanisms modulate 
intracellular calcium concentration and therefore the state of vascular tone (Blatter and 
Wier, 1994). 
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Figure 3. The different signal transduction pathways within vascular cells, which are 
involved in mediating the action of vascular cell contraction and relaxation. EDHF; 
endothelial-derived hyperpolarising factor (EDHF), ET-1; endothelin-1, NO; nitric oxide, 
NOS; NO synthase. Adapted from Channick, R. N. and Rubin, L. J. (2002) 'Endothelin 
Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension.' 
Advances in Pulmonary Hypertension, 1(1) pp. 13-17.  
 
The role of the different mechanisms alone or in combination in mediating, modulating and 
controlling the vascular tone is dependent on the type of the blood vessel, its territory and 
its corresponding size (luminal diameter). Some evidence suggest the contribution of 
endothelium-dependent hyperpolarisation in the control of endothelial vasomotor 
function in the majority of human blood vessels (Bellien et al., 2008). Although the role of 
EDHF becomes prominent in the presence of NO-synthase inhibitors, EDHF has also been 
suggested to play a key role in dilation under physiological conditions assessed in presence 
of NO in both resistance and conduit arteries (Honing et al., 2000; Bellien et al., 2006). NO 
may display a major part in some dilator-pathways, where EDHF has a minor backup role 
(Bauersachs et al., 1996) and vice versa and/or in combination. For instance, it is well 
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established that conduit vessels such as the aorta rely on NO more than EDHF-related 
pathway in mediating vascular dilation;  in contrast to coronary arteries that mainly depend 
on EDHF-related pathways or a combination of both NO and EDHF. In the current study, we 
have used mesenteric arteries, which have been shown to depend mostly on EDHF-related 
pathway, similar to that found in many vascular beds within the human body. These 
microvascular beds, including cerebral arteries (McNeish et al., 2005), coronary arterioles, 
peripheral muscular arterioles, skin arterioles, gastroepiploic arteries, omental arteries, 
mesenteric arteries (White and Hiley, 1997), renal arteries and venous vessels, were 
suggested to have a characteristic EDHF activity (Bellien et al., 2008). However, the type of 
the vascular bed as well as accompanying position of an artery within the vascular tree, 
may determine the related contractile and dilatory pathway present. Table 1 summarises 
the main studies that related specific endothelial-dependent dilatory pathways as assigned 
to different vascular types and territories. 
 
It was previously shown that nanomolar concentrations of endogenously released NO 
initiate and maintain the ACh-induced relaxation of the rat superior mesenteric artery 
(Simonsen et al., 1999), with these being independent of EDHF-related hyperpolarisation 
to ACh (Crane et al., 2003). This indicates the importance of NO as a vasodilator in the latter 
arteries. The contribution of NO is found most prominent in large-sized conduit vessels 
such as the aorta, carotid, femoral arteries and superior MAs (with an unstretched luminal 
(internal) diameter of 650 µm) (Hwa et al., 1994) whereas that of EDHF is most prominent 
in small- and microvessels (such as arterioles, meta-arterioles and capillaries.) (Hinton and 
Langton, 2003). The latter vessels distribute and control the blood perfusion into tissues 
and are involved in microcirculation of microvascular beds such as distal MAs (Shimokawa 
et al., 1996) and capillaries. In the review by Mulvany and Aalkjaer, they regarded small 
arteries as prearteriolar vessels with lumen diameter less than 500 µm in diameter 
(Mulvany and Aalkjaer, 1990). It was suggested that these small arteries, contribute to 
regulation of the peripheral resistance, with this being more evident in vessel sized 
between 10-200 µm in diameter (Mulvany and Aalkjaer, 1990). This idea was further 
supported through the presence of a deeper resting membrane potential and greater ACh-
induced hyperpolarisation in the distal MAs compared to those in the aorta (with the 
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expression of eNOS in the aorta being higher than that in the distal MAs) (Shimokawa et 
al., 1996). The EDHF was found to account for 50% or more of dilation experienced in 
medium-sized (<500 µm in diameter) arteries (e.g. first-order MAs of the superior MA) 
(Garland and McPherson, 1992), while EDHF on the other hand, is the main dilator in small 
(~200-300 µm diameter; e.g. second and third-order MAs) and resistance-sized arteries and 
arterioles (e.g. fourth- and higher-order MAs running along the gut)    (Burnham et al., 2006; 
Leo et al., 2011; Shimokawa et al., 1996; Koeppen et al., 2004). Arterioles are located in the 
transparent part of the mesentery and stem from first- or second-order branches of the 
superior mesenteric artery, and they give rise to small capillary networks that supply the 
mesentery. Thus, the contribution of EDHF to small arterial dilation is thought to increase 
as the vessel size decreases; with the latter phenomenon being more established in 
resistance arteries with a diameter <100 µm in diameter (Zhao et al., 2013)  and mesenteric 
terminal arterioles (40 µm in diameter) (Hald et al., 2012). Due to their size (145-300 μm), 
the dilation of second and third order MAs employed in this current study is likely to be 
mediated mainly by EDHF (Hwa et al., 1994).  
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Table 1. Endothelial-dependent dilatory pathways as related to different vascular beds.  
Vascular Bed Model 
Studied  
Stimulus  Pathway(s) 
Identity  
Reference 
Carotid artery Guinea pig ACh EDHF (Quignard et 
al., 2002) 
Forearm 
microvasculature 
Human Bradykinin EDHF (Halcox et al., 
2001) 
Femoral arteries Rabbit ACh and  
and the calcium 
ionophore of 
bradykinin 
(A23187) 
NO and EDHF (Plane et al., 
1995) 
Aorta Rat ACh NO (Yan et al., 
2007) 
Coronary arterioles Human Hydrogen 
peroxide (H2O2) 
EDHF (Zhang et al., 
2012) 
Superior mesenteric 
arteries (650 µm 
diameter) 
Rat ACh NO (Hwa et al., 
1994) 
Mesenteric arteries 
(250 – 300 µm 
diameter) 
Human H2O2 EDHF (Matoba et al., 
2002) 
Mesenteric 
resistance arteries 
(200 µm diameter) 
Rat ACh EDHF  (Hwa et al., 
1994) 
Subcutaneous 
resistance arteries 
Human ACh EDHF (Coats et al., 
2001) 
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1.2.2.1 The Contractile Mechanisms in Small Arteries 
The mechanism of VSMC contraction is initiated in response to changes in the external 
environment including exogenous physical (mechanical), electrical and chemical stimuli. 
Blood flow can induce intravascular pressure that may lead to a passive stretching of VSMCs 
causing VSMC-dependent contraction. Such phenomenon is referred to as myogenic 
response (Scotland et al., 2001; Kol'tsova et al., 2010). Vasoconstriction is also mediated in 
response to various vasoconstrictor agonists acting on receptors located on the VSMC 
membranes. The common vasoconstrictors include; norepinephrine acting through α1-
adrenoceptors and prejunctional α2-adrenoceptors (released from the sympathetic nerves 
that innervate blood vessels), angiotensin II (Ang II) (De Mello, 2013) acting through AT1 
receptors (Griendling et al., 2000), arginine vasopressin (AVP) acting through V1a receptors 
(Yamamoto et al., 1997), endothelin-1 (ET-1) (Loesch et al., 1997) acting through ETA 
receptors, thromboxane A2, platelet-activating factor and phenylephrine (Phe) acting 
through α1-adrenergic receptor subtypes (Minneman, 1988). These receptors are coupled 
to G proteins, which upon conformational change provoked by vasoconstrictor-agonist 
receptors stimulate phospholipase C (PLC) activity via the activation of adenylyl cyclase, 
which catalyses the formation of cAMP (Figure 4). PLC acts on the membrane-bound lipid 
phosphatidy inositol 4-5 bisphosphate (PIP2) to catalyse the formation of diacyl glycerol 
(DG) and inositol 1,4,5 triphosphate (IP3). DG and IP3 act as second messengers, where IP3 
binds to IP3 receptors on the sarcoplasmic reticulum (SR) (Zhou et al., 2008) to allow the 
opening of voltage-gated calcium ion (Ca2+) channels (Vaca and Kunze, 1995) to allow the 
mobilisation and release of intracellular Ca2+ [Ca2+]i to initiate smooth muscle contraction. 
DAG and Ca2+ activate protein kinase C (PKC) (Geng et al., 1994), which phosphorylates 
specific regulatory target proteins contributing to vascular smooth muscle contraction. 
Free [Ca2+]i can also combine with an acid protein called calmodulin (CaM). The Ca2+/CaM 
complex activates myosin light chain kinase (MLC Kinase) (Sato et al., 1995) which 
phosphorylates the 20 kDa light chain of myosin found on the myosin heads in the presence 
of ATP. The phosphorylation of myosin light chains leads to the molecular cross-bridge 
formation between the myosin heads and the actin filaments. Phosphorylation enables the 
molecular interaction of myosin with actin fibres. Hence, the sliding effect results in 
vascular smooth muscle contraction. Ca2+ can trigger Ca2+-sensitive chloride (Cl-) channels 
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allowing Cl- efflux and membrane depolarisation to take place. The depolarisation of the 
membrane leads to the opening of L-type Ca2+ channels and extracellular Ca2+ influx 
eliciting VSMC contraction. The activation of Ca2+-sensitive potassium ion (K+) channels via 
the high Ca2+ concentration leads to the hyperpolarisation of cellular membranes. Hence 
the electromechanical coupling, resulting from the membrane potential, to determine 
[Ca2+]i concentration as well as the positive- and negative-feedback loops, both regulate 
[Ca2+]i storage and mobilisation (Carl et al., 1996). [Ca2+]i concentration thus displays a key 
factor in the regulation of the vascular tone and vascular smooth muscle contractility, not 
only through electromechanical coupling, but also through modulating the open 
probabilities of ion channels within VSMC membranes (Carl et al., 1996). The channels 
activated by [Ca2+]i include; large-conductance potassium channels, chloride ion channels, 
and nonselective cation channels has been described, as well as block of delayed rectifier 
potassium channels and [Ca2+]i-induced inactivation of Ca2+ channels (Carl et al., 1996). 
Hence the concentration of [Ca2+]i depends upon the balance between the cellular calcium 
entry, the calcium release by the intracellular storage sites and either the re-sequestering 
of calcium by the SR back into storage sites or its removal out of the cell (via an ATP-
dependent calcium pump or by the sodium-calcium exchanger) or both (Paltauf-
Doburzynska et al., 1999).  
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Figure 4. The Phosphoinositide Cascade: An illustration of the VSMC-dependent 
contraction in response to vasoconstrictors. Upon stimulation by e.g. angiotensin II (Ang 
II), the AT1 receptor that is coupled to G proteins, causes its conformational change to 
stimulate phospholipase C (PLC) activity via the activation of adenylyl cyclase (AC). AC 
catalyses the formation of cAMP. PLC acts on the membrane-bound lipid phosphatidy 
inositol 4-5 bisphosphate (PIP2) to catalyse the formation of diacyl glycerol (DG) and 
inositol 1,4,5 triphosphate (IP3). IP3 binds to the IP3 receptor (IP3-R) on the sarcoplasmic 
reticulum (SR)  to allow the mobilisation and release of intracellular Ca2+ [Ca2+]i to initiate 
vascular smooth muscle contraction. DAG and Ca2+ activate protein kinase C (PKC), which 
phosphorylates specific regulatory target proteins contributing to smooth muscle 
contraction. Free [Ca2+]i can also combine with an acid protein called calmodulin (CaM). 
The Ca2+/CaM complex activates myosin light chain kinase (MLC Kinase) which 
phosphorylates the light chain of myosin. Phosphorylation enables the molecular 
interaction of myosin with actin fibres leading to smooth muscle contraction. The 
depolarisation of the membrane leads to the opening of L-type Ca2+ channels and 
extracellular Ca2+ influx eliciting VSMC contraction. Author originated.  
 
Another pathway to VSMC contraction involves the 20-hydroxyeicosatetraenoic acid (20-
HETE) pathway (Fleming, 2001) (Figure 5). Following VSMC stimulation, phospholipase A2 
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(PLA2) activation leads to the liberation of arachidonic acid (AA) from membrane 
phospholipids (Fleming, 2001). AA may act as a substrate for the generation of 20-HETE, a 
reaction catalysed by cytochrome P450 (CYP) 4A through ω-hydroxylation (Fleming, 2001). 
20-HETE is an essential component of the signal transduction cascade activated by several 
hormonal systems; including ET-1 and Ang II that have roles in regulating the blood 
pressure (Imig, 2000; McGiff and Quilley, 1999; Harder et al., 2000). The action of 20-HETE 
is mediated via the decreases in the open probability of calcium-dependent K+ channels 
(K+Ca) and inhibits the Na-K-ATPase, which leads to depolarisation of the VSMCs, the 
activation of L-type Ca2+ channels and subsequent contraction (Fleming, 2001). 20-HETE 
and epoxyeicosatrienoic acids (EETs) (in particular 11,12- and 14,15-EET) activate several 
intracellular protein kinases including tyrosine kinases, the p38 mitogen activated protein 
kinase (MAPK), and extracellular-signal-regulated kinases 1 and 2 (Erk1/2) and increase the 
proliferation of various cell types, including vascular smooth muscle cells and ECs 
respectively (Uddin et al., 1998; Fleming, Fisslthaler, Michaelis, et al., 2001). 
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Figure 5. A schematic representation of mechanisms of vascular contraction and 
relaxation in relation to the epoxyeicosatrienoic acid (EET) and 20-
hydroxyeicosatetraenoic acid (20-HETE) pathways. AA; arachidonic acid, CoA-SH; acyl 
coenzyme A synthase, CYP 4A; cytochrome P450 2A, K+Ca; calcium-dependent K+ 
channels, PL; membrane phospholipids, PLA2; phospholipase, sEH; soluble epoxide 
hydrolase. Adapted from Fleming, I. (2001) 'Cytochrome p450 and vascular homeostasis.' 
Circ Res, 89(9), Oct 26, pp. 753-762. Copyright © American Heart Association. 
 
 
1.2.2.2 The Vasodilatory Mechanisms in Small Arteries 
The vasodilatory mechanisms in small arteries are initiated in response to mechanical 
stimuli (e.g. shear stress) and various vasorelaxing or vasodilator factors and agonists. 
These include; epinephrine acting through beta (β)2-adrenoceptors; cytokines, bradykinin, 
acetylcholine (ACh; released from the cholinergic autonomic nerve terminals and acting on 
muscarinic receptors on the vascular endothelium, e.g. muscarinic M3 receptors (Hsu et 
al., 2009)); prostacyclin (PGI2; acting through IP receptors), histamine (Adeagbo and 
Henzel, 1998) and substance P (Mathison and Davison, 1993). The presence of (activating) 
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agonist provokes a number of pathways depending on the agonist used and the 
bioavailability of a particular pathway’s constituents (Figure 6), which includes the basal 
levels of mediators as well as their relative gene expression. A number of pathways are 
involved in mediating vasodilation including the EDHF- (Mehrke and Daut, 1990; 
Marchenko and Sage, 1993; Welsh and Segal, 2000; Hoepfl et al., 2002), NO- and 
prostacyclin (PGI)-dependent pathways (Bachschmid et al., 2005). Both EDHF and NO 
pathways play pivotal role in mediating endothelial-dependent dilation in small arteries. 
These will be explained in greater detail below.  
 
 
Figure 6. Schematic representation of EC-VSMC interactions to control vascular 
relaxation. CYP450 2c; cytochrome P450 2C, EETs; epoxyeicosatrienoic acids, K+Ca; 
calcium-dependent K+ channels, PLC; phospholipase C. Adapted from Ozkor, M. A. and 
Quyyumi, A. A. (2011) 'Endothelium-derived hyperpolarizing factor and vascular 
function.' Cardiol Res Pract, 2011 p. 156146. 
 1.2.2.2.1 The Nitric Oxide and Prostacyclin-related Pathways 
Endothelium-derived NO is an important component of vascular homeostasis through its 
ability to regulate vascular tone (Lefroy et al., 1993). In the endothelium, NO is synthesised 
by the oxidation of L-arginine (forming L-citruline and NO) using a NO synthase (NOS), of 
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which three isoforms exist (endothelial-derived NO synthase (eNOS), neuronal NOS (nNOS) 
and inducible NOS (iNOS)). eNOS is the main NO synthase associated with the endothelium 
(Kvasnicka, 2003). The regulation of the activity of eNOS and its constitutive expression 
helps to maintain a basal production of NO, to keep vessels in a relaxed state (Cardillo et 
al., 1997; Dawes et al., 1997; Brodde, 1994).  
 
eNOS is subject to various forms of regulation including availability of cofactors and 
substrates, subcellular localisation, protein-protein interactions and phosphorylation 
(Govers and Rabelink, 2001). Exogenous stimuli such as shear stress as well as various 
agonists stimulate ECs within vascular beds and increase the activity of eNOS (Kagota et al., 
1999) and cyclooxygenase (COX) (Scotland et al., 2005), providing H2O2, NO and 
prostacyclin (PGI) (Pearson et al., 1983)-mediated dilation respectively (Figure 3). The 
increase in the intracellular concentration of Ca2+ can generate the Ca2+/CaM complex 
(Wang et al., 1995), which can either directly (Presta et al., 1997) or indirectly through 
CaMKII (Kida et al., 2012) activate eNOS. The phosphorylation of the Ser-1177 residue-
bearing reductase domain of eNOS by CaMKII and the subsequent transfer of electrons 
from the reductase domain to the oxidase domain (Stuehr et al., 2001) favours the 
generation of NO. The reductase domain of eNOS converts molecular oxygen (O2) and 
nicotinamide adenine dinucleotide phosphate (NADPH) to superoxide (O2•−) and NADP+ 
respectively (Stuehr et al., 2001). The electron transfer from the reductase domain to the 
haem group in the oxidase domain of eNOS is mediated by the Ca2+/CaM complex (Ghosh 
et al., 1998). The Ca2+/CaM complex binds to a consensus site in the eNOS reductase (Abu-
Soud and Stuehr, 1993; Presta et al., 1997), which is linked to the oxidase domain via a Thr-
495 residue (Fleming, 2010). Agonists which activate the phosphatidylinositol 3 kinase 
(PI3K)/Akt signalling pathway (Fulton et al., 1999; Michell et al., 1999) result in promotion 
of eNOS activity by increased Ser-1177 phosphorylation and/or Thr-495 dephosphorylation 
(Harris et al., 2001; Michell et al., 2001; Fleming, Fisslthaler, Dimmeler, et al., 2001; 
Hisamoto et al., 2001; Dimmeler et al., 1999; Gallis et al., 1999). Upon the generation of 
NO by eNOS, the latter diffuses from the EC vicinity into the VSMC where it binds to soluble 
guanylate cyclase leading to activation of cGMP (Cardillo et al., 1997). cGMP in turn 
activates cGMP-dependent protein kinase G (PKG) leading to Ca2+ resequestration  to the 
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SR, enhanced Ca2+ pumping through the indirect stimulation of the Ca2+-dependent ATPase 
pump and the inhibition of Ca2+ influx via channel phosphorylation. The elaborations of 
these mechanisms lead to a reduction in [Ca2+]i causing muscle relaxation. PKG also acts as 
a phosphatase to dephosphorylate myosin light chains also resulting in the relaxation of 
the smooth muscle cell, and hence the vessels.  
 1.2.2.2.2 The Endothelial-Derived Hyperpolarising Factor-related Pathways 
A number of EDHFs have been identified which function by inducing hyperpolarisations of 
VSMCs leading to dilation. There are multiple potential EDHF-dependent pathways (Quilley 
and McGiff, 2000; Griffith, 2004) contributing to the regulation vascular tone (Feletou and 
Vanhoutte, 1988) in various vascular beds (Bellien et al., 2008). These include; the 
epoxyeicosatrienoic acid (EET), hydrogen sulphide (H2S) and hydrogen peroxide (H2O2) 
pathways, which will be described in more detail.  
 
1.2.2.2.2.1 The Epoxyeicosatrienoic Acid Pathway 
The main EDHF-related pathway that has been identified is that involving the production 
of EET. This pathway is initiated via the action of various stimuli, which activate PLA2 on EC 
membranes. The activation of PLA2 may cause a conformational change that leads to the 
liberation of AA from the membrane phospholipids of ECs (Ozkor and Quyyumi, 2011) 
(Figure 6). Its metabolism by cyclooxygenases such as CYP epoxygenases  (Fleming, 2001; 
Node et al., 1999; Michaelis and Fleming, 2006) and CYP monooxygenase (Miura and 
Gutterman, 1998) generate stereo-speciﬁc AA epoxides regioisomers or AA-derived EETs 
(e.g. 5,6-, 8,9-, 11,12-, and 14,15-EETs) (Rosolowsky and Campbell, 1996). There are 
different isoforms of CYP enzymes including; CYP 2C gene family (CYP 1A1 (Wu et al., 1997), 
CYP 2B, CYP 2B6 (Wu et al., 1997), 2C (Fisslthaler et al., 1999), 2C8, 2C9 (Potente et al., 
2003), 2C10 and 2J2 in humans). EET is considered as an essential component for the EDHF-
mediated responses in small vessels (Campbell et al., 1996; Fisslthaler et al., 1999; Fleming, 
2004). Here, EET can transfer across the extracellular space to modulate smooth muscle 
membrane potential (Chen et al., 1991; Mombouli et al., 1996; Popp et al., 1996; 
Gebremedhin et al., 1998) via direct EC-VSMC vicinity coupling and the activation of 
membrane-bound channels on ECs and/or gap junctions (Griffith, 2004; Fleming and Busse, 
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2006). Previous reports suggested that EETs may act in an autocrine manner on ECs by 
activating voltage-gated Ca2+ channels (Luckhoff and Busse, 1990; Kamouchi et al., 
1999) and/or transient receptor potential (TRP)V4 channels. These channels promote Ca2+ 
inﬂux, further increasing Ca2+ concentration and stimulating various potassium channels on 
the EC and VSMCs membranes to cause hyperpolarisation and the release of potassium 
ions into the subendothelial space (Figure 6). The gap junctional communication between 
the ECs and VSMCs displays a critical phenomenon for the rapid spread of the electrical 
current from the EC to the smooth muscle cell layers (Griffith et al., 2004). The resulting 
vascular relaxation can therefore be secondary to the closing of voltage-operated Ca2+ 
channels and associated reductions in the influx of extracellular Ca2+ that sustain 
contraction in VSMCs (Griffith, 2004). There is some evidence to suggest that the 
metabolism of EETs into their diol products, the dihydroxyeicosatrienoic acids (DHETs) 
(VanRollins et al., 1996) is catalysed by the epoxide hydrolases. DHETs along with other 
esterified lipids may form an intracellular storage of EETs, from which EETs can be liberated 
upon cell activation independently of CYP activity (Weintraub et al., 1997). DHETs (such as 
11,12-DHETs (Fang et al., 1996) and 14,15-DHETs (Fang et al., 1997) in particular) may 
participate in the relaxation of small arteries in an endothelial-dependent manner (Figure 
5). In summary EETs and in some cases DHETs may both induce smooth muscle cell 
hyperpolarisation and vascular relaxation through the activation of Ca+2-dependent 
potassium channels (KCa+) and inhibiting L-type Ca2+ channels (Fleming, 2011).  
 
Once formed, EETs are either metabolised to DHETs, incorporated into membrane 
phospholipids by acyl coenzyme A synthase (CoA-SH), or leave the endothelial cell without 
modification. EETs have an effect in modulating the role of endothelium in relaxation. 
Previous studies suggested an action of EETs via putative EET receptors to upregulate the 
expression of cyclooxygenase-2 (COX-2) via a heterotrimeric G protein/adenylyl 
cyclise/cyclic AMP (cAMP)/protein kinase A (PKA)/cAMP response element-binding protein 
(CREB)-dependent signalling pathway (Michaelis and Fleming, 2006), thus leading to the 
modulation of EC vasodilation at the transcriptional level. Other nuclear receptors and 
transcription factors (TFs) that mediate the actions of EETs involve; nuclear factor κB (NF-
κB) (Node et al., 1999),  peroxisome proliferator-activated receptors (PPAR)-α (Cowart et 
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al., 2002), PPAR-γ (Liu et al., 2005) and fatty acid binding proteins (FABPs) such as H-FABP 
(Widstrom et al., 2001). EETs were also shown to induce EC proliferation (Michaelis and 
Fleming, 2006) via the phosphorylation and activation of Akt (Potente et al., 2003), PI3K, 
MAPK (Pozzi et al., 2005) and KCa+ channels.  
 
The basis of EETs’ action involve the passive transmission and spread of electrical signals 
from the vascular endothelium to the SMC layer via gap junctions to precede the rapid 
hyperpolarisation event of the ECs (Griffith, 2004). The spread of current through gap 
junctions along the vessel wall (Segal and Duling, 1989) is followed by a subsequent current 
decay. The current decay depends on the initial hyperpolarisation event (Emerson et al., 
2002), the length constant of the vessels receiving the current and the regenerative 
mechanisms involved in conducting the hyperpolarisation (Goto et al., 2004). The distal 
spread of the current through the regenerative mechanism of increased K+ in the interstitial 
or extracellular K+ (Mehrke and Daut, 1990; Hurjui et al., 2011) are mediated by the 
activation of various potassium channels located on both ECs and VSMCs membranes 
(Gordon and Martin, 1983; Mehrke and Daut, 1990; Wiecha et al., 1998; Miura et al., 1999; 
Faehling et al., 2001; Miura et al., 2001; Wolfram Kuhlmann et al., 2004; Ozkor et al., 2011). 
These channels include; ATP-sensitive potassium channels (KATP) (Rivers et al., 2001; 
Horiuchi et al., 2002; Crane et al., 2004), inwardly rectifying potassium channels (KIR) of 
three types; small-conductance calcium-activated potassium channels (SKCa), 
intermediate-conductance calcium-activated potassium channels (IKCa) (Edwards et al., 
2000; Bychkov et al., 2002) and large-conductance calcium-activated potassium channels 
(BKCa) (Edwards et al., 1998; Frieden et al., 1999), and sodium-potassium ATPase (Na+/K+-
ATPase) pumps (Ashcroft, 1988; Noma, 1983; Seino, 1999). KATP channels consist of a pore-
forming KIR-6.x tetramer and a regulatory sulphonylurea receptor (SUR) tetramer (Cao et 
al., 2002), which confers sulphonylurea sensitivity (Standen et al., 1989; Cook and Hales, 
1984; Inagaki et al., 1996). KATP channels are found in different isoforms (Fujita and Kurachi, 
2000; Gopalakrishnan et al., 1999; Koh et al., 1998; Chutkow et al., 1996; Suzuki et al., 2001) 
and combinations yielding tissue-specific K+ channels with subtly different properties 
(Inagaki et al., 1996; Inagaki et al., 1997; Isomoto et al., 1996; Yamada et al., 1997). For 
instance; in the rat mesenteric artery the combination of four KATP channel subunit genes 
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were identified, namely rat-specific vascular tissue (rv)-KIR6.1, rvKIR6.2, rvKIRSUR1 and 
rvSUR2B (Cao et al., 2002), displaying over 99.6% amino acid sequence identity with 
previously reported isoforms. Hence, hyperpolarisation of the smooth muscle layer is 
achieved by the combined effects of the closure of voltage-gated channels leading to a fall 
in [Ca2+]i concentration as well as the increase in K+ inside VSMCs and the subsequent 
vasodilation. 
 
1.2.2.2.2.2 The Hydrogen Sulphide Pathway 
H2S is a gasotransmitter synthesised by several different enzymes from cysteine by 3-
mercaptopyruvate sulphuresterase (3MST), cystathionine β-synthase (CBS) and/or 
cystathionine γ-lyase (CSE) (Osmond, 2012) in ECs (Wang, 2009; Skovgaard et al., 2011; Pan 
et al., 2012). It has recently been thought to contribute to microvascular dilation though a 
calcium-dependent activation of eNOS within ECs (Kida et al., 2012) (Figure 7).  
 
 
Figure 7. Schematic representation of the H2S-related pathway. Adapted from Kida, M., 
Sugiyama, T., Yoshimoto, T. and Ogawa, Y. (2012) 'Hydrogen Sulfide Increases Nitric 
Oxide Production with Calcium-dependent Activation of Endothelial Nitric Oxide 
Synthase in Endothelial Cells.' Eur J Pharm Sci, Nov 10.  
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1.2.2.2.2.3 The Hydrogen Peroxide Pathway 
H2O2 is generated from the spontaneous dismutation from superoxide anion radical (O2•−) 
or dismutation of superoxide by superoxide dismutase (SOD) (Stuehr et al., 2001), of which 
three isoforms exist (Faraci and Didion, 2004), localised to different cellular compartments. 
The Cu,Zn-SOD (SOD1) isoform (Okado-Matsumoto and Fridovich, 2001) is the most 
abundant isoform found associated with the vascular wall (Didion et al., 2002). It was 
previously found to dismutate superoxide (O2•−) generated by eNOS and suggested to have 
a protective role in prolonging the half-life of NO (Mugge et al., 1991). A study by Fujiki, 
regarded eNOS as one of the major contributor for the synthesis of H2O2 (Fujiki et al., 
2005). Another isoform of SOD was identified as the extracellular-SOD (ecSOD, SOD3) and 
was found to dismutate extracellular superoxide to protect the diffusion of NO (Fukai et al., 
2002). However the latter was excluded as a source of EDHF (Morikawa et al., 2003). The 
protective role of SOD in ECs as a scavenger for superoxide radicals generated by eNOS and 
the production of H2O2 was suggested to restore and improve the myoendothelial 
communication as a result of a reduction in reactive oxygen species (ROS) generation 
(Griffith et al., 2005).  
 
In a study by Lui et al., the presence of H2O2 in human isolated coronary arterioles, derived 
from mitochondria, was associated in flow-mediated dilation (Liu et al., 2003). There are 
different signal transduction pathways that have been suggested to mediate the action of 
H2O2 leading to the hyperpolarising effect of the latter in certain blood vessels, such as 
human mesenteric arteries (Morikawa et al., 2004) (Table 1). In a study by Barlow et al., 
H2O2 action was suggested to be mediated through BKCa channels and the EET-related 
signalling cascade in coronary arteries (Barlow et al., 2000). Similarly H2O2 was found to 
dilate human coronary arterioles through the opening of BKCa channels via a mechanism 
involving protein dimerisation and activation of protein kinase G (PKG)-Iα in human 
coronary artery smooth muscle cells (Zhang et al., 2012). In the mesenteric artery, H2O2 
was suggested to act via the disulphide dimer activation of PKG1α to activate BKCa channels 
and lead to an enhancement of EDHF-mediated actions in mice (Ohashi et al., 2012). A 
recent study by Choi et al., suggested a role of H2O2 in increasing the expression of KCa+ 
channels through the upregulation of phosphorylated ERK expression and the 
30 
 
 
downregulation of repressor element-1-silencing transcription factor (REST) expression 
using a primary cultured human umbilical vein ECs (HUVECs) as a model (Choi et al., 2013).  
 
A model for the generation of H2O2 was suggested via the increase in the intracellular 
concentration of Ca2+ along with caveolin-1 (Ohashi et al., 2012) acting through an 
alternative fashion to generate H2O2 by the activation of the reductase domain of eNOS. 
This pathway involves the dual action of both Ca2+/CaM-dependent protein kinase (CaMK) 
kinase β (CaMKKβ), which phosphorylates the eNOS at the Ser-1179 residue and caveolin-
1, which antagonises CaMK binding via its interaction with the reductase domain and 
oxidase domain of eNOS (Ohashi et al., 2012). The binding of caveolin-1 to eNOS shifts the 
electrons from the oxidase domain to the reductase domain and assists in the generation 
of H2O2 via O2•− (Ohashi et al., 2012). The compromise in the electron transfer, as a result 
of the action of caveolin-1 on eNOS, inhibits NO synthesis (Ghosh et al., 1998) and favours 
the EDHF-related  pathway.  
 
In summary EDHFs cause hyperpolarisation through multiple pathways involving the 
epoxyeicosatrienoic acid, H2S and H2O2 pathways. EDHF action can be blocked 
experimentally, using potassium channel inhibitors. These inhibitor peptides including; 
charybdotoxin, apamin and TRAM-34 (1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole) 
can be used to study the pharmacological effects of various potassium channels involved 
in mediating the EDHF actions. Charybdotoxin was shown to be a selective blockers for BKCa 
(Archer et al., 1994; Franca-Silva et al., 2012), whereas apamin and TRAM-34  were shown 
to block SKCa (van der Staay et al., 1999) and IKCa (Wulff et al., 2000) respectively with high 
affinity. Because charybdotoxin is mainly involved in blocking channels mostly presented 
by the VSMCs (Miller et al., 1985), apamin and TRAM-34 are used specifically to block 
potassium channels associated with ECs. 
 
 
 
 
 
31 
 
 
1.2.3 Pathophysiological Considerations to Vascular Function 
Vascular injury can impair vascular integrity and/or cause a compromise, disruption, 
impairment, blockage and/or depletion of the EDHF release and/or action and/or NO 
bioavailability (Alonso and Radomski, 2003; Pacher et al., 2007), generation and/or their 
associated mechanisms (mediators and/or facilitators). This may lead to an imbalance in 
vasoconstrictor and vasodilator mediator release from ECs (termed endothelial 
dysfunction), upregulation of adhesion molecules and ultimately vascular disease 
(Marchesi et al., 2009; Sakellariou et al., 2011). The ability of the vascular endothelium to 
generate NO is critical in small vessels when the EDHF-mediated response is affected and 
vice versa. Thus NO may act as a backup system to EDHF in instances when the latter is 
compromised (Gaubert et al., 2007). In disease states, the EDHF-mediated responses 
become resistant to vascular diseases such as atherosclerosis, thus a potential vascular 
injury may eliminate the NO-back-up system offered by EDHF and thus lead to the 
progression and/or worsening of the condition (Urakami-Harasawa et al., 1997; Shimokawa 
and Matoba, 2004; Shimokawa, 2010). Diseased or injured blood vessels may produce 
increased levels of ROS, in particular O2•− (Griendling et al., 2000), a marker of oxidative 
stress, where superoxide is subject to dismutation by SOD into H2O2 (Griendling et al., 
2000). Reduced bioavailability of NO may be a result of decreased synthesis of NO and/or 
increased superoxide generation, which is suggested to react with NO, producing 
peroxinitrite (ONOO−) (Beckman et al., 1990; Sotnikova et al., 2011). This phenomenon can 
lead to a low [NO]/[ONOO-] ratio, which can act as an indicator of nitroxidative/oxidative 
stress  (Kalinowski et al., 2004; Villa et al., 1994; Heeba et al., 2007) and ultimately lead to 
the upregulation of genes (Tumur et al., 2010) involved in inflammation and coagulation of 
the vasculature (Pober and Sessa, 2007; Pahl, 1999). Hence, it is essential that the 
endothelial function is preserved for the maintenance of vessel diameter and hence 
optimal blood transport around major organs and tissues.  
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1.3 NPs and their Potential in Medical Interventions  
 
The requirement for an accurate delineation, sensitive visualisation, specific targeting and 
monitoring in medical diagnostic and prognostic procedures has promoted the application 
of nanotechnology as an alternative strategy to conventional histological, imaging and drug 
delivery systems (Patricio et al., 2011). Nanobiotechnology and the use of nanomaterials 
have displayed a platform for intervention in medicine in aiding new pathways to diagnostic 
and therapeutic options (Hrkach et al., 1997; Pires et al., 2012). According to the publicly 
available specifications standards driven by the British Standards Institution (BSI), 
nanotechnology is defined as “the application of scientific knowledge to manipulate and 
control matter in the nanoscale in order to make use of size- and structure-dependent 
properties and phenomena distinct from those associated with individual atoms or 
molecules or with bulk materials”. Nanobiotechnology, however, is an interdisciplinary 
science that bridges areas in physics, chemistry and biology to understand and apply 
concepts in nanomaterials and their properties. Both concepts are used in manufacturing 
small nanoscale materials (Jain, 2005). According to BSI, a nanomaterial is described as 
“material with any external dimension in the nanoscale or having internal structure or 
surface structure in the nanoscale”. According to BSI, NPs are defined as “nano-objects with 
all three external dimensions in the nanoscale (size range from approximately 1 nm to 100 
nm)”. NPs display the basis for this nanotechnology and behave as whole units in terms of 
their transport and properties (Prabhu et al., 2011). Due to their small size, NPs exhibit 
various properties including; large surface area, high surface reactivity and strong 
adsorbing ability (Xu et al., 2004). The different physical, chemical and biological properties 
of NPs depend on their chemical synthesis, composition (coating and polymerisation) and 
reactivity (Wiesenthal et al., 2011).  
 
The biomedical application of nanomaterials (Skrabalak et al., 2007) depend on their 
material composition (Yacobi et al., 2007), shape (Gong et al., 2010), size (Sun and Chow, 
2008), concentration (Davda and Labhasetwar, 2002), cellular permeability, 
biodegradability, bioactivity (Suh et al., 2009) and toxicity (Warheit et al., 2004; Mortensen 
et al., 2008). Nanomaterials of different types such as quantum dots (QDs), silica NPs 
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(SiNPs) and carbon nanotubes (CNTs) have displayed potential tools for use in medical 
applications; including; imaging diagnostics (bio-imaging or sensing) (Roy et al., 2012) and 
medical therapeutics (Cherukuri et al., 2004; Borm and Müller-Schulte, 2006).  
 
Despite the potential clinical uses of NPs, previous studies have suggested a toxic behaviour 
of selected NPs (Akhtar et al., 2010; Aillon et al., 2009). NPs are very small and in addition 
to their high penetrability into tissues, cells and organelles they display a large surface area 
of exposure for non-specific interactivity with different biological molecules (Klein, 2007; 
Cedervall et al., 2007). This includes the interaction and/or adsorption of biomolecules such 
as proteins and lipids onto NP surfaces in biological environments (Ehrenberg et al., 2009), 
leading to the formation of a ‘Corona’ (Monopoli et al., 2011). This phenomenon may lead 
to the re-organisation of the NP surface, altered surface chemistry and conformation 
leading to varied interaction (Monopoli et al., 2011). Thus, there is a concern regarding the 
application of nanomaterials in biomedicine due to the limited information on their 
biocompatibility such as stability, porosity, solubility (Kingsley et al., 2006), biodistribution 
and fate (interaction and clearance) in living systems. Thus, a better understanding and 
appreciation of the behaviour and monitoring of these nanomaterials in vitro as well as in 
vivo is necessary to meet such demands and appreciate the benefits and potentially 
associated  health risks (Ferrante et al., 2012) in the long-term. Among the different NPs 
present, SiNPs and CNT have displayed a greater potential for use in biomedical research 
due to their unique properties enabling their use for imaging diagnostics and targeted drug 
delivery. 
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1.3.1 SiNPs – Properties and Applications  
There is a growing interest in the fabrication of silica NPs (SiNPs) for applications in cell 
tracking, imaging diagnostics (Choi and Chen, 2003; Giri et al., 2005; Hsiao et al., 2008; 
Sokolov and Naik, 2008; Tsai et al., 2008; Barshan-Tashnizi et al., 2009; Motwani et al., 
2011), drug delivery (Christofidou-Solomidou et al., 2002; Slowing et al., 2009) and medical 
therapeutics (Zhou et al., 2011; Lu et al., 2007) due to their tuneable size and stability under 
flow conditions. Colloidal SiNPs can be synthesised using the Stöber sol-gel method 
described in 1968 (Stöber et al., 1968) and the water-in-oil (W/O) reverse microemulsion 
method as carried out by Chen et al. (Chen et al., 2013). Stöber sol-gel method 
uses tetraethyl orthosilicate (TEOS), aqueous ammonia solution (NH3·H2O) and water in 
absolute ethanol in order to generate the SiNPs, hence the silica matrix can be produced 
by the controlled hydrolysis of TEOS in water nanodroplets with the initiation of ammonia 
(Chen et al., 2013). SiNPs can also be fabricated to form ordered pore structures 
(mesoporous SiNPs; MSiNPs) with a greater surface area in contrast to non-porous 
(amorphous) SiNPs, hence the capability to accommodate various molecular species for 
potential system drug delivery (Vivero-Escoto et al., 2010). SiNPs have been shown to be 
highly reactive and can interact efficiently with biological material due to their large surface 
area to volume ratio (Mortensen et al., 2008). SiNPs can be incorporated into various 
nanomaterials and nanocomposites for use in biomedical research; including tissue 
engineering scaffolds (Wang et al., 2012; de Matos et al., 2013). SiNPs are thus of special 
interest as they can be tagged by thousands of luminescent molecules making them 
attractive tools in clinical applications. 
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1.3.1.1 The Synthesis of SiNPs 
Silicon dioxide represents the basic molecular structure of silica-based materials. It has a 
characteristic crystalline structure, where the atoms or molecules are arranged in an 
ordered array in a  liquid or solid phase (Figure 8 ). The sol-gel method is used to 
synthesise SiNPs with non-porous amorphous (non-ordered) or crystalline (regular lattice) 
structure. The term sol-gel refers to the fabrication of particles in the form of a gel or 
monodispersed solution and was first described by Stöber et al. in 1968 (Stöber et al., 
1968). It uses the principle of precipitation and encompasses the use of inorganic 
precursors such as metal halides, metal salts and alkoxides (M(OR)x), all mixed in solution 
to form the initial particles in a single synthetic step. The initial synthesis of SiNPs involves 
the hydrolysis of the inorganic precursor followed by condensation to synthesise the silicon 
oxide. The colloidal silica generated as a result of the sol-gel method facilitates the 
production of siloxane polymer from organosilica compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. A three-dimensional schematic representation of the crystalline structure of 
silicon dioxide in a quartz structure. Author originated. 
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The sol-gel synthetic route for SiNPs allows particle size control by altering the 
temperature, pH, dispersants and precursor concentrations (Giesche, 1994a). Hence, the 
reaction rate and growth rate of SiNPs can be manipulated by the use of for example acids 
or bases to affect the hydrolysis or condensation rate. Using low pH results in fast hydrolysis 
and in turn slow condensation favouring the formation of a gel. This phenomenon is 
reversed with high pH conditions leading into slow hydrolysis and fast condensation 
favouring a monodispersed solution (Oye et al., 2006). The change in the silica precursor 
and solvent concentrations can also affect the size and monodispersity of SiNPs. Stöber et 
al. were able to fabricate SiNPs at different size ranges (50 nm to 2 µm) using the latter 
phenomenon (Stöber et al., 1968). Furthermore, the change in temperature conditions was 
shown to affect the nucleation of SiNPs generated from hydrolysis of a silica precursor, 
known as tetraethyl orthosilicate (TEOS), in an alcohol solution and catalysed by ammonia  
(Figures 9 and 10) (Chang and Fogler, 1997). The hydrolysis reaction was followed by a 
condensation of the alkoxide silica (Si(OR)4) occurring by alcohol or water molecules to 
fabricate monodispersed silica spheres (Figure 10) (Chang and Fogler, 1997).  
 
 
Figure 9. The reaction scheme for the fabrication of silica nanoparticle; where (1) is the 
initial hydrolysis reaction step, (2) is the alcohol condensation reaction step and (3) is 
the water condensation reaction step. The overall reaction is given in step (4), where R 
denotes C2H5. Author originated. 
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Figure 10. Schematic illustration of the Stöber sol-gel reaction for the production of silica 
spheres. Author originated. 
 
A number of attempts have been carried out to produce smaller sizes of monodispersive 
SiNPs (below 100 nm) with smooth surface since Stöber et al. method was accomplished 
(Bogush et al., 1988; Giesche, 1994b). The demand for such NPs is of huge interest for 
biomedical applications. These attempts combined different factors that affect the reaction 
conditions such as changing the temperature as well as altering reagent concentrations 
(such as TEOS, NH3 and ethanol) to fabricate SiNPs at the desired sizes. Stöber et  al. used 
the phenomenon of reactant concentration (such as tetraethyl silicate concentration at 
0.28 mol dm-3)  and certain physical conditions (the occurrence of the reaction at room 
temperature) as the determinant factor in fabricating monodispersed SiNPs (Stöber et al., 
1968). Stöber et  al. represented the relationship between  particle  diameter  and  reactant  
(water  and  ammonia) concentration graphically (Stöber et al., 1968). However, using the 
Stöber at al. method to obtain larger particles (1-2 µm) tends to yield a poor size 
distribution, while very small particles (approx. 30 nm) tend to lack a smooth surface. 
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Bogush et al. had generated a model (growth-only) for synthesising silica in an effort to 
enhance the monodispersity of SiNPs (Bogush et al., 1988). The “growth-only” model relies 
initially on SiNPs nucleation where the starting materials fully react to form small core SiNPs 
known as “seeds”, followed by a diffusion-limited growth where TEOS is added in a molar 
ratio of 1:2 to water to coat the small SiNPs seeds (Bogush and Zukoski, 1991; Byers et al., 
1987). This latter model causes the gradual increase in particle size or seeding growth, 
preventing the aggregation between particles of the same size as experienced with the 
“aggregation-only” model (Bogush and Zukoski, 1991). The relationship between reactant 
concentration and particle size was expressed through an equation, which was derived 
through the fabrication of over 100 samples at 25℃ (Bogush et al., 1988). The particle 
diameter size generated depends on the total volume of TEOS added during the seeded 
growth (Bogush et al., 1988) and derived as follows; 
𝑑𝑑 = 𝐴𝐴[𝐻𝐻2𝑂𝑂]2𝑒𝑒𝑒𝑒𝑒𝑒 (−𝐵𝐵 [𝐻𝐻2𝑂𝑂]1/2) 
Where, d is the average particle diameter in (nm) and the reactant concentrations with the 
units of mol dm-3. The term A is specified in the above equation, was corrected by Razink 
et al. (Razink and Schlotter, 2007) as follows;. 
𝐴𝐴 = [TEOS]1/2 (82 + 151[NH3] + 1200[NH3]2  − 366[NH3]3) 
Furthermore, the B within the former equation was expressed as follows;  
𝐵𝐵 = 1.05 +   0.523[NH3] − 0.128[NH3]2 
Achieving smooth monodispersive SiNPs at a small size (10-100 nm) is difficult, as the 
particles tend to be granular in appearance due to the presence of ultra-fine particles 
surrounding the surface of SiNPs. 
 
 
 
 
 
 
 
 
 
39 
 
 
1.3.1.2 Stability of SiNPs 
Particles in the size range between 1-1000 nm are referred to as being colloidal, where they 
have a characteristic lyophobic or solvent hating behaviour when dispersed in a continuous 
medium (Baalousha et al., 2006). This minimises the interaction between the particles and 
continuous dispersed phase (Baalousha et al., 2006). The laws of free Gibbs energy and 
entropy change accompany random “Brownian” motion of NPs within a solution according 
to their kinetic energy and particle collision (Atkins, 2005). The stability of SiNPs is 
characterised by their ability to remain dispersed in suspension and have a reduced 
tendency to aggregate. Small size SiNPs disperse in a better fashion than larger ones, which 
have a tendency to settle quickly (Koohestanian et al., 2004) in a colloidal suspension 
according to gravity and viscous drag force laws. The increased ratio of electrostatic 
repulsive forces over the attractive forces (Van der Waals forces) that exist between the 
NPs (Pashley and Karaman, 2005) helps to prevent the particles from aggregating. There 
are different types of aggregation including; conservation, gelation, coagulation and 
flocculation (Figure 11). In addition, the pH and ionic strength of the solution containing the 
NPs can affect the stability of the latter NPs (Birdi, 2009). There is a demand for stable SiNPs 
in biological media in order to fulfil their role (Akbar et al., 2011). Particles can be linked 
into branches forming a three-dimensional network leading to increased viscosity followed 
by gelation, which is characterised by the formation of a solidified network that retains the 
liquid. Particles can also form bridges together that link them leading into flocculation, or 
become as closely packed clumps with each other leading into coagulation (Koohestanian 
et al., 2004; Akitoshi, 2005). The absorption of materials onto the particle surface leads to 
reduced hydrophilicity and more concentrated liquid phase, which is immiscible in the 
aqueous phase termed “Conservation”.   
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Figure 11. Stable colloidal nanoparticles undergoing the flocculation and coagulation 
process of aggregation. Author originated. 
 
The stabilisation of NPs can lead to more monodispersed NPs and can be achieved 
sterically, by creating a surface charge on the NP surfaces or the use of capping agents. 
Capping agents have the limitation of changing the properties of the intact NPs surfaces.   
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1.3.1.3 Surface Charge of SiNPs 
The overall surface charge of the SiNP is related to the carboxylic groups surrounding the 
surface. This charge determines NPs reactivity and interaction with other NPs and the 
surrounding tissue, cells and/or molecules. Hence, SiNP interaction with the surrounding 
tissue, cells and/or molecules is responsible for minimising aggregation (Ju-Nam and Lead, 
2008), dispersive stability, the viscosity, flocculation and film forming abilities of NPs.  
 
NPs are prone to coating with ions and/or molecules when left in an electrolyte solution 
leading to changes in their surface charge, stability and hence properties. The coating leads 
to the formation of what is termed “the electrochemical double layer (EDL)”, which is 
described as the interface between two phases, whether it is solid/liquid, liquid/liquid or 
liquid/gas, which possesses properties in the bulk phase. The EDL is regarded as a phase 
boundary having different distribution of electrical charges, therefore producing an 
electrical double layer, which has a potential that is different to both phases. The Stern 
model provided a graphical model for the charge distribution of particles in the EDL (Figure 
12). When NPs are placed in solution that contains electrolytes of anion or cation origin, a 
monolayer of the electrolyte is adsorbed onto the particle surface in a non-specific and/or 
specific manner forming an inner Helmholtz plane (IHP). This causes the NPs to become 
positively charged with a higher tendency to interact with other NP surface(s), whereas the 
counter-ions become dehydrated in the inner layer. The extent of the overall potential (ψ i) 
of the NP surface depends on the strength of interaction between NPs and ions with the 
possibility of formation of a second layer of hydrated rigidly bound counter-ions referred 
to as the outer Helmholtz plane (OHP). Together, both the IHP and OHP with a particular 
thickness (δ) form the Stern layer. The control of the kinetics of the crystal growth of SiNPs 
and NPs aggregation using the sol-gel precipitation method with some alterations, can lead 
to the generation of an organised array of small and monodispersed SiNPs with surface 
stability (Giesche, 1994b). The latter can be achieved by incorporating dye molecules 
(Marchisio et al., 2006) and coating NPs with inorganic groups to overcome the poly-
distribution (Iler, 1979; Andersson et al., 2004) and surface instability.  
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Figure 12. Scheme of the electrical double layer surrounding a nanoparticle in solution. 
The negatively charged particle is surrounded by firmly attached positively charged ions 
forming the Stern layer. Zeta potential gives an indication of the colloidal systems 
stability. This figure was adapted from Malvern. (2013) Zetasizer nano user manual. (Apr) 
Vol. 3: Malvern Instruments Ltd.  
 
The Debye Landau Verwey Overbeek (DLVO) theory is one theory that is used to describe 
the stability of lyophobic colloids, such as the SiNPs. Other, non-DVLO theories are also 
proposed. These will be described in the section below.    
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1.3.1.3.1 The DLVO Theory 
The DLVO was developed by Derjaguin and Landau in 1941 to describe the stability of 
colloidal solutions, which was dependent on Van der Waals attraction and electrostatic 
repulsion. The DVLO, which contributes to interface science, was further confirmed by 
Verwey and Overbeek to determine the interaction between charged surfaces in solution. 
The nano-scale provides a higher surface area per unit mass compared to bulk materials. 
When NP size is reduced, the high surface area generated possesses high surface energy, 
which can cause the NPs to react with each other resulting in aggregation (Ju-Nam and 
Lead, 2008). The DVLO theory is translated as the sum of attractive and repulsive forces 
because of double layer of counterions. This is where the attractive forces (VTotal) are 
the Van der Waals attraction (VA) and the repulsive forces are original electrostatic forces 
(VR) (Burns et al., 2006; Churaev, 1999). Particles with their charged surfaces in 
suspension are considered as electro-neutral entities due to their ability to form a 
surrounding diffuse layer of oppositely charged ions. When particles come into close 
contact, a diffuse layer overlap is created forming an osmotic pressure between the 
particle surfaces. Hence, particle separation in suspension is achieved through the 
presence of the electrostatic repulsive forces that results from such overlap. The degree 
of dispersion within the lyophobic colloidal solution depends on the maximum repulsive 
energy that can be created between particle surfaces (The total potential energy curves 
for a lyophobic colloid V (1) and for a colloid with a maximal repulsive energy VR (1) 
respectively; Figure 13).  
 
The addition of electrolytes into the colloidal solution (The total potential energy curve V 
(2); Figure 13) favours Van der Waals attraction between particle surfaces as opposed to the 
repulsive energy that exists (VR (2); Figure 13). There is a correlation between particle 
surface potential and the electrolyte concentration within a colloidal suspension. When the 
electrolyte concentration is increased, particle surface potential is decreased leading to the 
compression of the diffused layer and the reduction in the repulsive forces. The latter helps 
the particles to overcome the electrostatic energy barrier thus leading to aggregation 
(Figure 13). The minimal amount of reduction in repulsive force required to remove the 
energy barrier is referred to as the critical coagulation concentration of electrolytes. Higher 
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concentrations of electrolytes lead to the further reduction in the energy barrier and thus 
rapid aggregation of NPs (The total potential energy curve V (3); Figure 13) (Shaw, 1992). 
 
 
Figure 13. The total energy of interaction (V(1),  V(2) and V(3) ) between two particles, 
acquired from the sum of attraction curve (VA) and repulsion curves (VR(1), VR(2) and 
VR(3)). Author originated. 
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1.3.1.3.2 Non-DLVO Interactions 
The DLVO theory used to describe the stability of particles within numerous colloidal 
systems (Ninham, 1999; Norrish and Rausell-Colom, 1961; Donners et al., 1977; 
Israelachvili and Adams, 1978; Pashley et al., 1986) does not account for the additional 
interactions within silica solutions (Hartley et al., 1997; Pashley, 1981). These include NP 
surface interactions with the other surfaces, the solvents as well as ionic species. Due to 
the dielectric-continuum nature of the solvent, additional repulsion (VSolv) may be 
produced by the interaction between the highly structured hydration layer surrounding the 
particle surface-to-solvent and solvent-to-solvent. The existence of steric repulsion (VSter) 
between surfaces containing grafted polymers can also cause them to come close to each 
other. The DLVO theory differs from the non-DVLO theory in that it considers point 
charges, defined as the dimensions of the charge or charged ions to be infinitely interacting 
with particle surfaces at equal concentrations and different electrolyte types in an ion-
specific manner. The degree of point charges depends on the distance between an ion 
and a NP surface, solvent or another ion but does not provide accurate estimation of any 
interaction between the ions to NP surface, solvent or another ion. According to the DVLO 
theory large SiNPs in an alkali solution (pH 2) will have no charge and be in the least stable 
region in contrast to previous studies, which suggest NP steric stabilisation due to the 
hydrogen bonding between the water molecules and the hydroxyl groups attached to the 
particle surface forming an interactive monolayer (Koohestanian et al., 2004; Michael and 
Zhuravlev, 2005; Kobayashi et al., 2005). The stability and dispersion of NPs therefore 
depends on the surface properties, surface interactions and the surrounding environment.  
 1.3.1.3.3 Ion specificity 
Ion specific adsorption influences the stability of the dispersion of colloidal NPs. The 
dispersion of NPs is affected by the ions surrounding its surface. When ions are in close 
contact with the particle surface, they are able to indiscriminately interact with the surface 
with a great screening efficiency leading to NPs dispersion destabilising even when lower 
concentrations of electrolyte are present (Lyklema, 2003). According to the Stern model, the 
absorbability of ions to the SiNPs surfaces is dependent on ion charge and size. Thus, highly 
charged ions and small ions have greater absorbability; whereas large-sized ions and less 
46 
 
 
charged ions have lower absorbability (Grahame, 1951; Gierst and Herman, 1966).  
 
Ions can be categorised depending on how they interact with the solvent (Marcus, 1994; 
Marcus, 2009). The presence of structure-maker water forming ions such as Li+ and Na+ 
ions can cause the solvent to become structured on the particle surface. In contrast, the 
presence of structure-breaker ions can cause the solvent to become less structured on the 
particle surface compared to the bulk phase. Hence, the ions can promote or destroy water 
structures on the particle surface (Dumont et al., 1990; Gierst et al., 1966). The adsorption 
due to numerous oxides can be described as like seeks like. Oxides with a high isoelectric 
point (IEP), such as aluminium, are referred to as structure-maker surfaces and thus the 
structure-maker ions will adsorb on their surface, while structure-breaker surfaces such as 
Silica have low IEP (Dumont et al., 1990; Franks, 2002). Depending on the charge 
fluctuations and strength of the ion-to-ion correlation, ion-to-ion interactions within the 
double layer may lead to the build-up of an attractive electrostatic pressure between two 
NP surfaces (Kjellander, 1996; Lyklema, 2003). The latter interactions are thought to be 
stronger than the Van der Waals attractive forces (Kjellander, 1996; Labbez et al., 2009). 
The double layer is generated when two approaching surfaces containing high ion density 
interact causing repulsion to occur. However, depending on the ionic density of either 
surface when the ions are adsorbed close to one surface,  lower ion density is generated 
at the mid-plane and causing the attractive force to predominate. 
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1.3.1.4 Surface Stabilisation 
Surfactant agents such as polymers, biological or organic molecules that encapsulate or 
surround (dope, coat or cap) NPs can add surface stability and prevent NP aggregation and 
sedimentation while maintaining dispersed NPs. Kobayashi et al. confirmed that larger 
SiNPs follow the DLVO theory (Kobayashi et al., 2005). At high pH where there is a low ionic 
strength, the rate constant decreases and there is a slow tendency for the large SiNPs to 
aggregate, whereas at low pH where there is a high ionic strength, the aggregation 
becomes fast. In contrast, small SiNPs below 80 nm in size become well dispersed at a low 
and high pH values with less tendency to aggregate. Hence, Kobayashi et al. proposed the 
hairy model theory considering small SiNPs as stable NPs due to the presence of additional 
repulsive forces as postulating hairy layers with poly (silicilic acid) chains surrounding the 
particle surface (Kobayashi et al., 2005). 
 1.3.1.4.1 SiNPs as Fluorescent Nanoprobes – mechanisms for SiNPs probe loading  
Core SiNPs can be doped with fluorescent and luminescent dyes such as tris (2,2’-
bipyridyl)ruthenium (II) chloride hexahydrate (Rubpy) (Wu et al., 2008), fluorescein 
isothiocyanate (FITC) or rhodamine B isothiocyanate (RBITC) as fluorescent signal elements 
either by steric hindrance or by covalent bonding (Chen et al., 2013). This promotes their 
use as agents for bioimaging (Canton et al., 2011) and biosensing (Barshan-Tashnizi et al., 
2009) due to their fluorescent capabilities. The fluorescent signal detected from dye-doped 
SiNPs may vary in intensity depending on the type of dye used, its bonding to other 
conjugates and its corresponding stability; hence SiNPs can be used in the targeted 
recognition (labelling and tracking) of cellular organelles and biological markers in a 
targeted and/or untargeted manner (Shi et al., 2010). The dye-doped fluorescent SiNPs can 
be further stabilised using photostable linker compounds and used to recognise for 
example cancer cells in vitro (Chen et al., 2013). The study by Chen et al. doped SiNPs of 60 
± 5 nm in size with FITC or RBITC conjugated with dextran (RBITC-Dextran) (Chen et al., 
2013). These NPs were further conjugated (with a secondary antibody (goat anti-rabbit 
IgG)) or functionalised (with rabbit anti-epithelial cell adhesion molecule (EpCAM) antibody 
on the surface of the polyethylene glycol (PEG)-terminated modified FITC-doped or RBITC-
Dextran-doped SiNPs) by covalent binding to the PEG linkers using the cyanogen bromide 
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method (Chen et al., 2013). The functionalised rabbit anti- EpCAM NPs, used for the 
targeting of the human breast cancer SK-Br-3 cell surface tumour marker, as compared with 
fluorescent dye labelled IgG SiNPs, displayed better stability of fluorescence as well as 
photostability under continuous irradiation (Chen et al., 2013). Another study by Wu et al. 
suggested the use of Rubpy dye-encapsulated SiNPs for the sensitive detection of 
interleukin (IL)-6 (IL-6), on a microarray format, thus promoting the latter use as labels with 
high fluorescent intensity, photostability and biocompatibility for the clinical detection of 
IL-6 related diseases in vivo (Wu et al., 2008). The 50 nm Rubpy-doped SiNPs were 
fabricated using a simple one-step microemulsion synthesis and the non-ionic surfactant 
system entailing Igepal CA520 ((C8H17)-C6H4-O-(CH2-CH2-O)5H) and n-heptane (Wu et al., 
2008). The CA520 and heptane system was suggested to have a good solubility for both the 
surfactant and water, and has a large, stable single phase microemulsion region in the 
phase diagram (Wu et al., 2008). Hence, the encapsulation of dye molecules within a silica 
matrix or the doping of SiNPs with dyes may add stability to SiNPs, enhance their optical 
properties and thus display a platform for the specific targeting of cytokines or proteins to 
aid the clinical diagnosis of biomarkers. 
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1.3.1.5 SiNPs Applications in Medical Diagnostics  
Previous studies have suggested the use of nanomaterials for the visualisation and 
targeting of tumours and for drug-delivery (Sá et al., 2012). SiNPs of 20-200 nm size have 
been employed in the targeting of vessels in ischaemia for diagnostic and therapeutic 
purposes  (J. Kim et al., 2011). SiNPs-based ultrasmall inorganic hybrid nanoparticles, “C 
dots” (Cornell dots) were used for the first time in patients with metastatic melanoma as 
part of a clinical study assessing (the safety, pharmacokinetics, clearance properties and 
radiation dosimetry of) iodine-labelled and cRGDY peptide-modified positron emission 
tomography (PET) C dots (124I-cRGDY-PEG-C dots) after iv administration (Phillips et al., 
2014). These hybrid PET-optical imaging agents were suggested to be biocompatible and 
well-tolerated as they exhibited in vivo stability and were capable of being preferentially 
taken up and localised within disease sites and were excreted over a 2-week period (Phillips 
et al., 2014). Such studies may form a platform for the clinical translation or safe use of 
silica-based NPs as a delivery system for imaging probes possibly replacing the invasive 
surgical procedures in human cancer lesion detection, staging, diagnosis and management 
(Phillips et al., 2014).    
 
Dysregulation of MicroRNAs is associated with a number of diseases including cancer and 
may display a marker for a particular disease and/or its progression. A recent study by Li et 
al. had developed fluorescent dye-doped SiNPs (fabricated by the reverse microemulsion 
method) for target-cell-specific delivery and intracellular microRNA imaging (Li et al., 2015). 
Surfactant molecules were co-immobilised on the surface of SiNPs to aid the guided 
delivery of the latter agents specifically to human breast cancer cells in vitro by adhering to 
cell surface molecules with high affinity (Li et al., 2015). Thus, the highly sensitive 
luminescent non-viral vector transfection nano-agents may display a platform for nano-
based diagnostic research in a clinical setting. 
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1.3.1.6 SiNPs Applications in Medical Therapeutics 
SiNPs may have a potential in cancer treatment. A study by Badr et al. showed that SiNPs 
loaded with snake venom (Walterinnesia aegyptia venom;  WEV) were able to enhance and 
robustly sensitise the human breast cancer cells isolated from cancer biopsies to cellular 
growth arrest and death over WEV alone ex vivo (Badr et al., 2014). The route of cancer cell 
apoptosis was suggested via the increase in the levels of free radicals (including ROS, 
hydroperoxide and nitric oxide) and caspases activities (including caspase-3, caspase-8 and 
caspase-9) (Badr et al., 2014). The phenomenon of drug-loading and slow drug-release via 
the aid of SiNPs loaded with chemical therapeutics may have a pivotal role in effects 
observed on enhanced toxin and/or drug action in vivo. This can be explained in part by the 
ability of NPs to be endocytosed and/or phagocytosed by cells, resulting in the 
internalisation of the encapsulated drug (Barratt, 2003). 
 
Due to the therapeutic effects of small interfering RNA (siRNAs) and the obstacles 
accompanying their specific targeting, studies have developed methods using SiNPs as 
candidates for siRNA delivery in vivo. A study by Chen et al. used magnetic mesoporous 
SiNPs for lung cancer treatment (Chen et al., 2014). The siRNA designed by the Chen et al. 
group was loaded into the mesopores of SiNPs, followed by polyethylenimine (PEI) capping, 
PEGylation and fusogenic peptide KALA modification. The resultant SiNPs exhibited a 
prolonged half-life in the bloodstream, enhanced cell membrane translocation, were 
capable of escaping endosomes and possessed favourable tissue biocompatibility and 
biosafety (Chen et al., 2014). Together, the latter properties of SiNPs enabled the in vivo 
imaging of target tissues and the specific suppression of tumour growth and metastasis in 
subdermal and orthotopic lung cancer models when loaded with vascular endothelial 
growth factor (VEGF) siRNA (Chen et al., 2014).  It has also been shown that polycationic 
SiNPs decorated with PEI were capable of delivering siRNA for the purposes of gene 
silencing and hence disease prevention (Kapilov-Buchman et al., 2015). PEI is a positively 
charged branched polymer of 25 kDa in size of biocompatible nature (Kapilov-Buchman et 
al., 2015). PEI was attached to the SiNPs via a non-covalent inorganic linker cerium (III) 
cations (Ce3+) between both polyNH2-SiO2 NP surface and the polycationic PEI polymer 
(Kapilov-Buchman et al., 2015). Thus, the use of PEI-modified SiNPs for siRNA delivery may 
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have a therapeutic potential overcoming the obstacles of inefficient delivery and/or the 
off-target effect of sole siRNA. 
 
Various studies have shown that SiNPs can be utilised in aiding guided stem cell delivery 
and/or implantation to injured sites that require stem cell therapy thereby overcoming cells 
death and the consequences of ischemia, inflammation, immune response, mis-injection 
and/or implantation into fibrotic tissue (Jokerst et al., 2013). In the study by Jokerst et al. 
multimodal, fluorescent silica-based NPs (300 nm) were used for cell sorting, real-time 
ultrasound-guided cell delivery and implantation at high-resolution and long-term 
monitoring by magnetic resonance imaging (MRI) (Jokerst et al., 2013). The study 
demonstrated that SiNPs increased the ultrasound and MRI contrast of labelled human 
mesenchymal stem cells (hMSCs) 700 and 200% versus unlabelled cells respectively, and 
allowed cell imaging to be performed in animal models for 13 days after implantation 
(Jokerst et al., 2013). The SiNPs used were biocompatible with no effects observed on hMSC 
cell metabolic activity, proliferation, or pluripotency (Jokerst et al., 2013). This may be in 
part due to the in vivo aggregation of SiNPs into larger silica frameworks that amplify the 
ultrasound backscatter. This guided cell-delivery and multimodal optical/ultrasound/MRI 
intracardiac cell-tracking may act as a platform for improved cell therapy in the clinic by 
minimising misdelivery or implantation into fibrotic tissues (Jokerst et al., 2013). SiNPs, 
whether used as a delivery system and or guiding routes for therapeutic strategies, may 
therefore display a platform for future therapy for a wide-range of diseases. However, the 
drawbacks to such potential of SiNPs may due to the unknown fate and/or the 
indiscriminate interference of SiNPs with other tissues or biological processing leading to 
injury and disease.  
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1.4 Methods used for NP Characterisation 
NPs can be characterised by their morphology, size and surface charge. In the following 
section, the techniques used to determine the morphology, size and surface charge of NPs 
are presented. NPs sizes have been determined by electron microscopy. The hydrodynamic 
size and stability of NPs however can be examined in suspension based on their Brownian 
motion. The application of NPs and the understanding of their biological reactivity requires 
accurate determination of their characteristics. 
 
 
1.4.1 Scanning Electron Microscopy 
The Scanning Electron Microscopy (SEM) is an analytical instrument that can be used to 
characterise the physical properties of nanomaterials, such as morphology, shape and size 
as well as the distribution of nanomaterials within cells and tissues (Kim et al., 2015). The 
objective lens design in scanning electron microscopes can combine the electrostatic and 
magnetic fields to maximise optical performance while reducing field influences at the 
sample. The Gemini-SEM relies on in-lens detection for efficient signal detection by 
detecting secondary (SE) and backscattered (BSE) electrons in parallel (Figure 14). The 
detectors are arranged on the optical axis, which reduce the need for realigning the imaging 
time. This high power resolution technology allows the imaging of nano-sized materials at 
high signal-to-noise ratios, with the introduction of high voltages from the beam 
throughout the column for efficient sample detection (Figure 15).  The resolution of the 
images obtained depend on optimising the geometry and electrostatic and magnetic field 
distributions by the lenses utilised. 
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Figure 14. Schematic cross section of Gemini optical column. Adapted 
from http://www.zeiss.co.uk/microscopy/en_gb/products/scanning-electron-
microscopes/geminisem.html#gemini--optics, access date: 2015. 
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Figure 15. An image of a scanning electron microscope (GeminiSEM 500 by Carl Zeiss) 
based at Manchester Metropolitan University; operated previously by Dr. Vladimir 
Vishnyakov. 
 
 
1.4.2 Transmission Electron Microscopy 
NP characterisation in terms of morphology and diameter size can be examined using the 
transmission electron microscope (Figure 16). Transmission electron microscopy (TEM) can 
also be used to visualise NPs uptake by cells and tissues from in vitro, ex vivo and in vivo 
studies. The specimen is secured in standard sized grid within an airlock chamber, which 
holds the specimen in a channel leading into the vacuum in order to prevent the build-up 
of pressure in other areas of the microscope. The electron emission source, located on the 
top column of the TEM, contains the tungsten filament, which generates a stream of 
electrons (electron beam) (Tanaka, 2014). The electron beam is transmitted through the 
vacuum pipe into the specimen and subsequently detected by TEM, producing an image 
for the specimen. The electron beam is controlled by electromagnetic lenses (Pennycook 
and Nellist, 2002).  
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Figure 16. A schematic representation for the components of a TEM (top); containing an 
electron source, electromagnetic lens, sample holder, airlock chamber and imaging 
system.  
Image adapted from http://www.hk-phy.org/atomic_world/tem/tem02_e.html, access 
date: 2015). Image of the transmission electron microscope (Technai 12 Biotwin by 
Philips) based at the University of Manchester; operated by Dr. Aleksandr Mironov 
(bottom).  
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1.4.3 Dynamic light scattering 
Dynamic light scattering (DLS) is a non-invasive technique capable of characterising 
particles in suspension using the Malvern Zetasizer Nano ZS (Figure 17). The term light 
scattering refers to the passage of a monochromatic light from a beam source through the 
samples, such that the intensity of light scattered by the particles is detected. The intensity 
of the scattered light is time dependent and relies on the Brownian motion of the particles. 
This latter phenomenon is used to determine the translational diffusion coefficient D which 
is converted into the hydrodynamic diameter (RH) using the Stokes-Einstein equation 
(Kaszuba and Connah, 2006), as follows;  
RH =  
𝐾𝐾𝐾𝐾
6πηD
 
Where η represents the viscosity of the solvent, k is the Boltzmann constant and T the 
temperature of the medium (Medebach et al., 2007). Since only the hydrodynamic 
diameter of a particle is determined by DLS, SEM and TEM are used to measure the size of 
the particle without the solvation shell, thus providing a more accurate measurement of 
NP surface diameter.  
 
 
 
 
 
Figure 17. An image of Malvern Zetasizer Nano ZS used for DLS and Zeta potential 
measurements (left) with the data acquisition system (PC) (right). 
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1.4.4 Zeta Potential  
NP interactivity with biological systems and cells may depend on NP surface charge as well 
as other factors such as size and dosage. Negatively charged NPs can be repelled by 
negatively charged species (such as some proteins and cellular surfaces) whereas positively 
charged ones can be attracted to cellular surfaces and some proteins (E. C. Cho et al., 2009; 
Villanueva et al., 2009). The surface charge of NPs is determined by their Zeta potential, 
which is defined as electric potential of the solid-liquid interface (the slipping plane 
(Delgado et al., 2005)) between the particle surface and the surrounding fluid (Kirby and 
Hasselbrink, 2004). Ions that surround the particle form an electrical double layer (Figure 
12). The inner part of this double layer is called the Stern layer where ions are firmly 
attached to the particles, whereas the outer part belongs to the diffuse layer where ions 
are loosely attached (Figure 42). Within the latter outer region an additional boundary, the 
slipping plane, is defined. The movement of ions between the Stern layer and the slipping 
plane coincide with particle’s movement whereas ions on the other side of the slipping 
plane do not follow a particle’s movement (Malvern, 2013). Hence the electric potential at 
the Stern layer is called “Stern Potential”, whereas that of the slipping plane is called the 
Zeta potential (Kaszuba and Connah, 2006) (Figure 12). NPs in suspension or electrolyte 
solution move towards the oppositely charged electrode within an electric field E. The 
linear relation between the steady state-electronic velocity of the particles ve and the 
applied uniform and weak electric field are used to calculate the electrophoretic mobility 
Ue of the particles, as illustrated in the equation below (Delgado et al., 2005). 
𝑉𝑉𝑒𝑒 = 𝑈𝑈𝑒𝑒𝑈𝑈 
The Zeta potential z can then be calculated applying the Henry equation (Malvern, 2013), 
as follows; 
𝑈𝑈𝑒𝑒 = 2 𝜺𝜺 𝑧𝑧 𝑓𝑓(𝑘𝑘𝑘𝑘)3𝜂𝜂  
The Henry’s function f(ka) is equal to 1.5 for Zeta potential measurements performed in 
aqueous solutions with moderate electrolyte concentrations. The electrophoretic mobility 
is dependent on the dielectric constant ε and the viscosity η  of the medium as well as on 
the Zeta potential (Malvern, 2013). The latter is dependent on the charge present on NP 
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surface, the pH of the system, the electrolyte concentration of the solution, the type of 
electrolyte and the type of solvent (Delgado et al., 2005). 
 
Hence, the magnitude of forces between particles measured by Zeta potential can be 
calculated from the electrophoretic mobility of the samples solution (Figure 18). The 
samples are placed into a micro-electrophoresis cell attachment that contains electrodes 
on both sides. When a potential is applied, it causes the particles to undergo 
electrophoresis, which is to move to the electrode with the opposing charge. The laser 
Doppler velocimetry (LDV) method is used to measure the velocity, in order to quantify the 
unit field strength mobility. The relevant amount of repulsive forces that exist between NPs 
renders them dispersed in suspension whereas attractive forces lead  to NP aggregation 
(Shaw, 1992).   
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Figure 18. Micro-electrophoresis cell attachment used to measure the samples velocity 
by a laser Doppler velocimetry within the Malvern Zetasizer Nano series machine.  
 
1.4.5 Fluorescence Spectroscopy 
Fluorescence spectroscopy enables the visualisation of NPs. This can be conducted using 
the Hitachi fluorescence (or similar) spectrophotometer F-2500 (Figure 19). When a 
fluorescent sample is excited at a particular wavelength, it may lead to the loss of energy 
by heat or fluorescence emittance.  The emission wavelength is longer than excitation 
because vibrational energy is lost as heat. The basic components of fluorescence 
spectrophotometer consists of a light source that produces high-energy radiation. This 
radiation passes through a monochromator and then a beam divider, where the excitation 
wavelength is selected.  The beam then passes through the sample contained within the 
cuvette. The excited molecules within the sample cause the fluorescence radiation to 
transpire in all directions. This radiation will pass through a second monochromator 
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positioned at a right angle to the cuvette, in order for the emitted fluorescence to enter 
the detector and measured as a fluorescent signal (Kealey and Haines, 2002; Glencross et 
al., 2011).  
 
 
Figure 19. An image of the Hitachi fluorescence spectrophotometer F-2500. 
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1.5 The Influence of SiNPs on Biological Systems 
 
Despite their numerous applications and high demand, SiNPs role(s), their effects and their 
biocompatibility in living systems have been poorly studied. Various attempts have been 
carried out to investigate the role and effects of SiNPs on whole animals and cell models in 
order to investigate their role in biological systems, and assess their biosafety to justify 
their administration in vivo for diagnostic purposes and therapeutic interventions. In vivo 
studies have shown the ability of SiNPs to enter the blood stream, leading to their systemic 
uptake where they can be detected within organs that are distal to the exposure site (M. 
Cho et al., 2009; So et al., 2008). It was suggested that the biodistribution of SiNPs was 
dependent on their surface functionalisation (Yu, Hubbard, et al., 2012). SiNPs may exhibit 
cytotoxic behaviour depending on their shape, aspect ratio, the surface area per unit mass 
and interactions with target molecules (Akhtar et al., 2010).  
 
 
1.5.1 The Influence of SiNPs on Cells in vitro 
A study carried out by Thomassen et al. (2010) using SiNPs of 2-335 nm in size, showed that 
their toxicity on a human endothelial cell line was related to the degree of NP contact with 
the cell surface (Thomassen et al., 2010). SiNPs incubation with human lung epithelial cells 
(Akhtar et al., 2010) and myocardial cells (Ye at al., 2010), resulted in their uptake. SiNPs 
uptake was accompanied by the generation of ROS (Park and Park, 2009) and the 
subsequent oxidative stress damage to the different cells. A previous study by Kasper et 
al., suggested the harmful effects of small sized SiNPs (30 and 70 nm) on reducing lung 
epithelial cell viability, triggering NP-induced inflammatory responses (Kasper et al., 2013) 
and illustrated the dependence of SiNP size on mediating the cellular effects. Incubating 
cultured human lung epithelial cells with a concentration up to 0.5 mg/mL of luminescent 
SiNPs (equivalent to 5 x 1011 NP/mL) (50 ± 3 nm in diameter) caused a drastic reduction in 
cell survival in contrast to a concentration of 0.1 mg/mL, which did not show a significant 
reduction in cell survival rates (Jin et al., 2007).  
 
In a recent study; 50 nm but not 500 nm amorphous SiNPs were shown to induce human 
umbilical vein endothelial cells’ (HUVECs) cytotoxicity in a size-dependent fashion following 
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24 hours of incubation (Nemmar et al., 2014). The latter model indicates the importance of 
higher-surface-area-to-volume ratio in favouring biochemical interactions. The influence of 
SiNPs was also tested under flow conditions in vitro (Freese et al., 2014). A particular study 
by Freese et al. indicated that HUVECs under physiological cyclic stretch culture conditions 
did not enhance the uptake and/or the cytotoxicity of amorphous SiNPs when compared 
to those internalised by the static culture conditions (Freese et al., 2014).  
 
 
1.5.1.1 Modes of NP Cellular-Uptake and Behaviour Path in vitro 
The route of uptake of NPs into cells may be dependent on several factors including; 
nanomaterial composition and cell type, NP surface functionalisation, cellular metabolism 
(Rejman et al., 2004) and cell surface markers (glycoproteins, cell surface integrins, 
receptors, ion channels and adapter proteins). The uptake pathway that may mediate NP-
cellular entry is critical to determining the NP fate and intracellular distribution including 
the attachment of different sets of proteins or enzymes and the formation of a “protein 
corona”. NPs can be exposed to proteins and/or changing pH values which might lead to 
changes in the protein corona (Nel et al., 2009), ion release or particle decomposition 
(Stark, 2011) all of which may contribute to altering the fate of NPs. A number of 
mechanisms of NP uptake exist, these include; endocytosis, pinocytosis and cytoskeleton 
rearrangement. Examples of endocytosis mediated uptake are described below.  
 1.5.1.1.1 Clathrin-mediated Endocytosis  
Previous studies have indicated the internalisation of 500 nm sized SiNPs via clathrin-
dependent endocytosis and macropinocytosis in dermal fibroblasts (Zhang et al., 2010), 
200 nm fluorescent microspheres via clathrin-dependent endocytosis by B16-F10 cells 
(Rejman et al., 2004), and 150 nm and 200 nm sized monodisperse hydrogel particles via 
the clathrin-mediated pathway in HeLa cells (Gratton et al., 2008). Changing the cell type 
can also influence the pathway of NPs uptake. For instance, when B16-F10 cells were used 
the internalisation of the 500 nm sized of SiNPs fluorescent microspheres was mediated via 
a clathrin-independent pathway (Rejman et al., 2004). 
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1.5.1.1.2 Cytoskeleton Rearrangement-mediated Endocytosis  
NPs uptake may also be dependent on the actin and tubulin networks, where actin 
filaments or microtubules may play a role in facilitating the uptake of NPs. Actin filaments 
act to provide a framework supporting the PM and hence determine the shape of the cell 
(Lodish, 2000). They may have an influence on phagocytosis, macropinocytosis and 
clathrin- dependent and independent processes. The microtubule network serves as track 
for the motor protein mediated transport of membrane vesicles as it spans the cell from 
the nucleus to the cell membrane (Lodish, 2000) and is thus responsible for the active 
transport of endosomes. When disrupted by cytochalasin D (at 5 μg/mL (Dausend et al., 
2008)) or nocodazole (at 10 μg/mL (Rejman et al., 2004; Dausend et al., 2008)) actin 
filaments but not microtubules showed the internalisation of silicon NPs (1600 nm and 
3200 nm) in HeLa cells and the process is thought to be actin-dependent (Dausend et al., 
2008). In contract, microtubule disruption did not affect the uptake of negatively charged 
polystyrene particles (113 nm) (Dausend et al., 2008) but reduced the uptake of 50 and 100 
nm SiNPs by more than 50% whereas 200 nm particles uptake was only reduced by 25% 
(Rejman et al., 2004). This indicates that actin cytoskeleton is actively involved in clathrin-
dependent uptake of NPs (Merrifield et al., 2002) whereas microtubules contribute to the 
further distribution of cargo inside the cell.  
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1.5.2 The Influence of SiNPs on the Vasculature ex vivo and in vivo 
The lining EC layer displays the first initial contact surface for NPs when intravenously 
injected for diagnostic and/or therapeutic purposes. In light of the limited awareness 
regarding nanomaterial fate in biological systems, the blood vessels may be a victim to such 
innovative technology. Hence, an appreciation of the role and fate of NPs in blood vessels 
is essential to draw conclusions and set up decisions on the applicability and possible 
incorporation of such technology in the clinic. The fate of NPs may be determined by their 
deposition, biodistribution, bioaccumulation and/or incomplete breakdown in the 
vasculature, as well as to being prone to immunological attack and/or clearance due to 
prolonged exposure. These foreign materials may thus lead to chronic macrophage 
activation and in turn to chronic inflammation (Donaldson and Tran, 2004). For instance; a 
study conducted by Corbalan et al. suggested the capability of amorphous SiNPs of causing 
endothelial dysfunction in human umbilical vein ECs (Corbalan et al., 2011) thus promoting 
disruption of vascular homeostasis (Corbalan et al., 2012). These effects were mediated via 
a NO/peroxynitrite imbalance associated with an increased peroxynitrite (ONOO-) 
production leading to a low [NO]/[ONOO-] ratio (Corbalan et al., 2012) and platelet 
aggregation within the blood stream via adenosine diphosphate and matrix 
metalloproteinase 2-dependent mechanisms (Corbalan et al., 2012) respectively. Du et al. 
suggested that intratracheal-instilled SiNPs could pass through the alveolar-capillary 
barrier into systemic circulation with their concentration in the heart and serum being 
dependant on the particles size and dosage (Du et al., 2013). It may be speculated that the 
effects of NPs on blood vessels may vary in large and small blood vessels, based on the 
elaboration of endothelial derived mediators and hence NPs may have different 
consequences on each type of vascular bed as well as segments within the vascular tree. 
Studies investigating the long-term biodistribution of SiNPs in vivo, suggested their 
clearance from the brain, muscle, liver, spleen and adipose tissue and the distribution and 
accumulation within the reticuloendothelial system including the lungs and kidneys for at 
least 8 weeks (Malfatti et al., 2012). 
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1.5.2.1 Routes of Vascular Exposure to NPs 
There are different routes of exposure of blood vessels to NPs or NP delivery depending on 
the way in which NPs are administered, using experimental and real-time approaches. NPs 
can be inhaled, orally administered and intravenously (Arap et al., 2013; Wang et al., 2013) 
or intra-arterially injected. This exposes the vasculature via two modes of NP-vascular 
penetration and/or uptake; namely intravascular (also termed intraluminal) and 
extravascular. The vasculature can be intravascularly exposed to NPs via iv and intra-
arterial injection in vivo (Seliger et al., 2007) or infusion and perfusion ex vivo. The intra- 
coronary arterial infusion of NPs was demonstrated to reach the myocardium, liver and 
lung as well as vascular media and adventitia (Labhasetwar et al., 1998). Infusion catheters, 
which are inserted into the lumen of blood vessels, can be used to infuse NPs into the target 
tissues or organs. It is also possible to deliver drug-loaded NPs coating drug-eluting stents 
via inserting the latter into the lumen of large and medium size arteries for localised, 
implant-based drug delivery or through perfusion holes through the vessel walls, 
preventing restenosis. Utilising either approach, NPs can come in direct contact with the 
EC layer lining the vessel wall where they can be taken up either actively or passively. To 
promote the active uptake of NPs, they can be specifically tagged with specific ligands to 
target ECs and become actively internalised (Margolis et al., 2007).  
 
The vasculature can also be extravascularly exposed to NPs via inhalation or oral 
administration in vivo or superfusion ex vivo. The latter enables NPs to translocate and 
infiltrate through extracellular tissues and interstitial spaces and come in contact with the 
outer adventitial layer of blood vessels. The effects of NP uptake may be in part related to 
the way in which they are administered and NP dosage and biodistribution may undergo 
redundancy if for example administered via inhalation as opposed to direct injection into 
the blood stream. This phenomenon was confirmed by Oberdorster, who suggested the 
decrease in the amounts of NPs biodistributed following intravenously administration 
versus those inhaled through the respiratory track (Oberdorster, 2010). This may be due to 
slow translocation of inhaled NPs into the circulatory system as well as the small amounts 
compared to the dose that was originally administered (Oberdorster, 2010). NP 
translocation across alveolar epithelial cells and capillary endothelial cells into the blood 
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may have taken place through different forms of caveolae, involving capillary endothelial 
small and large fenestrae and intercellular gaps. It is critical to note however that in disease 
states NPs may move across widened tight junctions (TJs) (Oberdorster et al., 2005). 
Furthermore, the extravascular exposure to NPs through other routes (e.g. the 
gastrointestinal (GI) track and the dermis), may not prevent the latter from reaching and 
localising in the blood (Jani et al., 1990) and in nearby lymph nodes, where they can 
penetrate through vessel walls via the adventitial layer and reach into the EC layer 
(Manolova et al., 2007; Manolova et al., 2008). NPs absorbed through the mucosa via 
inhalation, GI tract ingestion or via skin absorption may originate from pollutants and 
components of chemical, cosmetic and food reagents (Jani et al., 1990; Nemmar et al., 
2004). Whether through their properties (ability to translocate) and/or high 
concentrations, NPs from intravenous, intradermal and intraperitoneal routes may deposit 
in the extracellular spaces and integrate into the surrounding blood and lymph vessels with 
blood being the ultimate target of exposure. In this way, NPs may bypass the vasculature, 
if specifically targeted or may deposit in blood vessels following exposure regardless of the 
initial exposure site.   
 
1.5.2.2 The Effects of SiNPs on Large Vessels 
Previous findings from our group suggest that the acute (30 minute) exposure of rat aortic 
vessels to SiNPs [100 and 200 nm nonmodified and positively charged NPs at 1.1 × 1011 
NP/mL] resulted in their uptake by the lining ECs with no detrimental effect on conduit 
arterial function (Akbar et al., 2011). The 100 nm and positively charged SiNPs had a greater 
degree of attenuation on the dilator responses of the aortic vessels in contrast to the 
unmodified 200 nm particles, suggesting the detrimental effect of surface charge rather 
than NP size on vascular function (Akbar et al., 2011). Another study by Farooq et al. 
demonstrated the attenuation of endothelial-dependent vasodilator responses by 30 and 
70 nm SiNPs and dye-encapsulated SiNPs (1.96 × 1012 NP/mL) in aortic vessels whereby the 
degree of attenuation was related to NP surface area rather than size (Farooq et al., 2013). 
A study conducted by Courtois et al. on isolated pulmonary arteries, has also shown that 
titanium dioxide (TiO2) NPs can lead to an attenuated vasodilator function in these vessels 
through ROS-dependent mechanisms (Courtois et al., 2008).  
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1.5.2.3 The Effects of NPs on Small Vessels 
Limited information is available regarding the effect of SiNPs on the vasculature, specifically 
on small sized vessels. However, animal inhalation studies have provided some insight. For 
example, Nurkiewicz et al. previously reported the impairment of murine systemic (skeletal 
muscle) microvascular (arteriolar) endothelium-dependent dilation following pulmonary 
(extravascular) exposure of rats to particulate matter encompassing TiO2 (0.1-2.5 μm in 
size) (Nurkiewicz et al., 2004). The attenuated dilation was related to a local inflammatory 
event evidenced by significantly higher polymorphonuclear leukocyte (PMNL) cell counts 
and venular leukocyte adhesion and rolling provoked by the NPs (Nurkiewicz et al., 2004). 
The Nurkiewicz’s group further characterised the effect of pulmonary particulate matter 
exposure on systemic microvascular function in rats intratracheally instilled with TiO2 (at 
0.1 or 0.25 mg for 24 hours per rat) (Nurkiewicz et al., 2006). They identified changes in 
some bronchoalveolar lavage markers of inflammation (e.g. focal alveolitis and increased 
PMNL rolling and adhesion in paired venules), impairment of endothelium-dependent 
arteriolar dilation and a local oxidative stress in the microvascular wall from the lungs of 
rats at sites of particle deposition exposed to 0.1 mg TiO2 (Nurkiewicz et al., 2006). The 
inhalation exposure of rats to smaller TiO2 NPs (20 nm in size) produced more detrimental 
microvascular dysfunction characterised by blunted arteriolar dilations and induced 
arteriolar constrictions with the presence of particle-containing macrophages seen in 
intimate contact with the alveolar wall (Nurkiewicz et al., 2008). The endothelium-
dependent vasodilation in subepicardial arterioles from the coronary microvascular bed in 
rats was also significantly impaired by the inhalation exposure to TiO2 NPs (21 nm in size) 
(LeBlanc et al., 2009) and multi-walled carbon nanotubes (MWCNTs) from aerosols 
(Stapleton et al., 2012). The observations with TiO2 NPs were suggested to be mediated via 
a reactive oxygen species (ROS)-dependent mechanism (LeBlanc et al., 2010), 
inflammatory-dependent mechanism (Nurkiewicz et al., 2011) and the reduction in NO 
bioavailability (Knuckles et al., 2012).  
 
A very recent study by Nemmar et al., demonstrated a significant reduction in the 
endothelium-dependent relaxation (at ACh concentration of 0.1 µM) of rat small MAs 
(third-branches) following the exposure to amorphous SiNPs (of 50 and 500 nm size 
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respectively, at 50 µg/mL) in vitro using the wire myography system (Nemmar et al., 2014). 
Another type of NPs such as cerium dioxide (CeO2) (4-6 nm size) that is used as a fuel 
catalyst was found to significantly impair endothelium-dependent and endothelium-
independent dilation of mesenteric and coronary arterioles in a dose-dependent manner 
following 24 hours of pulmonary exposure (Minarchick et al., 2013).  
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1.5.2.4 Preliminary Study Leading to this Project 1.5.2.4.1 QDs 
Our previous study demonstrated that the acute intravascular exposure to quantum dots 
(QDs) resulted in their uptake into the ECs of small MAs (Figure 20) (Shukur et al., 2013). 
Their uptake was accompanied by an attenuated endothelial-dependent (acetylcholine; 
ACh) and independent (sodium nitroprusside; SNP) vasodilation dependent on their surface 
coatings and concentration ex vivo and in vivo (Figure 21) (Shukur et al., 2013). The dilator 
response of the QDs-injected rat  to the endothelial-independent agonist (SNP) in vivo was 
lower than that after incubation in PSS and ex vivo (Shukur et al., 2013). These findings have 
implications in the use of QDs for imaging diagnostics and therapeutic intervention, 
particularly in disease states where SNP based drugs are utilised (Shukur et al., 2013). This 
study was the first study to be conducted on small vessels using QDs, which prompted the 
present study to investigate the influence of dye-encapsulated SiNPs on small arterial 
function and contractility.   
 
 
Figure 20. Representative TEM micrographs showing uptake of POSS-PCU coated QDs by 
ECs lining a mesenteric vessel (A: at 2,900 mag; B: inset at 23,000 mag). C: uptake of POSS-
PCU coated QDs by endosomal structures within an endothelial cell (arrows; 30,000 mag). 
Adapted from Shukur, A., Rizvi, S. B., Whitehead, D., Seifalian, A. and Azzawi, M. (2013) 
'Altered sensitivity to nitric oxide donors, induced by intravascular infusion of quantum 
dots, in murine mesenteric arteries.' Nanomedicine, 9(4), May, pp. 532-539. 
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Figure 21. The influence of QD incubation on vasodilator responses. ACh (A) and SNP (B) 
responses after incubation in PSS (control; squares; n = 4) are compared to responses 
after incubation in MUA coated QDs (diamonds; n = 5); and after incubation in POSS-PCU 
coated QDs (triangles; n = 5). ‘n’ is number of vessels. * p<0.05 and **p<0.01, error bars 
= SE. Adapted from Shukur, A., Rizvi, S. B., Whitehead, D., Seifalian, A. and Azzawi, M. 
(2013) 'Altered sensitivity to nitric oxide donors, induced by intravascular infusion of 
quantum dots, in murine mesenteric arteries.' Nanomedicine, 9(4), May, pp. 532-539. 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
 
1.5.2.4.2 Carbon Nanotubes 
Carbon nanotubes (CNTs) are one of the most popular nanomaterials. There has been 
increasing interest in the development and applications of carbon nanotubes due to their 
potential in industrial and medical applications (Tosun and McFetridge, 2010). Recent 
applications of CNTs include the development of scaffolds and drug delivery systems 
(Bottini et al., 2006). Despite rapidly emerging applications of CNTs, little is known about 
the biocompatibility of these nanomaterials and/or their influence on blood vessels. 
Previous studies reported an increase in the expression of inflammatory mediators such as 
IL-8 in response to CNTs in both human alveolar epithelial cells (Baktur et al., 2011) and 
human epidermal keratinocytes (Monteiro-Riviere et al., 2005) using two types of CNTs; 
the single-walled and the multi-walled CNTs, respectively. Overall, these studies suggest 
that oxidative stress is one possible mechanism of toxicity related to the CNTs uptake into 
cells (Shvedova et al., 2003). A study by Cui et al. reported the effects of single-walled CNTs 
on the inhibition of human HEK293 cell proliferation, induced cell apoptosis and decreased 
cellular adhesive ability (Cui et al., 2005). In vitro studies involving CNTs suggested no 
inﬂammatory response from macrophage cells (Allen et al., 2001; Allen et al., 1994; Linder 
et al., 2002) or cytotoxic eﬀects on ﬁbroblasts or osteoblast cells (Allen et al., 1994; Allen 
et al., 2001).  
 
1.5.2.4.2.1 CNTs uptake by MAs 
Single-walled CNTs originally purchased from Sigma (Poole, UK), were provided and 
functionalised by Seyed Yazdan Madani under the supervision of Prof. Alexander M 
Seifalian (UCL). Following the luminal infusion of the CNTs (of 20-40 nm in length and 2.7 
nm in width) into MAs, they were observed to be clustered in aggregated clumps inside the 
vascular lumen with no evidence of uptake (Figure 22).  
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Figure 22. TEM images (A-F) illustrating the predominant presence of CNTs outside the 
vascular endothelium of the MAs after 30 minute of incubation. The CNTs are 
represented by black cylinder structures inside ECs (arrows). 
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1.5.2.4.2.2 Influence of CNTs on Vascular Responses  
The influence of CNTs (at a calculated concentration of 1 mg/mL) on the vasoconstrictor 
and vasodilator responses of the mesenteric vessels were assessed ex vivo.  
 
1.5.2.4.2.2.1 Vasoconstriction  
Incubation in CNTs ex vivo, did not have an effect on the overall contractile responses of 
the vessels to Phe; (At 1 µM Phe, the mean percentage constriction was 68.09 ± 5.15% vs. 
47.44 ± 6.56% after incubation in PSS and CNTs respectively, n=4 and 3 respectively, 
unpaired t test, NS; Figure 23).  
 
 
Figure 23. The influence of CNTs on the Phe-induced contraction. ‘n’ is number of vessels, 
error bars=SE. 
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1.5.2.4.2.2.2 Vasodilation  
Incubation in CNTs ex vivo, had no overall effect on the magnitude of the endothelial-
dependent dilator responses to ACh in Phe pre-constricted vessels; (At 100 nM ACh, the 
mean percentage dilation was 78.77 ± 8.58% vs. 71.87 ± 14.89% after incubation in PSS and 
CNTs respectively, n=6 and 3 respectively, unpaired t test, NS; Figure 24).   
 
 
Figure 24. The influence of incubation in the CNTs on the ACh-induced relaxation in Phe 
pre-constricted vessels. ‘n’ is number of vessels, error bars=SE. 
 
The was a trend of decrease in the endothelial-independent dilator responses to SNP 
following the incubation in CNTs infused ex vivo at SNP concentrations of 10-8 to 10-4 M but 
this reduction was not significant; (At 100 nM SNP, the mean percentage dilation was 
102.30 ± 4.03% vs. 65.77 ± 11.26% after incubation in control and CNTs respectively, n=4 
and 3 respectively, unpaired t test, NS; Figure 25).   
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Figure 25. The influence of incubation in CNTs on the SNP-induced relaxation in Phe pre-
constricted vessels. ‘n’ is number of vessels, error bars=SE. 
 
No uptake of CNTs was observed by the ECs. This may explain the lack of any effects on 
vascular function. The influence of SNP responses may relate to direct interaction of CNTs 
with the SNP drug itself. Following their incubation intraluminally, CNTs were visualised 
mainly within the lumen of the vessel. CNTs did not affect Phe-induced contraction nor 
ACh-induced relaxation, but led to an overall trend of reduction to SNP-induced 
vasodilation. The slight compromise in SNP-related dilation may be due to the 
biomechanical influence of these nanotubes on the ECs and/or VSMCs function, as these 
were not visualised inside ECs surrounding the vascular lumen. The strong Van der Waals 
forces that attract carbon atoms together, may have caused CNTs to be aggregated and 
retained within the vascular lumen, hence surface functionalisation may not be sufficient 
for them to enter the vascular moiety and/or dissolve in the media. The biomechanical 
effect of the latter NPs may be translated by the interference with, and/or disruption of, 
the vascular relaxation in response to SNP. Our results contradict earlier studies indicating 
the detrimental effects of carbon black NPs on mesenteric artery function in response to 
0
20
40
60
80
100
120
-8 -7 -6 -5 -4
Re
la
xa
tio
n 
(%
)
SNP (Log M)
Control (n=4) CNTs ex vivo (n=3)
76 
 
 
agonists (Vesterdal et al., 2012). The study by Vesterdal et al. suggested a significant 
decrease in the vasoconstrictor response to Phe as well as the vasodilator responses to ACh 
and SNP when mesenteric arteries were incubated in 100 μg/mL of carbon black NPs (of 14 
nm size and surface area of 300 m2/g) (Vesterdal et al., 2012). The uptake of the CNTs by 
ECs and the vessel wall has not been identified in this preliminary study, but the TEM 
images show the aggregation of these nanotubes in the vascular lumen. The uptake of the 
pristine CNTs into the mouse J774.1A macrophage-like cell line was previously 
demonstrated by Cherukuri et al. where the macrophage-like cells appeared to 
phagocytose CNTs at a rate of approximately one CNT per second, without cytotoxicity 
(Cherukuri et al., 2004). Further experiments are needed following the exposure to CNTs 
to identify their underlining effects, using appropriate surface coating or functionalisation, 
to prevent their aggregation. The influence of CNTs on SNP responses may also be due to 
their interference with the action of SNP, in a similar way to the effect of QDs on SNP 
responses (Shukur et al., 2013).  
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1.5.2.4.3 Dye-doped Silica Nanoparticles 
An earlier research study conducted by Dr. Teba Mohamed from our nanovascular group 
at Manchester Metropolitan University demonstrated that intravascular exposure of dye 
doped silica nanoparticles led to their rapid uptake within ECs lining the MA blood vessel 
Figure 26). 
 
A 
  
B
 
Figure 26. TEM images (A & B) illustrating the internalisation of dye doped SiNPs (100 
nm) into the endothelial cell lining a mesenteric artery after a 30 minute incubation 
period. The SiNPs are represented by black spherical structures inside ECs (arrows). 
Images courtesy of Dr. T. Mohamed (MMU). The author gratefully acknowledge the 
support of Dr. Carolyn Jones (Maternal and Foetal Health, St. Mary’s Hospital, 
Manchester) for the tissue processing and electron microscopy.  
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1.6 Gap in Understanding NP-Small vessel Interaction(s) 
 
The approaches used to promote the safe application of NPs includes the enhancement of 
their biocompatibility (by optimisation of their dosage, chemical composition and/or 
surface chemistry) and their specific targeting to localised tissues within the body. To fulfil 
this goal, the behaviour, subsequent role (interaction and interference), impact, fate as well 
as the downstream mechanism(s) that accompany NP exposure and/or uptake need to be 
further established. SiNPs are of special clinical interest and will constitute the focus of this 
project. The influence of NPs at the physiological, cellular and molecular levels need to be 
addressed particularly in small arteries due to the limited information in this regard and 
their important role in regulating blood perfusion into organs and tissues. 
 
 
1.7 Aim and Objectives 
 
The aim of the current study was to investigate the direct influence of SiNPs on small 
arterial function and contractility. The ultimate goal of this research initiative was to 
highlight the potential benefits and/or risks associated with the vascular uptake of SiNPs 
and suggest alternative strategies to enable the future safe application of these agents in 
vivo. The scope of this study may, in part, display a platform for the translation of NP 
research into vascular biomedicine. 
 
The main objectives of the current study: 
 
1. To fabricate and characterise SiNPs using chemical techniques. 
 
2. To examine the uptake and biodistribution of SiNPs in rat small mesenteric arteries 
and organs, using TEM and ICP analysis. 
 
3. To investigate the influence of the intravascular infusion of NP on the physiological 
responses of small mesenteric arteries ex vivo as well as in vivo. 
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 4. To determine the mechanism of any altered vascular responses induced by NP 
uptake using inhibition studies.  
 
 
1.8 Hypothesis  
 
The hypothesis of this current study states that SiNPs will compromise vascular responses 
to pharmacological agonists. This is due to their uptake and interaction with the vascular 
cells influencing specific cellular pathways related to the contractile and dilator machinery. 
The null hypothesis states that there is no significant change induced by the SiNPs on 
vascular responses.  
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2.1 SiNP Synthesis  
 
Mono-dispersed dye-encapsulated fluorescent SiNPs (SiO2) of defined diameters were 
fabricated according to the Stöber sol-gel and Ismail (Stöber et al., 1968; Ismail et al., 2010) 
methods with some modifications (Table 2). The initial stages in the synthesis of SiNPs 
involved the incorporation of the rhodamine B isothiocyanate (RBITC) core within silica 
(Figure 27). Briefly 40 mg of RBITC dye was stirred with 600 µL of 3-
aminopropyltrimethoxysilane (APS, as linking agent) at room temperature (~20℃) in a 
bijoux with a magnetic stirrer (flea). The reaction vessel was filled with nitrogen gas and 
mechanically stirred for 3-4 hours in the absence of light (covered with foil) until turned 
from dark red into orange.  Ammonium hydroxide (NH4OH) (taken from a bijoux on a 
zeroed balance; such that it read minus the required amount due to evaporation control), 
absolute ethanol, dH2O and TEOS were magnetically stirred for 15 minutes. 50 µL of APS 
coupled with RBITC was added. SiNPs of varying diameter and morphology were obtained 
by reacting different molar ratio of the reagents (Table 2).  The reaction solutions were 
centrifuged at 6000 rpm for 20 minutes and the supernatant solution discarded. 
Sedimented NPs were re-dispersed in absolute ethanol by vortex mixing and 
ultrasonication. The solution was re-centrifuged at 6000 rpm for further 20 minutes and 
the supernatant discarded again; NPs were re-dispersed in distilled water and then 
characterised (Figure 28). SiNP suspensions were subjected to sonication before their use.  
 
 
Figure 27. An image of silica suspension; left) without RBITC dye and right) with RBITC 
dye.  
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Table 2. SiNP samples synthesised according to different methodologies and reactant 
concentrations. 
NP Sample (Batch) dH2O EtOH NH4OH TEOS Solution Stirring (hours) 
1A 0.7938 g 100 mL 0.7032 g 8.3533  g 3 at 20℃ 
1I 1.9092 g  70.6663 g 4.8637 g  2.11 g 
24 on at 62℃ on a hot 
plate 
1B 0.8301 g   1.7684 g 4.1584 g 3 at 20℃  
2A 0.883 g   1.7421 g 4.16 g 3 at 20℃  
2I 1.9055 g 69.8784 g  4.58 g 2.1117 g 24 at 60℃ 
3A 1.7165 g 100 mL 0.7497 g 4.1637 g 4 at 20℃ at 5.8 mot 
3B 1.7384 g 90 mL 3.6701 g  4.1684 g 3 at 20℃ at 4 mot 
D1 without dye 2.985 mL  100 mL 4.85 mL 3.78 mL 3 at 20℃  
D2 without dye 2.985 mL 100 mL 4.85 mL 3.78 mL 3 at 20℃  
D2   60 mL 4 mL 3 mL 3 at 20℃ at 4.2 mot 
D3   60 mL 4 mL 3 mL 3.5 at 20℃ at 5.8 mot 
DA2   60 mL 4 mL 3 mL 3.5 at 20℃ at 5.8 mot 
DA3   60 mL 4 mL 3 mL 3 at 20℃ at 5.8 mot 
DA4   60 mL 4 mL 3 mL 2.5 at 20℃ at 5.8 mot 
DA5   60 mL 4 mL 3 mL 2.5 at 20℃ at 5.8 mot 
DA6   60 mL 4 mL 3 mL 2.5 at 20℃ at 5.8 mot 
A2 without dye 2.99793 g 200 mL 4.8688 g 3.7768 g 3 at 20℃  
A2  3.3346 g 200 mL 4.85 g 3.7909 g  3 at 20℃ 
A3 2.9775 g 250 mL 4.89 g 3.776 g 3 at 20℃ at 5 mot 
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Figure 28. An image of A3 SiNP sample; left) in suspension and right) dry product.  
 
 
2.1.1 Determination of RBITC Dye Present in SiNPs using Fluorescence 
Spectroscopy  
The fluorescence measurement experiments were performed to confirm the presence of 
RBITC dye within the SiNPs suspensions used in this study. 4 mL of whole SiNPs suspensions 
(without dilution) were added into a specialised UV cuvette after sonication and placed 
inside the Hitachi fluorescence spectrophotometer F-2500 (Figure 19). Using the 
fluorescent emission (λem) mode, the λem from the silica samples was measured at an 
excitation wavelength (λex) of 540 or 554 nm.    
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2.2 SiNP Characterisation 
 
NP size was determined by dynamic light scattering (DLS) also known as photon correlation 
spectroscopy using a Malvern Zetasizer Nano ZS instrument. Following SiNP suspension 
sonication, the NP solution was diluted 1:100 in dH2O (10 µL of NP drop into 0.90 mL of 
dH2O) and placed into a polystyrene cuvette. The instrument illuminates the particles with 
a laser, which results in intensity fluctuations in detected scattered light.  The fluctuations 
are a consequence of Brownian motion of the particle, which is dependent on particle size, 
so analysis of the fluctuations allows calculation of particles size. The particles were 
dispersed in water or PSS for analysis and were allowed sonicated before size and Zeta 
potential analysis. NP size was also confirmed by scanning electron microscopy (SEM) at a 
working distance of 10 mm (just above 20 mm on the adjustment rotator) and transmission 
electron microscopy (TEM). A few drops of the NP solution within the Zeta machine 
cuvettes was dried onto a clean silicon surface in a 60℃ oven, imaged by SEM (Gemini-SEM 
500 from Carl Zeiss Supra 40VP FEG), and coated with gold at 20 mAms voltage. Average 
NP size was determined by measuring particle diameters with reference to the typography 
scales on micrographs. TEM was also used to assess the size and closely observe the surface 
of SiNPs. SiNPs were added at a diluted dosage of 1:500 (50 µL into 4.95 mL of water) onto 
formvar-coated TEM copper grids (3.05 mm, 400 mesh; Agar scientific) for visualisation 
under TEM. 
 
2.2.1 Determination of SiNPs Zeta Potential 
SiNPs were redispersed in distilled water for analysis, as described above. SiNP Zeta 
potential was determined using the Malvern Zetasizer nano ZS instrument. The NP solution 
containing 0.02% weight was injected into the Malvern disposable Zeta capillary cell. The 
electrophoretic mobility was obtained by performing laser Doppler velocimetry.  The Zeta 
potential was calculated using the electrophoretic mobility measurement. The Zeta 
potentials were measured in distilled water and in PSS. 
 
 
 
85 
 
 
2.3 Vascular Function Studies Ex Vivo 
 
2.3.1 Animal Preparation  
Male Wistar rats (150-250 g) were humanely euthanised in accordance with the ‘Animals 
(Scientific Procedures) Act 1986’ and Institutional guidelines, by stunning followed by 
cervical dislocation of the neck. The mesenteric bed of each rat was removed and placed 
on a clear glass dissecting dish containing a silicon base (pinned for dissection) in ice-cold 
physiological salt solution (PSS) [composition [mM]:  119 NaCl, 4.7 KCl, 1.2 MgSO4, 7 de-
ionised (dH2O), 25 NaHCO3, 1.17 KHPO4, 0.03 K2EDTA, 5.5 glucose, 1.6 CaCl22H2O; pH 7.4] 
(Figure 29). Water purified by Milli-Q purification system was utilised for all studies. 
 
Figure 29. An image displaying a section of the mesentery excised from a Wistar Rat. The 
mesenteric vessels are seen surrounded by the perivascular tissue.  
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2.3.2 The pressure Myography System (Preparation and Cannulation) 
Second- to third order arteries from the mesentery (145-300 μm initial diameter, 3-4 mm 
in length) were finely dissected (the fat tissue layer and connective tissue surrounding each 
vessel were also removed; Figure 30) and mounted between two glass cannulae (tied using 
fine thread), fixed in place on a modified pressure myography chamber (Living Systems 
Instrumentation, Burlington, VT, USA; Figure 31) (Shahid and Buys, 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. An image displaying the mesentery excised from a Wistar Rat [top] exposing 
the arteries after removal of the perivascular fat [bottom]. 
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The mounting of the mesenteric artery on a pressure myograph chamber is a very delicate 
procedure and requires extensive practice to avoid any damage to the endothelial cell 
layer. Two knots of thread were tied on both cannulae, which were used to tie the mounted 
vessel and keep it in place. Arteries were initially pressurised to an intravascular (luminal) 
pressure (IvP) of 60 mmHg and maintained at that pressure using a pressure servo-control 
unit (Living Systems, Burlington, USA); the system tubing and valve systems was initially 
checked for leaks to ensure a sealed pressurised circuit.  
 
 
Figure 31. An image of the pressure myography vessel chamber illustrating the position 
of the cannulae [top right] and a mounted artery [bottom right].  
 
 
 
 
 
 
 
 
Mounted artery on 
Pressure Myograph.
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All vessels were constantly superfused in a continuous source of PSS at 37℃, pH 7.4, and 
gassed with 95% air-5% CO2 (from a standard gas cylinder), with the superfusate entering 
and leaving the chamber via luer connections in the side of the chamber. This was done 
under a Nikon inverted microscope to allow for optimal resolution in visualising the tissues 
(Figure 32).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. An image of the pressure myography system, where the vessel chamber is 
placed on inverted microscope connected to a pressure servo system.  
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Lumen and internal diameters of the vessel were constantly measured using a video 
dimension analyser, with data recorded on the computer using Chartlab 5 software 
(Powerlab system, AD Instruments, UK) for later analysis (Figure 33). Where appropriate, 
arteries were superfused with Ca2+-free PSS containing 2 mM EGTA for 20 - 30 minutes to 
obtain passive diameters and allow the vessel to relax completely.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. An image of the diameter of the vessel being constantly monitored, in real 
time, and diameter changes are recorded using chart lab recorder.  
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2.3.3 Experimental Protocols 
The viability of the mesenteric arteries was assessed for their ability to constrict to a high 
potassium solution (KPSS; composition [mM]:  78.2 NaCl, 60 KCl, 1.2 MgSO4, 7 dH2O, 25 
NaHCO3, 1.17 KHPO4, 0.03 K2EDTA, 5.5 glucose, 1.6 CaCl22H2O; pH 7.4) and the 
constriction agonist phenylephrine (Phe). The influence of SiNPs on MAs was assessed by 
measuring the degree of changes in vascular contraction and relaxation in response to 
various vasoconstrictors and vasodilators before (in non-treated control vessels), and 30 
minutes subsequent to intraluminal infusion and incubation in PSS (control) or SiNPs (at a 
flow rate of 50 µL/min). The intraluminal infusion was conducted as follows: The pressure 
servo-control unit was turned off and a 1 mL syringe was inserted into one end of the 3-
way luer connection in the side of the pressure myograph chamber.  0.5 ml of diluted SiNP 
solution (in PSS) was slowly administered via the syringe. The 3-way luer valve was closed 
off and pressure increased to 60 mmHg, using the pressure servo unit. Vasoconstrictor 
responses (Phe, 10-9-10-4 M and AVP, 10-13-10-6 M) and endothelial-dependent 
(Acetylcholine (ACh), 10-13-10-3 M) and -independent (sodium nitroprusside (SNP), 10-13-10-
3 M and papaverine (PAPA), 100 µM) dilator responses were used to assess the repeatability 
of the contractile and dilator responses of MAs before (initial responses; control) and after 
the incubation in PSS (second responses). All chemicals (such as Phe, AVP, ACh, SNP and 
PAPA and reagents (such as NG-nitro-L-Arginine; L-NG-Nitroarginine (L-NNA), apamin and 
TRAM-34) were obtained from Sigma-Aldrich (Poole, UK). Chemical molar concentrations 
were calculated as shown in appendix 5. Responses after incubation in PSS were used as 
controls to compare with SiNPs responses. Thus, initial responses were compared to 
second responses to PSS and second responses to PSS were compared to second responses 
to SiNPs. After each vessel reached its sub-maximal constriction (using Phe concentration 
range of 1-10 µM) and stabilised, an ACh dose-response concentration in KPSS or Phe were 
used and maximum dilation measurement was taken when the vessel was allowed to 
stabilise. PSS washout period was essential to allow the MA to revert its diameter back to 
the starting level (in full dilatory mode) before the next contraction.   
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2.3.4 Inhibition Studies 
For the inhibition studies, in a separate set of experiments, vessels were mounted as before 
and responses to ACh were assessed before and 30 minutes after incubation in inhibitors 
including; L-NNA, apamin, TRAM-34 and indomethacin (Sigma-Aldrich, Poole, UK). 
Inhibitors were intraluminally infused into the MA as well as superfused continuously 
throughout the experiment. Dilator responses were assessed in the presence of inhibitors. 
Vessels were also co-incubated in L-NNA and SiNPs to assess the effects on function.  
 
 
2.4 Vascular Function Studies in Vivo 
 
In vivo experiments were carried out at UCL. Animal procedures were conducted in 
compliance with institutional guidelines and UK Home Office requirements (Project License 
70/6616). Animals were given food and water ad libitum and housed in a 12 hours/12hours 
light dark cycle. The rat was anaesthetised in an induction chamber using 2% isoflurane. 
Maintenance of anaesthesia was achieved by the use of 1.5-2.0% isoflurane via a concentric 
oronasal mask connected to an anaesthetic circuit. Core body temperature was maintained 
at 37.0 ± 0.5℃ using a heating pad linked to a rectal temperature probe. The in vivo study 
involved the quick intravenous injection of SiNPs into the tail vein of a 300 g unconscious 
male Wistar rat. The appropriate volume of SiNPs stock solution was concentrated by 
spinning in a centrifuge and resuspended in a total volume of 100 µL in PSS for the iv 
injection. SiNPs were given at the same dosage used in our ex vivo studies (5.32 x 
1011 NP/mL dosage), taking into consideration the blood volume, thus 5.32 x 1011 NP/mL of 
SiNPs per 1 mL of animal blood. Each Kg of animal weight corresponds to a circulatory blood 
volume of about 50 mL of blood; thus, a 300 g animal contained 15 mL of blood. After 
injection, the rat was monitored for a period of 2 hours and then terminated by cardiac 
catheterisation and scarified.   
 
At the end of the in vivo experiment, the rat mesentery, and associated vessels (aortic and 
pulmonary) were dissected-away and placed in ice-cold PSS. Other tissues such as the 
brain, lung, heart, stomach, liver, spleen, small intestine, large intestine, kidneys, bladder, 
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tail and thyroid were also excised. The tissues were fixed in 2% gluteraldehyde for a period 
of 30 minutes to be further analysed. Additional tissues were snap frozen in liquid nitrogen 
and kept at -80℃. A small length of mesenteric vessel was excised and placed on ice for 
further physiological analysis. A first- or second order artery from the mesentery (200-400 
μm initial diameter, 2-3 mm in length) from the SiNP-injected rat was dissected out using 
fine forceps and mounted between two glass cannulae fixed in place on a modified 
pressure myography chamber at 60 mmHg intra-vascular pressure (IvP) and constantly 
superfused with gassed PSS at 37℃, pH 7.4, as described above. The viability of the 
mesenteric artery was determined by its ability to constrict to a high potassium 
physiological salt solution (60 mM KCl). Constrictor responses to phenylephrine (Phe), 10-
9 -10-4 M) was initially assessed, followed by the endothelial-dependent (ACh, 10-10 -10-3 M) 
and independent (Sodium Nitroprusside- SNP 10-10 -10-3 M) dilator response in a Phe-
preconstricted vessel.  
 
 
2.5 Tissue Fixation and TEM  
 
At the end of the functional studies, vessels were carefully untied from the glass cannulae 
and immediately fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer 
(containing 4.8 g sodium cacodylate in 80 mL of dH2O and made to reach pH 7.4 with 0.1 
M HCL), pH 7.3 over 2 hours at 22℃. The samples were preserved in a wash buffer 
(containing 40 mL of 2.5% glutaraldehyde and 0.003 g calcium chloride (CaCl2)) in the fridge 
before processing by TEM. The samples were postfixed with reduced osmium (1% OsO4 + 
1.5% K4Fe(CN)6) counterstain for 1 hour, then dehydrated in a series of alcohols, infiltrated 
with TAAB LV resin and polymerised for 24 hour at 60℃, as described previously (Akbar et 
al., 2011) (Appendix 5). Ultrathin 70 nm sections were cut with Leica ‘Ultracut S’ 
ultramicrotome and placed on copper grids. The grids were observed in Tecnai 12 Biotwin 
TEM at 80 kV. Direct visualisation of nanomaterials in the MAs and various tissues was 
carried out using TEM, which was used to verify the presence of nanomaterials in the 
vascular wall, vascular cells or other tissues and demonstrate the evidence and the extent 
of nanomaterial uptake (if any). 
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2.6 Inductively Coupled Plasma Mass Spectrometry 
 
Inductively coupled plasma mass spectrometry (ICP-MS; Perkin Elmer, UK) was used in 
order to quantify and calculate the relative amount of the silica (Si) metal in a sample 
containing the ex vivo-relevant amount. The sample was diluted in 5 mL dH2O and 
subjected to analysis using ICP-MS. Additionally, to verify SiNPs uptake by vessels and other 
organs (for the in vivo biodistribution studies), ICP-MS was used to measure Si 
concentration. Briefly, vessels were weighed and placed into 500 µL lysate buffer solution 
[containing 1% sodium dodecyl sulphate (SDS; Sigma, Japan, 0.5 g), 0.1 M NaCl (0.29 g), 
0.05 M tris(hydroxylmethyl)aminomethane (0.03 g) and Tris (0.39 g) in 25 mL of dH2O at 
pH 8; with 250 μL of the protease inhibitor cocktail] and allowed to digest over 48 hours at 
room temperature. The lysate was subsequently mixed in 1 mL high purity (70%) nitric acid 
(HNO3; Sigma, UK) in glass tubing and placed in an oil bath at 115℃, for 2-3 hours as 
described previously (Al-Jamal et al., 2009). The solution was made up to 5 mL in distilled 
water and analysed. A standard curve was used to quantify the amount of metal in the 
tissues, using standards (Sigma, UK), in the same background solution as that of the tissue 
solutions. The limit of Si quantification was 50 ng/mL. 
 
 
2.7 Protein Phosphorylation Studies  
 
2.7.1 Sample Preparation for Protein Extraction – Non-functional Studies  
A non-functional study was performed by infusing PSS or SiNPs (at 5.32 x 1011 NP/mL) into 
the whole mesenteric tree of the rat (dissected from the rat mesentery) in a petri-dish 
containing gassed PSS and placed on a hot plate at 37℃ (Figures 34 and 35). The infusion 
of PSS or SiNPs was performed by the use a 1 mL syringe inserted into the cannula tubing 
end, where the arterial tree is attached. Following 30 minutes of incubation in SiNPs, MAs 
were stimulated with 10 µM of ACh for 5 minutes. Segments were pooled after 
experimentation, and 100 MA segments (first-sixth order MAs) were collected per 
experimental condition, from 4 animal mesenteries (from a total of 400 MAs and 16 animal 
mesenteries) (Figure 35).   
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Figure 34. Vessel Pooling for non-functional studies and protein extraction. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Non-functional on the whole rat mesentery studies including SiNPs infusion ex 
vivo.  
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2.7.2 Sample Lysis and Homogenisation  
250 µL of lysis buffer obtained from the Proteome Profiler Human Phospho-Kinase Array 
(R&D Systems, Abingdon, UK) containing protein inhibitors cocktail was placed in each of 
the Eppendorf tubes corresponding to mesenteric vessels treated at a different condition. 
Samples were briefly sonicated three times for 5 seconds at 5 µm amplitude on ice. The 
tubes were incubated on ice in a rocker shaker placed in the cold room for 20 minutes. The 
vessels were placed in the sonicator for 5-10 seconds to break the DNA. Using the small 
Eppendorf tube homogeniser (Sigma, UK), the vessels were ground by rotation of the 
homogeniser in order to dissolve them in the buffer. Tissues were spun down at 13,000 
rpm in a centrifuge for 20 minutes at 4℃ (the tubes were facing the inside of the centrifuge 
chamber). After spinning, the supernatant containing the total protein of the original 
sample was removed and placed into a fresh Eppendorf tube leaving the derbis and debris 
pullet. The procedure was repeated to maximise the protein yield from MAs.  
 
2.7.3 Protein Quantification   
The protein content of the samples was determined using the Pierce BCA protein assay kit 
(Reference number: 23225; Thermo SCIENTIFIC, UK). This protein assay is a dye-binding 
assay in which a differential colour change of a dye occurs in response to various 
concentrations of protein. The protein estimation technique was used to quantify the 
amount of solubilised proteins obtained in the tissue lysates from MAs allowing calculation 
of the volume of lysate necessary to perform a proteomics analysis. The protein standard 
dilutions were prepared as shown in appendix 6. Extra volume was prepared for bubble 
formation and/or pipetting errors. 10 μL aliquots of each dilution was pipetted in a 96-well 
flat-bottomed plate in triplicate. 10 µL volume from a total volume of 40 µL of each diluted 
(1:6) protein sample to quantify was pipetted in a 96-well flat-bottomed plate in triplicate; 
that is 6.67 µL of each protein sample added to 33.33 µL of lysis buffer. The dye solution 
was prepared by mixing 1 part of reagent A of the protein assay kit with 50 parts of reagent 
B in a 50 mL Falcon tube. As a blank to calculate background, 10 μL of the dye solution was 
pipetted into the plate in triplicate. The dye mixture was vortexed and filtered it using a 0.2 
μm filter and a 20 mL syringe. The filtered volume was transferred into a different 50 mL 
Falcon tube. The dye solution was poured into a Gilson reagent reservoir and pipetted into 
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the 96-well plate at 190 µL per well using a multichannel pipette (both protein containing 
and blank wells). The plate was incubated for 30 minutes at 37℃. The plate was read in a 
Synergy HT microplate reader (Biotek, UK) using the Gen 5 2.05 software at an absorbance 
of 562 nm. The optical units read by the microplate reader were exported to an excel file 
to create an XY table with 3 replicates for each experimental point. The standard linear 
regression blot was used to create the line equation, R2 calculation and to interpolate 
unknown values, allowing the quantification of the protein content in the lysates in mg/mL 
(Appendix 6). The final protein concentration was calculated according to the dilution 
factor.  
 
2.7.4 The Detection of Phosphorylated Proteins Patterns 
A proteomic approach for the detection of the relative phosphorylation levels of 46 
intracellular kinases was utilised using the Proteome Profiler Human Phospho-Kinase Array 
(Catalogue #ARY003B, R&D Systems, Abingdon, UK). This screening procedure was used to 
investigate the phosphorylation levels of proteins involved in mediating the actions of 
eNOS and EDHF in rat MAs following SiNP uptake. The phospho-protein expression levels 
were detected in 100 MAs after exposure to SiNPs at 5.32 x 1011 NP/mL for 30 minutes as 
part of a non-functional study using the proteome array kit according to the manufacturer’s 
instructions. Briefly, capture and control antibodies were spotted in duplicate onto 
nitrocellulose membranes containing 46 kinase phosphorylation sites for the human 
phospho-kinase array (outlined in Table 3). 1 mL of array buffer was added to each well of 
the 8-well plate for blots in duplicates (to part A and B in duplicates; Figure 36). The blots 
were incubated in buffer for 1 hour (Figure 36). The buffer was aspirated from the plate. 
Tissue extracts containing 450 µg of total protein (form the recommended range of 200-
600 µg of total protein per assay set) were diluted in lysis buffer (making a final volume of 
2 mL) and incubated with the phospho-kinase array overnight at a volume of 950 µL per 
well of sample condition in duplicates. The array was washed to remove unbound proteins, 
followed by incubation with a cocktail of biotinylated detection antibodies. Streptavidin-
HRP and chemiluminescent detection reagents were applied, and a signal was produced at 
each capture spot corresponding to the amount of protein bound, if any. After incubation, 
membranes were developed using enhanced chemiluminescence reagents (Hyperfilm ECL; 
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Amersham, UK) and immediately exposed to LI-COR scanner. Protein-positive spots on the 
mini-blots were visualised using the WestPico chemiluminescent substrate and quantified 
using ImageJ software (NCBI) and protein expression was normalised to a positive control, 
which was represented in each membrane.  
 
Table 3. The 46-kinase phosphorylation sites for the human phospho-kinase array 
proteomics blot. 
Akt (S473)  Hck (Y411) PRAS40 (T246) 
Akt (T308) HSP27 (S78/S82) Pyk2 (Y402) 
AMPK alpha1 (T174) HSP60 RSK1/2/3 (S380/S386/S377) 
AMPK alpha2 (T172) JNK pan (T183/Y185, T221/Y223) Src (Y419) 
beta-Catenin Lck (Y394) STAT2 (Y689) 
Chk-2 (T68) Lyn (Y397) STAT3 (S727) 
c-Jun (S63) MSK1/2 (S376/S360) STAT3 (Y705) 
CREB (S133) p27 (T198) STAT5a (Y694) 
EGF R (Y1086) p38 alpha (T180/Y182) STAT5a/b (Y694/Y699) 
eNOS (S1177) p53 (S15) STAT5b (Y699) 
ERK1/2 (T202/Y204, T185/Y187) p53 (S392) STAT6 (Y641) 
FAK (Y397) p53 (S46) TOR (S2448) 
Fgr (Y412) p70 S6 Kinase (T421/S424) WNK-1 (T60) 
Fyn (Y420) PDGF R beta (Y751) Yes (Y426) 
GSK-3 alpha/beta (S21/S9) PLC gamma-1 (Y783)  
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A 
 
B 
 
C 
 
D 
 
Figure 36. Images illustrating the procedure for mini-blots used in the proteomics array 
kit; where A) Labelling and preparing the mini-blots, B) Incubation of blots with the MA 
lysates, C) Incubation of the blots with the antibodies and D) Protein spot detection on a 
LI-COR platform. 
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2.8 Statistical Analysis 
 
A generalised linear mixed model (GLMM) approach was performed for the statistical 
analysis of the data obtained using the IBM statistical package for social sciences (SPSS) 
version 19.0 (Breslow and Clayton, 1993).  The GLMM that is used in this current study is 
an extension to the generalised linear model in which the linear predictor contains random 
effects, in addition to the usual fixed effects for sample effects regression analysis of 
grouped data. This model provides an extension of the linear mixed models to non-normal 
data (in our case % response values). This fixed-effects model of analysis of variance was 
applied due to the existence of different parameters or independent variables across 
different sets of experiments that can influence the dependent variable. The dependent 
variable in our case is the dilator response elicited by ACh and SNP which is expressed as 
percentage relaxation (corresponding to the increase from the pre-constricted maximal 
Phe value), or the constrictor response by Phe. The independent variables include: the 
number of the mesenteric vessel segments used, incubation type of the vessels [PSS, SiNPs 
at high dosage, SiNPs at low dosage, SiNPs with L-NNA, SiNPs with SOD, inhibitors (L-NNA, 
indomethacin, apamin and TRAM-34; alone or in combination] and chemical concentration 
(10-13 – 10-3 M) of the agonist used (Phe, ACh or SNP). As each vessel employed in this 
current study was repeatedly assessed (before as well as after incubation) for the different 
agonist concentration, we have also taken into the account the co-variant. The co-variant 
is the weight of each vessel i.e. how many occasions it was measured for either % 
contraction or relaxation. This allowed for the estimation of the ranges of response variable 
values that the independent factors would generate in a particular set of experiments. This 
whole analysis determined two factors, which are the ‘incubation type’ and the ‘agonist 
concentration’ to be responsible for the main significant effects contributing to the 
variation in vascular % responses (contraction or relaxation). This justified the use of 
repeated measures (one-, two-, three- or multi-variate) analysis of variance (ANOVA) for 
multiple sample mean comparisons due to the vessels being repeatedly measured for their 
responses to different agonist concentrations. The ANOVA test were performed to specify 
which incubation type is contributing to the significance of results (% response 
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measurements). The pairwise adjustments identified the particular dose(s) that lead to the 
significance of results among the different incubation types.   
 
The number of mesenteric vessel segments is expressed as n, which represents the number 
of vessels utilised for each set of experiments. Data is represented as mean ± standard error 
of mean (SE). Concentration response curves were assessed using the appropriate ANOVA 
test with subsequent pairwise comparisons to determine the main effects of dose and 
incubation as well as the interaction of effects. Bonferroni adjustments were used to 
correct for multiple comparisons. If a main effect was observed, Student’s paired or 
unpaired t-test (two tailed) was used to determine the locations of differences as 
appropriate. p<0.05 was considered to be statistically significant. The percentage dilation 
response of ACh and SNP was normalised to Phe constrictor responses and calculated as 
follows: 
 (Dilation –  Maximal Constriction)(Original Diameter –  Maximal Constriction)  𝑋𝑋 100 
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 Chapter 3. 
 
 
 
 
 
 
The Chemical 
Characterisation of SiNPs 
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3.1 The Absorption Spectra of SiNPs Samples using Fluorescence 
Spectroscopy  
 
The fluorescence absorption spectra of the A3 and DA3 SiNPs samples show peaks obtained 
at their expected wavelength (550-690 nm), confirming the presence of RBITC dye within 
the samples analysed (Figure 37). This is further illustrated by the pink colour observed with 
the A3 SiNPs substrate displaying a characteristic crystalline appearance in its dry form 
(Figure 28). In contrast, no absorption was detected by the A2 and DA1 SiNPs samples, 
which were prepared without dye (Figure 27). 
 
 
 
Figure 37.The fluorescence spectroscopy spectra indicating the presence of RBITC dye 
with an absorption of light at 550-690 nm wavelength region in different SiNPs samples 
with and without the dye.  
 
 
 
 
 
 
0
20
40
60
80
100
120
140
160
180
200
550 570 590 610 630 650 670 690
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 (A
.U
.)
Wavelength (nm)
A2 without dye
A3 with dye
DA1 without dye
DA3 with dye
103 
 
 
3.2 SiNP Hydrodynamic Diameter 
 
The DLS hydrodynamic diameter size for the different SiNPs samples synthesised according 
to the Stöber method measured between 94-2619 nm (Table 3). SiNPs with a DLS size 
distribution of above 200 displayed a higher tendency to sediment and aggregate in 
suspension (Table 4).  There was a clear change in SiNPs size depending on the 
concentration of the reaction reagents. Thus, reaction flasks exposed to the same physical 
conditions were able to generate SiNPs with different size ranges depending on the 
concentration of reagent used (Table 2).  
 
Table 4. The average hydrodynamic diameter size of different SiNP solutions in water or 
ethanol synthesised according to the Stöber method using the Malvern Zetasizer.  
Sample Size (nm) 
1A 1085 
1B 2619 
2A 960 
3A 225 
3B 2174 
D1 without dye 22400 
D2 without dye 299 
D2 315 
D3 360 
DA3 150 
DA4 160 
DA5  203 
DA6 184 
A2 without dye 103 
A2  146 
A3 138 
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3.3 SiNPs Topography and Morphology 
 
The SEM images obtained for different dye-encapsulated SiNP samples are shown in Figure 
38. The SEM images for DA5 and DA6 SiNPs samples shows mono-dispersed and uniform 
SiNPs with smooth spherical surfaces and an approximate overall relative diameter size in 
the range of 170-180 nm. In contrast, the SEM images for SiNP samples; 1Aa and 1B showed 
aggregation of NPs (Figure 38). The DLS measurements do not show agreement of size with 
the SEM images with slight differences of a factor of approximately 20-25 nm difference in 
favour of the DLS-measured samples. TEM analysis provides a more detailed and closer 
image to NP dispersion and size. Hence, the TEM diameter size was taken as the definitive 
SiNP size in contrast to the DLS size. NP size-related calculations are detailed in appendix 3.  
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Figure 38. SEM images of the Samples: 1A (A), 1B (B), DA5 (C and D) and DA6 (E and F). 
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3.4 SiNPs in a Blood Sample 
 
In order to examine SiNPs interaction with blood (if any); the changes to the DA3 SiNPs DLS 
size and Zeta potential were monitored after they were dispersed in a blood sample 
obtained from a 3 weeks old Wistar Rat (following DA3 centrifugation in water to remove 
ethanol). The latter SiNP sample was incubated in blood over 8 hours and size and Zeta 
potential was monitored in a sequential manner using the Malvern Zetasizer. There was a 
trend of increase in the size of D3 SiNPs in the blood after 4 hours of incubation reaching 
to 717 nm compared to 145 nm before incubation (100 runs in the Zetasizer; Figure 39). 
However, the D3 SiNPs size was reduced to 200 nm following 8 hours of incubation. The 
Zeta potential profile for the DA3 SiNPs in blood decreased from -32 to -37 mV for the 8-
hour duration of incubation (Figure 40).  
 
 
Figure 39. The changes in DA3 SiNPs size in a blood sample obtained from a 3 weeks old 
Wistar Rat over 8 hours using the Malvern Zetasizer. Values are an average of 100 
readings performed by the Malvern Zetasizer machine.  
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Figure 40. The changes DA3 SiNPs potential in a blood sample obtained from a 3 weeks 
old Wistar Rat over 8 hours using the Malvern Zetasizer. The mean of 100 runs is 
presented. 
 
The TEM images obtained for SiNPs incubation in blood demonstrate the presence of 
aggregated SiNPs (Figure 41). 
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Figure 41. TEM images of the DA3 SiNPs in blood sample following 8 hours of incubation.  
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3.5 The Shelf-life for DA3 and A3 SiNPs Samples 
 
DA3 (in ethanol) and A3 (in water and in PSS) SiNPs samples were specifically monitored 
over a time-course of 15 months in an attempt to predict their shelf-life in vitro. This may 
have an impact on the suitability of the storage medium used in this case, ethanol, water 
and PSS, and allow the understanding of NPs behaviour in an aqueous environment as 
applied to in vivo.  
 
 
3.5.1 DA3 and A3 Morphology 
The SEM and TEM images of the synthesised DA3 SiNPs sample stored in ethanol 
demonstrate that the NPs have a mono-disperse spherical morphology (Figures 42 and 43). 
The storage of the NPs over a one-year period has not affected the particle morphology, as 
the particle shape and size have remained similar (~110 nm).  
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Figure 42. TEM images of the DA3 SiNPs sample at month 1 (A-C) and month 15 (D-F).  
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Figure 43. SEM images of DA3 SiNPs sample in ethanol over time, where A) month one; 
B) month three; C) month five; D) month seven; E) nine; F) month eleven; G) month 
thirteen and H) month fifteen. 
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TEM analysis confirmed the size of the A3 SiNPs sample as 97.85 ± 2.26 nm (~98 nm). 
Compared to the DA3 SiNP sample, the SEM and TEM images obtained for the A3 SiNPs 
sample stored in water show the aggregation and change in shape of the NPs over a 15-
month period, from relatively smooth monodispersed NPs to more aggregated and rough 
or crunchy-looking NPs, with no significant changes to their size (Figures 44 and 45). A3 
SiNPs seem to be aggregated with the presence of different sizes of other medium size and 
tiny NPs in suspension and in some cases surrounding the A3 SiNPs (Figure 44).   
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Figure 44. TEM images of the A3 SiNPs sample at month 1 (A-C) and month 15 (D-F).  
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Figure 45. SEM images of sample A3 SiNPs sample in water over time, where A) month 
one; B) month three; C) month five; D) month seven; E) nine; F) month eleven; G) month 
thirteen and H) month fifteen. 
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The overall average hydrodynamic sizes of DA3 and A3 SiNPs samples were graphically 
presented for direct comparisons as stored in different media (Figures 46 and 47). There 
was no change in the size of A3 and DA3 SiNPs following 15 months of size measurements 
in water, ethanol and PSS (the mean size of A3 SiNPs sample in PSS was 128 ± 1.52 nm vs. 
129 ± 2.75 nm after month 1 and 15 respectively, n=4, paired t test, NS; Figure 46).  
 
 
Figure 46. The repeated analysis of the hydrodynamic average size of DA3 SiNPs in 
Ethanol and  A3 SiNPs in water for 15 months using the Malvern Zetasizer.  
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Figure 47. The repeated analysis of the hydrodynamic average size of DA3 SiNPs in 
Ethanol and  A3 SiNPs in water for 15 months using the Malvern Zetasizer.  
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3.5.2 DA3 and A3 Charge and Stability 
The DA3 and A3 SiNP samples were also monitored for their surface charge and stability in 
ethanol or water and PSS respectively over the course of 15 months (Appendix 4). There 
was a significant change in the Zeta potential of DA3 SiNPs sample in ethanol following 15 
months of Zeta potential measurements (the mean Zeta potential of DA3 SiNPs sample in 
ethanol was -37 ± 0.85 mV vs. -24 ± 1.07 mV after month 1 and 15 respectively, n=4, paired 
t test, p<0.0001). The Zeta potential measurements for the A3 SiNPs displayed significant 
changes in PSS only for a course of 15 months with slight fluctuations in Zeta potential for 
the SiNPs dispersed in water during the 15 months period (the mean Zeta potential of A3 
SiNPs sample in water was -41 ± 1.04 mV vs. -29 ± 5.57 mV after month 1 and 15 
respectively, n=4, paired t test, NS; Figure 48 and that of PSS -12 ± 0.38 mV vs. -15 ± 0.25 
mV after month 1 and 15 respectively, n=4, paired t test, p<0.001; Figures 49). Overall, 
SiNPs did not maintain their Zeta potential in ethanol and PSS as compared to water. 
However, the incubation in PSS increased SiNPs stability over time with the Zeta potential 
becoming more negative. 
 
 
Figure 48. The repeated analysis of the Zeta potential average of DA3 SiNPs in Ethanol 
and  A3 SiNPs in water for 15 months using the Malvern Zetasizer.  
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Figure 49. The repeated analysis of the Zeta potential average of A3 SiNPs in water and 
PSS for 15 months using the Malvern Zetasizer.  
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3.6 Discussion 
 
3.6.1 Fabrication and Characterisation of SiNPs 
The SiNP size and morphologies of the different sizes were determined by DLS, TEMs, SEMs 
and Zeta potentials using the Malvern Zetasizer and electron microscopy. The Derjaguin-
Landau-Verwey-Overbeek (DLVO) theory (Derjaguin and Landau, 1941; Verwey et al., 1948) 
describes colloidal dispersions stability. The theory describes that the total interaction 
energy between two particles is given by the sum of the attraction due to Van der Waals 
interactions and the electrostatic repulsion originating from the overlap of the charged 
diffuse layers. The Zeta potential provides a charge for the surface potential and can be 
used to indicate particle stability. A number of sol-gel precipitation methods were 
employed in the present study to synthesise SiNPs, based on the Stöber and Ismael 
methods (Stöber et al., 1968; Ismail et al., 2010). These yielded small aggregated NPs, which 
may be due to the experimental conditions explained by a narrow variation in the 
temperature and stirring conditions used. Thus, the methods were not repeatable but the 
synthesis of NPs using the modified Stöber method with different reagent ratios generated 
more desirable NP sizes and morphologies. In contrast to other samples made, the A3 SiNPs 
sample was prepared by using a slightly higher dilution of silica reagents in ethanol; namely 
TOES. The results suggest that using a large reaction vessel (250 mL) and a larger volume 
of ethanol (250 mL; acting as a medium for the interaction of silica precursors) enhanced 
the optimal dispersion for TEOS to nucleate more silica seeds. Improved monodispersity of 
silica seed growth and finer spherical morphology was achieved with an increase in the size 
of silica particles (~200 nm), which were achieved in the absence of water and lower 
volume of TEOS to ethanol (1:20 ratio). This finding was similar to a pervious study by Zhang 
et al., which suggested that the TEOS dilution in ethanol before its drop-wise addition (in a 
2-hour time-intervals) can suppress the generation of new nuclei and the aggregation or 
adhesion of particles. Thus, TEOS dilution in a drop-wise fashion can improve 
monodispersity of silica spheres (Zhang et al., 2003). In agreement with the study by Canton 
et al., we were able to produce smaller SiNPs dimensions by incremental changes to the 
reagents and the addition of more ethanol in a continuous drop-wise addition. Thus, 
increasing the ratio of water to hydrated ammonia used in the synthesis of the range of 
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SiNP samples, as well as the reduction of TOES, yielded smaller size NPs. These changes in 
silica precursor concentrations yielded small SiNPs that were approximately 100 nm in size, 
although with crunchy shell due to the characteristic appearance of ultra-fine silica seeds 
surrounding the silica surface as with the A3 SiNPs sample (Figure 44). Hence, the 
production of fine SiNPs surrounding the silica surface may be prevented by further 
optimising the method for making smooth SiNPs taking into account all the factors 
mentioned above. Thus, the synthesis of SiNPs requires fine-tuning of the reagents as well 
as experimental conditions to achieve the desired NP sizes and morphologies (Zhang et al., 
2003).  
 
The SEM images obtained for different SiNP samples confirm the fabrication of colloidal 
and monodispersed SiNPs despite the presence of aggregated NPs due to the variation in 
the reactant concentrations used. As previously recommended the addition of TEOS at a 
controlled rate (Nozawa et al., 2005) resulted in small particle size with a polydispersity 
index (PDI) values of less than 0.7, indicating that the A3 and DA3 samples were 
monodispersed. The optimisation of TEOS and NH3 concentrations, the type of solvent or 
media (H2O and ethanol) and the reaction temperature can hence control SiNPs size 
distribution and Zeta potential measurements (Rahman and Padavettan, 2012). For 
instance, increasing the amount of ammonia resulted in an increase of silanol groups on 
the SiNPs surface thereby causing the size of SiNPs to increase.  
 
 
3.6.2 The Stability of DA3 and A3 SiNPs over Time  
The RBITC dye-encapsulated monodispersed SiNPs samples; DA3 and A3 SiNPs were 
characterised over a 15-month period in different media (ethanol, water and PSS). The 
granular appearance of the A3 SiNPs, after a 15-month period, may have been caused by 
the silica seeds surrounding the individual SiNPs. In contrast, the DA3 SiNPs maintained 
their smooth surface characteristics in ethanol over time. The polydispersity index (PDI) of 
the DA3 and A3 SiNP samples did not significantly change over the 15-month storage 
period, with PDI values scoring below 0.3 nm, confirming the monodispersity of the 
samples. The A3 SiNP sample, however, became aggregated and rough in its outer surfaces 
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with time. Silica is known to decompose into silicic acid (DIACONU et al., 2010). During 
prolonged storage of the A3 SiNPs in water suspension, silicic acid release may have 
contributed to their aggregation with time. The latter may also be responsible for raising 
the pH of the storage medium, which can contribute further to the A3 SiNP changes in 
characteristics. The breakage of the Van der Waal forces keeping the nanospheres in shape 
and the distortion of the lattice structures of these NPs may be one cause. The other 
possible explanation for the variation in the morphology of A3 SiNPs sample over time may 
be due to the dissolution of these NPs in water with time. The dissolution of the SiNPs may 
give rise to silica seeds and enhance the aggregation of the NPs as well the responsibility 
of the crunchy-looking surface due to the surrounding tiny seeds. Dissolution is a process 
where a solution is formed after a solute is added to a solvent. The dissolution mechanism 
of SiNPs initially undergoes the dissociation of the sianol group (=SiO-H ⇋ SiO- + H+).  Then 
Si+4 atom undergoes a nucleophilic attack by water molecules to form a silica intermediate, 
(Si2O(OH)7-). Followed by the breaking of the siloxane bond =Si-O-Si=. Thus, distorting and 
breaking the nanosphere structure. The dissolution of the silica may have been initiated by 
the NPs (surface area, concentration) and/or water media over time. The large surface area 
due to the relatively small size of our A3 SiNPs sample, may have contributed to the 
enhanced dissolution of the NPs due to the greater accessibility to water molecules, 
thereby reducing the Zeta potential. This phenomenon was previously demonstrated in 
mesoporous SiNPs (Finsy, 2004; Huang et al., 2014). Other factors such as; temperature, 
pH, silicate concentration and metal oxide formation, all can affect the dynamic equilibrium 
between silicate dissolution and decomposition (Bass et al., 2007).  
 
Our results show that the Zeta potentials of the A3 SiNPs samples were unaffected by 
storage in water, suggesting that water maintains SiNP stability. The Zeta potential 
measurements of the DA3 SiNPs sample in ethanol significantly decreased, suggesting that 
ethanol may not maintain the stability of silica samples overtime. The neutralisation effect 
of PSS on the SiNPs surfaces may have decreased its negativity of the Zeta potential, which 
is expected due to a decrease in the extension of the diffuse repulsive layer caused by 
counter ion screening. The existence of the surface charge on SiNPs may be due to the 
deprotonation of silanol groups projecting from the SiNPs surfaces. An increase in cation 
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concentration causes an exchange of the hydrogens on the silanol groups (SiOH ⇋ SiO- + 
H+) (Derjaguin and Landau, 1993). The other possibility is that PSS may compete for SiNPs 
with water molecules and lead to reduced hydration layer formation. However, PSS over 
the course of 15 months improved the stability of SiNPs. 
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The Influence of SiNPs on 
Arterial Function, Ex Vivo  
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4.1 Control Vascular Responses (Repeatability) 
 
The results indicate that there was no overall significant difference before and after the 
incubation in PSS alone without nanomaterial(s) present. 
 
4.1.1 Repeatability of Responses to High Potassium Solution (KPSS) 
The incubation of mesenteric vessels in PSS alone over a 30-minute period led to no change 
in the vasoconstrictor responses to KPSS at 60 mM concentration (Figure 50; unpaired t 
test, NS). Most mesenteric vessels constricted in response to KPSS. The use of KPSS allowed 
for over 50% constriction by most mesenteric vessels ex vivo (Figure 50) confirming their 
viability. The vessel viability cut off value for inclusion was 50% KPSS constriction or over. 
Vessels that failed to reach 50% constriction by KPSS were excluded from further 
experimentation. The incubation in PSS alone had no overall effect on the KPSS contractile 
responses as compared to before incubation; (At 60 mM KPSS, the mean percentage 
constriction was 67.43 ± 3.51% vs. 78.49 ± 7.13% before (control) and 30 minutes after 
incubation in PSS respectively, n=56 and 7 respectively, unpaired t test, NS; Figure 50).   
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Figure 50. Responses to KPSS-induced Contraction, before (Control) and after incubation 
in PSS. ‘n’ is number of vessels, error bars=SE.  
 
 
4.1.2 Repeatability of Responses to Phe 
Similarly, the incubation in PSS alone had no overall effect on the Phe contractile responses 
as compared to before incubation. At the submaximal concentration of Phe (1 µM), the 
mean percentage constriction was 78.68 ± 3.78% vs. 68.69 ± 5.15% before (control) and 30 
minutes after incubation in PSS respectively, n=27 and 4 respectively, unpaired t test, NS; 
Figure 51). Some vessels developed episodes of continuous vasomotions upon the addition 
of the maximal concentrations of Phe, in some instances for a period of 20-30 minutes.  
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Figure 51. Responses to Phe-induced contraction, before (Control) and after incubation 
in PSS. ‘n’ is number of vessels, error bars=SE. One-factor repeated measures ANOVA. P 
values correspond to comparisons between PSS incubation vs. control Phe responses of 
MAs. 
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4.1.3 Repeatability of Responses to ACh 
ACh induced a concentration-dependent increase in the dilator response in all pre-
constricted vessels reaching optimal dilation at ACh concentration of 100 nM in control and 
PSS incubated vessels (Figure 52). There was no overall effect on the endothelial-
dependent ACh dilator responses following KPSS pre-constriction after the incubation in 
PSS as compared to before incubation. The effect of the incubation in PSS on the 
submaximal concentration of ACh (10 µM) was unaffected; (At 10 µM ACh, the mean 
percentage dilation was 86.44 ± 3.59 % vs. 70.78 ± 9.79% before (control) and 30 minutes 
after incubation in PSS respectively, n=9 and 4 respectively, unpaired t test, NS; Figure 52).  
 
 
Figure 52. Responses to ACh-induced relaxation in KPSS pre-constricted vessels, before 
(Control) and after incubation in PSS. ‘n’ is number of vessels, error bars=SE. One-factor 
repeated measures ANOVA. P values correspond to comparisons between PSS incubation 
vs. control ACh responses of MAs. 
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The incubation in PSS alone had no overall effect on the endothelial-dependent ACh dilator 
responses following Phe pre-constriction as compared to before incubation; (At 1 µM ACh, 
the mean percentage dilation was 97.35 ± 3.55 % vs. 96.15 ± 3.11% before (control) and 30 
minutes after incubation in PSS respectively, n=7 and 6 respectively, unpaired t test, NS; 
Figures 53 and 54). The effect of the incubation in PSS on the submaximal concentration of 
ACh (10 µM) was unaffected (At 10 µM ACh, the mean percentage dilation was 101.67 ± 
3.02% vs. 96.68 ± 7.82% before (control) and 30 minutes after incubation in PSS 
respectively, n=7 and 6 respectively, unpaired t test, NS; Figure 54). At an ACh 
concentration of 1 mM; the maximum concentration of ACh used, the vessels achieved 
more than 100% dilation; (At 1 mM ACh, the mean percentage dilation was 105.64 ± 6.41 
% vs. 101.76 ± 0.69% before (control) and after incubation in PSS respectively, n=7 and 6 
respectively, unpaired t test, NS; Figure 54). 
 
 
Figure 53. A representative trace of the responses to ACh in Phe pre-constricted vessels 
after incubation in PSS ex vivo. 
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Figure 54. Responses to ACh-induced relaxation in Phe pre-constricted vessels, before 
(Control) and after incubation in PSS. ‘n’ is number of vessels, error bars=SE. One-factor 
repeated measures ANOVA. P values correspond to comparisons between PSS incubation 
vs. control ACh responses of MAs. 
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4.1.4 The Influence of Incubation in PSS on MA Integrity ex vivo 
The mechanical luminal infusion of PSS through 1 mL syringe into the MA had no effect on 
the intact MA cellular layers as indicated in Figure 55.   
 
A 
 
B 
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D 
 
Figure 55. TEM images (A-D) representing the different cellular layers in a second order 
MA after 30 minute of incubation in PSS. 
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4.2 Influence of SiNPs on Vascular Responses  
 
The vasoconstrictor and vasodilator responses of the mesenteric vessels was assessed 
using the SiNPs at a concentration of 5.32 x 1011 NP/mL. Data analysed within the mixed 
model produced a significant differences associated mainly with the incubation types. 
Thus, the null hypothesis, that “there is no difference before or after the incubation with 
the nanomaterials (SiNPs and CNTs)” was rejected. 
 
4.2.1 Vasoconstrictor Responses  
4.2.1.1 KPSS Responses 
Incubation in SiNPs ex vivo, at 5.32 x 1011 NP/mL, had no overall influence on the contractile 
responses of vessels to KPSS; (the mean percentage constriction was 78.49 ± 7.13% vs. 
65.80 ± 7.04% after incubation in control and SiNPs respectively, n=7 and 10 respectively, 
unpaired t test, NS; Figure 56). 
 
 
Figure 56. The influence of SiNPs infused ex vivo on constriction responses to KPSS. ‘n’ is 
number of vessels, error bars=SE. 
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4.2.1.2 Phe Responses  
Incubation in SiNPs ex vivo, at 5.32 x 1011 NP/mL, led to a significant reduction in the 
contractile responses of vessels to Phe, at specific concentrations (1, 10 and 100 µM); (At 
10 µM Phe, the mean percentage constriction was 98.55 ± 1.45% vs. 36.51 ± 11.17% after 
incubation in PSS and SiNPs respectively, n=4 and 5 respectively, unpaired t test, p<0.05; 
Figure 57). The submaximal constriction to Phe was reduced when the vessels were 
incubated in SiNPs; (At 1 µM Phe, the mean percentage constriction was 68.69 ± 5.15% vs. 
36.47 ± 6.85% after incubation in PSS and SiNPs respectively, n=4 and 5 respectively, 
unpaired t test, NS; Figure 57). In contrast, incubation in a diluted dosage (1x) of SiNPs at 
1.01 x 1011 NP/mL (i.e. 5x less concentrated) did not affect the contractile responses of the 
vessels to Phe. The 1x SiNPs produced a dose-dependent increase in the level of responses 
to Phe (10-7 to 10-4 M) similar to control; (At 1 µM Phe, the mean percentage constriction 
was 68.69 ± 5.15% vs. 76.37 ± 5.15% after incubation in PSS and 1x  SiNPs respectively, n=4 
and 3 respectively, unpaired t test, NS; Figure 57).   
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Figure 57. The influence of SiNPs infused ex vivo at two different concentrations (5.32 x 
1011 and 1.01 x 1011 NP/mL) on the Phe-induced contraction. ‘n’ is number of vessels. 
*p<0.05, error bars=SE. Two-factor repeated measures ANOVA. P values correspond to 
comparisons between SiNPs incubated either at high or low dosage vs. control Phe 
responses of MAs. 
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4.2.1.3 AVP Responses 
All vessels constricted to AVP in a dose-dependent manner (Figure 58). In contrast to Phe, 
a similar behaviour of constriction to AVP was found when the vessels were incubated in 
SiNPs. The incubation in SiNPs had no overall effect on the contractile responses to AVP 
despite a significant decrease in the magnitude of constriction at 10 nM concentration of 
AVP; (At 10 nM AVP, the mean percentage constriction was 90.41 ± 2.10% vs. 97.40 ± 1.74% 
after incubation in control and SiNPs respectively, n=4, paired t test, p<0.05; Figure 58). 
Thus, SiNPs slightly reduced the contractile responses of the vessels to AVP in contrast to 
control vessels. 
 
 
Figure 58. The influence of SiNPs infused ex vivo on the AVP-induced contraction. ‘n’ is 
number of vessels. *p<0.05, error bars=SE. One-factor repeated measures ANOVA. P 
values correspond to comparisons between SiNPs incubated ex vivo vs. control AVP 
responses of MAs. 
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4.2.2 Vasodilator Responses  
4.2.2.1 Endothelial-dependent (ACh) Responses 
Incubation in SiNPs ex vivo, at 5.32 x 1011 NP/mL, led to a significant attenuation in the 
magnitude of the endothelial-dependent dilator responses to ACh following KPSS pre-
constriction, at specific concentrations (10-7 to 10-4 M ACh); (At 100 nM ACh, the mean 
percentage dilation was 74.25 ± 8.17% vs. 31.33 ± 8.72% after incubation in control and 
SiNPs respectively, n=4 and 5 respectively, unpaired t test, p<0.05; Figure  59).   
 
 
Figure 59. The influence of SiNPs infused ex vivo on the ACh-induced relaxation in KPSS 
pre-constricted vessels. ‘n’ is number of vessels. *p<0.05 and **p<0.01, error bars=SE. 
One-factor repeated measures ANOVA. P values correspond to comparisons between 
SiNPs incubated ex vivo vs. control ACh responses of MAs. 
 
 
 
 
0
20
40
60
80
100
120
-13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3
Re
la
xa
tio
n 
(%
)
ACh (Log M)
Control (n=4) SiNPs (n=5)
**
*
133 
 
 
Incubation in SiNPs ex vivo, at 5.32 x 1011 NP/mL, led to a significant attenuation in the 
dilator responses to ACh following Phe pre-constriction, at specific concentrations (10-7 to 
10-3 M); (At 1 µM of ACh, the mean percentage dilation was 96.15 ± 3.11% vs. 27.82 ± 5.13% 
after incubation in PSS and SiNPs at 5.32 x 1011 NP/mL respectively, n=6 and 11 respectively, 
unpaired t test, p<0.0001; Figure 60). The dilator responses were improved when the 
vessels were incubated with a lower dose of SiNPs (1.01 x 1011 NP/mL) in contrast to the 
more concentrated sample. The incubation in SiNPs at 1.01 x 1011 NP/mL produced no 
effects on higher concentrations of ACh (10-6 to 10-3 M), despite a significant decrease at 
the ACh concentration of 100 nM; (At 100 nM ACh, the mean percentage dilation was 78.77 
± 8.58% vs. 37.07 ± 9.44% after incubation in control and SiNPs at 1.01 x 1011 NP/mL 
respectively, n=6, paired t test, p<0.05; Figure 60). 
 
 
Figure 60. The influence of SiNPs infused ex vivo at two different concentrations (5.32 x 
1011 and 1.01 x 1011 NP/mL) on the ACh-induced relaxation in Phe pre-constricted vessels. 
‘n’ is number of vessels. *p<0.05, **p<0.01, #p<0.001 and ##p<0.0001, error bars=SE. Two-
factor repeated measures ANOVA. P values correspond to comparisons between SiNPs 
incubated either at high or low dosage vs. control ACh responses of MAs. 
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4.2.2.2 Endothelial-independent (SNP) Responses 
The endothelial-independent dilator responses to the NO donor, SNP were unaffected by 
incubation in SiNPs (at 5.32 x 1011 NP/mL) at SNP concentrations of 10-8 to 10-4 M, despite 
a slight trend of decrease (At 1 µM ACh, the mean percentage dilation was 106.17 ± 4.36% 
vs. 67.95 ± 16.48% after incubation in PSS and SiNPs respectively, n=4 and 6 respectively, 
unpaired t test, NS; Figure 61).  
 
 
Figure 61. The influence of SiNPs infused ex vivo on the SNP-induced relaxation in Phe 
pre-constricted vessels. ‘n’ is number of vessels, error bars=SE. One-factor repeated 
measures ANOVA. P values correspond to comparisons between SiNPs incubated either 
ex vivo or in vivo vs. control SNP responses of MAs. 
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4.2.2.3 Responses to PAPA 
The dilator responses to PAPA were unaffected by the infusion of SiNPs at 5.32 x 1011 
NP/mL ex vivo but showed a slight increase compared to control (At 10 µM concentration 
of PAPA, the mean percentage dilation was 89.04 ± 12.53% vs. 105.07 ± 2.79% after 
incubation in control and SiNPs respectively, n=3, unpaired t test, NS; Figure 62).  
 
 
Figure 62. The influence of SiNPs infused ex vivo on the PAPA-induced relaxation in Phe 
pre-constricted vessels. ‘n’ is number of vessel, error bars=SE. 
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4.3 Cellular Uptake of SiNPs into the MAs  
 
4.3.1 SiNPs Uptake at 4℃ 
Examination of the TEM sections demonstrate the presence of a large number of SiNPs of 
~100 nm in size, outside ECs of the mesenteric vessels after 30 minute of incubation (at 
5.32 x 1011 NP/mL), along the EC layer and inside the vessel lumen (Figure 63). There are 
also a number of SiNPs near EC membranes. Very few NPs were endocytosed inside ECs 
(Figure 63).  
 
A 
 
Figure 63. TEM image illustrating the predominant presence of SiNPs outside the vascular 
endothelium of the MAs after 30 minute of incubation. The SiNPs are represented by 
black spherical structures inside ECs (arrows). 
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4.3.2 SiNPs Uptake at 37℃ 
Examination of the TEM sections demonstrate the presence of SiNPs inside ECs of the 
mesenteric vessels after 30 minute of incubation (at 5.32 x 1011 NP/mL) (Figure 64). They 
were unevenly distributed and dispersed throughout the cytoplasm of ECs, but none were 
apparent in the nucleus. SiNPs were located either singly or in small clusters and were 
predominantly membrane-bound within vesicle structures, that may be of endosomal or 
lysosomal origin (Figure 64F), suggesting that an endocytotic pathway of uptake may be 
involved (Figure 64). SiNP may have also caused EC damage and full cell detachment (Figure 
65A) forming cellular debris in the regions lining the vascular lumen. SiNPs adhered to the 
basal lamina of the vascular wall (Figure 65B) and were found in regions near the VSMC 
layer and/or areas of VSMC damage (Figure 65C). In addition; in one section a total of 9 
SiNPs were able to penetrate the basal lamina and were found inside VSMCs (Figure 65C 
and -D), perhaps due to the disruption of the EC layer. The translocation of SiNPs into the 
latter regions coincided with areas of cellular damage in some instances. The 6 SiNP sizes 
found within the MA in the TEM images shown in Figure 64B measured 120, 120, 110, 110, 
110 and 130 nm respectively.  
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F 
 
Figure 64. TEM images (A-F) illustrating the internalisation of SiNPs into the vascular 
endothelium of the MAs after 30 minute of incubation. The SiNPs are represented by 
black spherical structures inside ECs (arrows). 
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 A 
 
B
 
C 
 
D 
 
Figure 65. TEM images (A-D) illustrating the internalisation of SiNPs into the basal lamina 
and vascular smooth muscle  cell layer of the MAs after 30 minute of incubation. The 
SiNPs are represented by black spherical structures inside ECs (arrows). 
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At elevated pressure (100 mmHg), there was no evidence of SiNPs uptake in the VSMC 
layer, but the occasional SiNPs (2 NPs) were found near areas of VSMC damage (Figure 66). 
The uptake of SiNPs was accompanied by functional effects on the MA, although this was 
examined only in one vessel. 
 
A 
 
B 
 
C 
 
D  
 
Figure 66. TEM images (A-D) illustrating the internalisation of SiNPs into the basal lamina 
and vascular smooth muscle cell layer of the MAs after 30 minute of incubation at 
elevated pressure of 100 mmHg. The SiNPs are represented by black spherical structures 
inside ECs (arrows). 
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4.4 Discussion  
 
4.4.1 Control Experiments  
KPSS acts by causing VSMC membrane depolarisation, bypassing the signal transduction 
pathways, due to the presence of extracellular potassium ions. The change in the PM 
potential activates Ca2+ channels in the membrane leading to an influx of extracellular Ca2+ 
and hence an increase in intracellular concentration of Ca2+. The fact that Phe induces 
higher vascular contractile response as compared to KPSS is because the former also 
mobilises intracellular Ca2+ from intracellular stores, leading to calcium influx and VSMC 
contraction in control and PSS-incubated vessels. While the role of Phe is mediated via its 
stimulation of the α1 adrenergic receptor, it is also suggested to suppress K+-induced 
hyperpolarisation in the rat MAs (Richards et al., 2001). KPSS was used to assess the 
viability of the vessels. All vessels constricted after incubation in KPSS. The non-viable or 
non-responsive vessels were excluded and these might have been damaged during or after 
dissection of the rats. Infusion in PSS and incubation for 30 minutes did not affect the 
contractile (KPSS and Phe) and dilator responses (ACh) of mesenteric vessels. Thus, the 
mechanical infusion, the pressure applied intravascularly while infusing with PSS as well as 
the incubation in PSS alone can be excluded as factors that may influence the vessel 
behaviour after the incubation in SiNPs. Hence, SiNPs are responsible in principle for the 
changes observed in the response of the vessels to the vasoconstrictors and vasodilators. 
 
The variability of vascular responses to the vasoconstrictors and vasodilators may be due 
to the small variation in the ages of the rats (in days) from which vessels were derived, 
slight variation in the size of the arterial segments mounted on the pressure myograph and 
the differential responses of the specific chosen segment along the arterial vessel (Kitazawa 
and Kitazawa, 2012). 
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4.4.2 SiNPs Vascular-Uptake Studies  
The 30-minute incubation period in SiNPs led to their cellular uptake as was evident by the 
TEM images obtained (Figures 64 and 65). The SiNPs were freely localised within ECs, inside 
the cytoplasm and in some cases inside vesicles without affecting cellular integrity in some 
of the electron micrographs obtained (Figure 64). However, in some cases, SiNPs were able 
to cause EC damage and detachment from the basal layer (Figure 65A and -B). This 
behaviour was accompanied by the translocation of SiNPs to the basal lamina of the vessel 
wall and a small number to the VSMC layer. This may be due to 1) Endothelial damage 
and/or detachment or 2) The capability of these NPs to cross different cellular barriers and 
tight junction proteins reaching to various vascular regions.  To investigate proposal 2 in 
more detail, further experiments are required with increased incubation periods for SiNPs. 
Perhaps the SiNPs incubation period was insufficient to cause more nanoparticles to 
translocate from the endothelium to the smooth muscle layer. 
 
The non-specific uptake of SiNPs may be related to an engulfment through pinocytosis, 
endocytosis and/or phagocytosis by the extracellular matrix constituents. It will be 
interesting to examine the uptake of SiNPs at low concentration to determine whether the 
uptake of these NPs is related to the observed physiological effects and/or the dependence 
of SiNPs uptake concentration of the NPs. Previous studies have emphasised the 
importance of NP size in determining the pathway of cellular entry (Vivero-Escoto et al., 
2010). Barbé et al. reported the internalisation and passage of SiNPs smaller than 50 nm 
but not above 300 nm through small intercellular openings in normal blood vessel walls in 
vivo (Barbé et al., 2004). A study by Shapero et al. detected the accumulation of amorphous 
SiNPs of 50 and 100 nm in size in lysosomes of lung epithelial cells after 24 hours of 
incubation (Shapero et al., 2011). It was also found that amorphous SiNPs at 2 x 1011 NP/mL 
with different sizes (30, 70 and 300 nm) were localised within human microvascular ECs 
and human lung adenocarcinoma cells, inside specialised flotillin-1- and flotillin-2-bearing 
endocytic vesicles (Kasper et al., 2013). The latter vesicles contain flotillin-1 and flotillin-2 
lipid raft proteins and thought to display a marker for late endosomal or lysosomal 
structures (Dermine et al., 2001; Glebov et al., 2006) and appear to exhibit a clathrin- or 
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caveolae-independent mode of endocytosis (Kasper et al., 2013; Langhorst et al., 2008; Ait-
Slimane et al., 2009). 
 
At physiological pH, the surface charge on SiNPs is predominantly negative (due to the 
presence of the carbonyl groups (COO-)). Some SiNPs seemed to form aggregates near the 
surface of ECs and were seen inside vesicle structures near the edges of the vesicles. It is 
assumed that due to the predominant negative charge on the SiNPs (not neutralised by 
ECs), this may have caused their repulsion from EC surfaces, perhaps via their negative 
membrane phospholipidic groups (Gamucci et al., 2014). The overall negative charge on 
the ECs layer may correspond to the ECM proteins, integrins and TJ proteins. The 
dependence of the nanomaterial surface polarity or charge on the non-targeted uptake 
was previously studied but yielded conflicting results; reviewed in Fröhlich (Frohlich, 2012). 
The other possibility for accumulation of SiNPs outside ECs is that they may have stimulated 
some form of an immune response (Fruijtier-Pölloth, 2012) from the ECs leading to the 
secretion of specialised vesicles to engulf the NPs, although these vesicles do not seem to 
be internalised or processed further inside the ECs. We assume that SiNPs have either 
become neutralised or gained positive charge or both by ECs secretions, ECM proteins, 
forming protein corona (Gamucci et al., 2014) and/or the ionic species found in PSS. The 
latter may have increased the overall size to charge ratio of SiNPs, altered their overall 
charge of and/or induced structural changes within their lattice structures in a fashion that 
facilitated their uptake into ECs. 
 
The mechanism whereby the nanoparticles enter and penetrate the PM is not fully 
understood, but alternative pathways may also be involved. However, in our study no 
uptake of SiNPs was evident at 4℃, suggesting that the uptake was an active process. 
Various studies have demonstrated the ability of SiNPs to penetrate tissues and cells in a 
manner that is dependent upon their material composition, surface charge and shape 
(Nabeshi et al., 2011). The internalisation of SiNPs by the ECs may be mediated through 
receptors that are specific or preferential to anionic ligands or through those favouring 
cationic ligands such as cell surface proteoglycans (Payne et al., 2007). The fact that the 
hydrodynamic size (size to charge ratio) of the SiNPs utilised for this study 98 nm, make 
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them prone to cholesterol-laden low-density lipoprotein (LDL) receptor or scavenger 
receptor-mediated internalisation (Zhang and Monteiro-Riviere, 2009) as these were 
previously suggested to possess similar size to charge ratio to LDL or acetylated LDL, 
normally recognised by these receptors. The suppression of the mechanisms for cellular 
uptake (Bakalova et al., 2008) (through inhibitors) may provide a new model for SiNPs-
cellular delivery mechanism. Inhibition in vitro and in vivo studies suggest four main 
pathways for the delivery of NPs into viable mammalian cells in particular; non-specific 
endocytosis and pinocytosis, microinjection, electroporation and peptide-induced 
transport (Dubertret et al., 2002; Mattheakis et al., 2004; Jaiswal et al., 2003; Chen and 
Gerion, 2004; Derfus et al., 2004). The localisation of our SiNPs within endocytic 
compartments may cause SiNP instability inside these targeted vesicles due to the presence 
of variable pH gradient across different intracellular compartments. The pH value in early 
endosomes is between 5.9 to 6.0 (Mukherjee et al., 1997), hence the stable pH may cause 
the SiNPs with their polar groups to expel each other and stay dispersed. The drop in pH to 
5.0-5.5 (Ryman-Rasmussen et al., 2007) and in some cases 4 (Mukherjee et al., 1997; 
Asokan and Cho, 2002) in lysosomes, may allow the carbonyl groups on the SiNP surface to 
become protonated. The protonation of SiNPs surfaces may result in an increase of intra-
endosomal pH and a charge gradient provoking a water influx and endosomal swelling and 
disintegration, resulting in the escape of SiNPs from the endo-lysosomal compartment 
(Nabiev et al., 2007). This may revert the SiNPs to neutral species resulting in SiNPs 
aggregation inside or outside of these vesicles and cause their subsequent damage. The 
damage to these SiNP-bearing vesicles may block their access to other proteins inside the 
EC cytoplasm leading to disrupted protein trafficking inside ECs. Together with the possible 
SiNPs aggregation inside ECs cytoplasm, the former may explain the impairment in 
endothelial-dependent dilation following SiNPs uptake and ultimately cause EC dysfunction 
and/or promote mechanism for cellular apoptosis. However, these speculations need to be 
further investigated and analysed on microvascular EC cultures in vitro.  
 
NP uptake was rapid and evident within 10 minutes of incubation. Decreasing or increasing 
the incubation period may result in different cellular uptake scenarios. Some of these may 
involve the uptake of SiNPs via more specialised mechanisms for cellular delivery following 
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extended incubation periods, the localisation and/or targeted delivery of nanomaterials to 
the VSMC layer or a reverse transport mechanism of internalised NPs out of cells into the 
vascular lumen. The uptake of SiNPs may involve special cellular adaptation strategy that 
may in part involve the gene expression of specialised vesicle structures for targeted 
internalisation, though there is no evidence to support such theory. Hence more detailed 
analysis would be necessary to account for all possibilities specifically nanomaterial 
trafficking, uptake, processing (localisation, targeting and/or metabolism) and 
nanomaterial-dependent roles (e.g. that of nanomaterial-induced entry, protein 
modification, transcription factor regulation and/or cellular gene expression). It is also 
essential to measure whether there is a time-dependent uptake i.e. a build-up of 
nanomaterial gradient as a function of time. This could also be useful in assessing the 
efficiency of the cellular uptake machinery and the factors that may account for their 
involvement in the nanomaterial-internalisation process. Such factors may be related to 
time-dependent or -independent vesicle formation, signalling pathways and/or 
downstream cellular effectors in addition to the type, size and concentration of the 
nanomaterial involved. One critical issue to consider is whether the internalised 
nanomaterials are dependent upon intracellular hydrodynamics and hence move down a 
concentration gradient in a disordered manner or whether they exhibit a more defined and 
uniform ordered pathway(s) that may or may not involve intracellular interactions and 
movement to other cellular layers. Hence, it will be worthwhile measuring the entropy 
change (Atkins, 2005) that couples such nanomaterial behaviour and assess the direction 
of nanomaterial route of adherence inside and outside cells whether in extracellular 
spaces, cellular paracellular spaces, tight-junctions and/or other cell types accounting for 
morphological and physiological changes accompanying such route.  
 
It is also not clear whether the prolonged incubation in NPs may enable their uptake into 
the nucleus of cells and/or in other organelles. Previous studies using QDs, suggest that a 
period of 4 hours was insufficient for the NPs to enter the nuclei of cells (Bakalova et al., 
2008). Hence, the absence of SiNPs from the nucleus may be due to insufficient time of 
exposure to the latter NPs, lack of an independent nuclear-related pathway of entry and/or 
a possible repulsion from the negatively charged DNA histones within the nucleus. Further 
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evidence and experimental approaches are needed to investigate this phenomenon. Thus 
the uptake-associated damage and/or toxicity to vascular function and integrity is possible 
and needs to be further tested in vivo as well as in vitro on endothelial microvascular cell 
cultures.  
 
4.4.3 The Influence of SiNPs on Vascular Function 
4.4.3.1 Effects of SiNPs on Vasoconstriction  
This is the first study to examine the effect of NPs on constrictor function of MAs. Phe acts 
via α1-adrenoceptors located on the membrane surface of the VSMCs to activate a Ca2+-
dependent sensitising pathway during the sustained late-phase contraction (Kitazawa and 
Kitazawa, 2012). The action of Phe is thought to be mediated via PKC leading to the 
phosphorylation and inhibition of myosin light chain phosphatase and subsequent 
sacroplasmic Ca2+ release and voltage-dependent Ca2+ influx (Kitazawa and Kitazawa, 2012). 
Hence, the compromise of the Phe-induced constriction and the unsustained constriction 
of the vessels at maximal Phe doses by SiNPs may be due to the random or the specific 
targeting and blockage of Phe receptor (thus acting as antagonist) and/or the enzymes, 
mediators and adaptor proteins involved in mediating the action of Phe. SiNPs may 
specifically target pathways leading to stimulation of VSMCs via α1-adrenoceptors, since 
no effects of SiNPs were observed on AVP responses. AVP acts via V1a vasopressin 
receptors which function via a different mechanism of contraction to that of Phe (Trandafir 
and Kaufman, 2007). 
 
4.4.3.2 Effects of SiNPs on Vasodilation  
4.4.3.2.1 Effects of SiNPs on ACh responses 
SiNPs significantly reduced ACh-related dilation of mesenteric vessels at specific doses. 
Previous studies have suggested that the vasodilation component in rat MAs may be 
elicited largely by EDHF (Crane et al., 2003). Consequently, the attenuation in dilation may 
be due to 1) the indirect or the direct role of SiNPs in targeting specific extracellular, 
intracellular and downstream factors involved in the EDHF-dependent pathway in ECs and 
2) the inability of NO to compensate for the loss in EDHF action due to the delayed NO 
production and/or the influence of SiNPs on eNOS or other factors involved in NO synthesis 
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and action. Additionally, the effect of SiNPs on EC function may be related to the 
interaction, disruption and/or blockage of the rat-specific muscarinic (M)-3 ACh receptors 
on ECs surface (Phillips et al., 1996), voltage-gated channels, gene expression as well as 
protein synthesis, trafficking and transport of the vasodilator machinery. Although in the 
case of the present study, effect on gene expression is excluded due to the acute nature of 
the study involving 30 minutes of NP incubation. SiNP surface may also generate ROS and 
that could quench NO, hence affecting vasodilation (Farooq et al., 2013).  
 
The inhalation studies of TiO2 NPs by Nurkiewicz group, suggesting NP’s detrimental effects 
on the microvascular function in the lungs with blunted arteriolar dilations and induced 
constrictions (Nurkiewicz et al., 2008) may be due to the disruption in NO signalling 
(Nurkiewicz et al., 2009) (support our findings). The TiO2 NPs were also capable of 
translocating into coronary arteries causing the impairment of the endothelium-dependent 
vasodilation in subepicardial arterioles from the coronary microvascular bed in rats 
(LeBlanc et al., 2009). A recent study by Nemmar et al., suggested a significant reduction in 
the endothelium-dependent relaxation (at ACh concentration of 0.1 µM) of rat small MAs 
(third-branches) following exposure to amorphous SiNPs (of 50 and 500 nm size 
respectively, at 50 µg/mL) in vitro using the wire myography system (Nemmar et al., 2014). 
Previous findings from our group also showed similar effects of SiNPs on the dilation of 
large rat aortic vessels. However, the study by Akbar et al. demonstrated that an acute 
exposure of rat aortic vessels to SiNPs of 100 and 200 nm nonmodified and positively 
charged NPs (at 1.1 × 1011 NP/mL) resulted in their uptake by the lining ECs with no 
detrimental effect on conduit arterial function (Akbar et al., 2011). Although the 100 nm 
and positively charged SiNPs had a greater degree of attenuation on the dilator responses 
of the aortic vessels in contrast to the unmodified 200 nm particles, these changes were 
not significant (Akbar et al., 2011). We suggest that our NPs have larger surface area to size 
ratio and can be surrounded by positive ions from PSS due to their negative surfaces (as 
determined by Zeta potential measurements) and hence interact more efficiently with the 
vascular ECs. Another study by Farooq et al. demonstrated the attenuation of endothelial-
dependent vasodilator responses by 30 and 70 nm SiNPs and dye-encapsulated SiNPs (1.96 
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× 1012 NP/mL) in aortic vessels whereby the degree of attenuation was related to NP 
surface area rather than size (Farooq et al., 2013).  
 
A previous study using a wide range of negatively surface-charged SiNPs (of a Zeta potential 
more than -30 mV) sizes (10, 50, 150 and 500 nm) resulted in SiNPs penetration of PMs and 
stimulated generation of NO by HUVECs and correlated with endothelial inflammation and 
necrosis (Corbalan et al., 2011). The generation of NO was followed by the production of 
oxidant and cytotoxic ONOO−, which is regarded as a major component of oxidative stress 
(Corbalan et al., 2011). This action of SiNPs was directly related to NP dosage specifically 
for the smaller-sized NPs (10 and 50 nm); thus with increased SiNPs dose, there was a rapid 
exponential rate of ONOO− release from ECs, possibly due to the large surface area in 
smaller SiNPs as opposed to larger ones (Corbalan et al., 2011). Hence, the production of 
ONOO− following SiNPs exposure significantly reduced the ratio of [NO]/[ONOO−] in a size-
dependent manner shifting the balance of maximal [NO]/[ONOO−] unfavourably with this 
being more effective at the smallest SiNP (10 nm) concentration of at 10 μg/mL (Corbalan 
et al., 2011). In contrast, our study used larger sized SiNPs of approximately 100 nm with 
an effect on vascular dilation in a wider context, where ECs were lining the vascular lumen 
as opposed to HUVECs in vitro, thus contributing to the different mechanism(s) of ECs 
damage. Therefore, the increased nitroxidative/oxidative stress may not directly relate to 
the impairment in ACh responses.  
 
The toxicity effect of rhodamine B dye that encapsulate SiNPs was previously studied and 
found to decrease the number of vascular ECs from the bovine aorta and VSMCs from 
murine aorta after 72 hours of incubation in vitro and inhibit the proliferation of human lip 
fibroblasts (Kaji et al., 1991). Although the dye molecules did not influence cellular 
detachment in the latter study, we suggest that the dye molecules may have a role in 
mediating SiNP-induced damage to ECs of the vessel lining hence inhibiting cellular 
proliferation (Figure 65A). This was previously supported by Kaji et al. where human lip 
fibroblasts experienced a degenerative change of their nuclei and an irregular shape of the 
cells as well as a decrease in their cell number following the incubation in 50 µg/mL of the 
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rhodamine B dye (Kaji et al., 1991). The direction and extent of such interference needs to 
be further investigated via molecular studies on MAs and cellular cultures. 
 4.4.3.2.2 Effects of SiNPs on SNP responses  
The results from the SNP experiments in the present study suggest that the NO-
independent pathways for mesenteric vessels are unaffected by the action of SiNPs 
suggesting that smooth muscle sensitivity to NO was unaffected by SiNP exposure. This 
finding was supported by other studies from our group, in large vessels described earlier.   
 
SiNPs uptake, delivery, localisation and distribution may have a biophysical as well as 
biochemical impact on cellular functions. These may include the disruption of the integrity 
of cellular paracellular pathways and/or TJ components, obstruction of cell trafficking (by 
e.g. blocking the accommodation of certain signalling molecules to their receptors) and the 
disturbance to cell membrane permeability to certain electrolytes. These changes may be 
due to the biophysical presence of the NP themselves inside the cells, their thermodynamic 
and hydrodynamic impact and the change in free energy (entropy change) (Atkins, 2005). 
All of these factors may influence the haemostasis of vascular tissue integrity and 
physiology. The state and fate of the NPs is also important such as the aggregation status 
of the NPs or their possible interactions, excretion and clearance.  
 
 
 
 
 
 
 
 
 
 
 
 
150 
 
 
  
 
 
 
 
 
 
Chapter 5. 
The Influence of SiNPs on 
Arterial Function, in Vivo 
(Vascular Function and 
Biodistribution Study) 
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5.1 Effects of SiNPs on Vascular Responses in vivo 
 
The intravenous injection of SiNPs (calculated at 5.32 x 1011 NP/mL) in vivo for a period of 
2 hours produced similar results to the ex vivo, mimicking the control vascular responses 
to Phe and ACh (in Phe pre-constricted vessels). However, there was a high variability with 
a high standard error of mean across the in vivo experiments.  
 
 
5.1.1 Vasoconstrictor Responses  
There was no overall change in the constrictor responses in MAs from the in vivo injected 
rat when superfused in high potassium solution (KPSS) at 60 mM concentration as 
compared to control, similar to ex vivo; (The mean percentage constriction was 78.49 ± 
7.13% vs. 71.29 ± 17.39% after incubation in control and SiNP injection respectively, n=7 
and 4 respectively, unpaired t test, NS; Figure 67). 
 
 
Figure 67. The influence SiNPs injected in vivo, on the KPSS-induced contraction. ‘n’ is 
number of vessels, error bars=SE.  
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There was no overall change in the Phe constrictor responses in MAs from the in vivo 
injected rat at lower concentrations of Phe (from 1 nM to 1 µM) as compared to control; 
(At 100 nM Phe, the mean percentage constriction was 15.85 ± 4.05% vs. 19.48 ± 13.57% 
after incubation in control and SiNPs respectively, n=4 and 3 respectively, unpaired t test, 
NS; Figure 68). However, intravenously-injected SiNPs caused an attenuation to Phe 
constrictor responses at higher concentrations (10 µM and 100 µM) compared to control, 
mimicking the ex vivo responses with the latter being more significant the 10 µM 
concentration of Phe; (At 10 µM Phe, the mean percentage constriction was 98.55 ± 1.45 
% vs. 81.30 ± 5.90 % after incubation in control and SiNP injection respectively, n=4 and 3, 
unpaired t test, p<0.05; Figure 68).  
 
 
Figure 68. The influence of SiNPs injected in vivo, on the Phe-induced contraction. ‘n’ is 
number of vessels. *p<0.05, error bars=SE. Two-factor repeated measures ANOVA. P 
values correspond to comparisons between SiNPs incubated either ex vivo or in vivo vs. 
control Phe responses of MAs. 
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5.1.2 Vasodilator Responses 
5.1.2.1 Endothelial-dependent (ACh) Responses 
The injection of SiNPs in vivo, at a final dosage of 5.32 x 1011 NP/mL, led to an overall trend 
of reduction in the magnitude of dilator responses to ACh specially at lower concentrations 
of ACh (10-13 to 10-8 M; similar to ex vivo responses), including the maximal concentration 
of ACh (1 mM). In vivo injected NPs however, produced significant reduction in the 
magnitude of ACh-induced dilation only at specific concentrations (100 nM and 1 mM of 
ACh; similar to ex vivo) following Phe pre-constriction of MAs. For instance at 100 nM 
concentration of ACh, the mean percentage dilation was 78.77 ± 8.58% vs. 16.42 ± 7.96% 
after incubation in control and SiNP injection respectively (n=6 and 3 respectively, unpaired 
t test, p<0.01; Figure 69). The dilator responses were improved at high ACh concentrations 
(1 µM – 100 µM) in vivo compared to ex vivo following SiNP injection. For instance, at 1 µM 
concentration ACh, the mean percentage dilations were 91.52 ± 12.80% vs. 27.82 ± 5.13% 
for in vivo and ex vivo exposure respectively (n=11 and 3 respectively, unpaired t test, 
p<0.0001; Figure 69). Despite the recovery of the dilator responses in vivo, the incubation 
in SiNPs significantly reduced the dilation of the vessels at the highest concentration of ACh 
(1 mM); (At 1 mM concentration of ACh, the mean percentage dilation was 101.76 ± 0.69% 
vs. 93.81 ± 1.80% after incubation in control and SiNP injection respectively, n=6 and 3 
respectively, unpaired t test, p<0.01; Figure 69). Hence, the injection of NPs in vivo 
displayed less detrimental effect compared to ex vivo.  
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Figure 69. The influence of SiNPs injected in vivo, on the ACh-induced relaxation in Phe 
pre-constricted vessels. ‘n’ is number of vessels. **p<0.01, #p<0.001 and ##p<0.0001, error 
bars=SE. Two-factor repeated measures ANOVA. P values correspond to comparisons 
between SiNPs incubated either ex vivo or in vivo vs. control ACh responses of MAs.  
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5.2.2.2 Endothelial-independent (SNP) Responses 
The endothelial-independent dilator responses to the NO donor, SNP were significantly 
affected by SiNPs that were injected in vivo at specific SNP concentrations (10 and 100 nM); 
(At 10 nM concentration of SNP, the mean percentage dilation was 74.67 ± 5.74% vs. 4.20 
± 2.80% after incubation in control and SiNP injection respectively, n=4 and 3 respectively, 
unpaired t test, p<0.001; Figure 70). The submaximal concentration of SNP also displayed 
a significant reduction in dilation in SiNPs-injected rat; (At 100 nM concentration of SNP, 
the mean percentage dilation was 102.20 ± 4.03% vs. 15.21 ± 13.40% after incubation in 
control and SiNP injection respectively, n=4 and 3 respectively, unpaired t test, p<0.01; 
Figure 70). Dilator responses were unaffected at higher SNP concentrations (1 µM, 10 µM 
and 100 µM) following SiNPs injection in vivo (n=3, NS; Figure 70).  
 
 
Figure 70. The influence of SiNPs injected in vivo, on the SNP-induced relaxation in Phe 
pre-constricted vessels. ‘n’ is number of vessels. *p<0.05, and #p<0.001, error bars=SE. 
Two-factor repeated measures ANOVA. P values correspond to comparisons between 
SiNPs incubated either ex vivo or in vivo vs. control SNP responses of MAs. 
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5.2.2.3 Responses to PAPA  
The vasodilator responses to the smooth muscle cell relaxant, papaverine were not 
affected by SiNPs injection in vivo; (At 100 µM concentration of SNP, the mean percentage 
dilation was 89.04 ± 12.53% vs. 104.53 ± 4.32% after incubation in control and SiNP 
injection respectively, n=3, paired t test, NS; Figure 71).  
 
 
Figure 71. The influence of SiNPs injected in vivo, on the PAPA-induced relaxation in Phe 
pre-constricted vessels. ‘n’ is number of vessel, error bars=SE. 
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5.2 Determination of SiNPs Uptake, Concentration and Biodistribution 
 
TEM and ICP analysis was used to verify and quantify SiNP uptake by the rat mesenteric 
arteries as well as their biodistribution within major organs (such as the lung, heart, aorta, 
mesenteric artery, liver, spleen and kidneys). The concentration of SiNPs was determined 
in NP samples, biological media (PSS) and samples (tissues and organs from in vivo tissues) 
using ICP. The measurements were mean values from three readings per sample per 
experiment. The ICP determined the relative amount of SiNPs when injected at 0.217 g for 
the A3 SiNPs and 0.103 g for the DA3 SiNPs samples respectively to obtain a final 
concentration of 5.32 x 1011 NP/mL of blood of the rat. These results were used to quantify 
the actual concentration SiNPs within solutions in ppm/mL by considering the estimated 
dilution factor. The uptake concentrations were expressed as percentage.  
 
 
5.2.1 Cellular Uptake of SiNPs  
Examination of the TEM sections demonstrated the presence of SiNPs inside various tissues 
(Figure 72). TEM sections were taken from a random tissue section related to one tissue 
type. Within the spleen, two SiNPs were identified of 106 and 94 nm in size respectively. In 
the kidney, NPs were located in connective tissues. In one section, examined at random, 
one SiNP (240 nm diameter) was identified inside a fibroblast cell within the kidney tubules.  
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Figure 72. TEM images of SiNP uptake by the lungs (A-C), heart (D-F), spleen (G-I) and 
kidney (J-L) from the in vivo injected rat. The SiNPs are represented by black spherical 
structures inside various tissues (arrows). 
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Within the aorta, SiNPs were identified within ECs. In one TEM section, examined at 
random, 8 SiNPs were present within the cytosol of ECs (Figure 73).  
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Figure 73. TEM images of SiNP uptake by the aorta from the in vivo injected rat (A-F). The 
SiNPs are represented by black spherical structures inside ECs (arrows). 
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Within the MAs, A few SiNPs (two of 80 nm in size and one at a 100 nm) were identified 
within the cytoplasm of ECs with none being identified in the nucleus, VSMC layer or the 
adventitia in a random TEM section (Figure 74).  
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Figure 74. TEM images of SiNP uptake by MAs in vivo injected rat (A-I). The SiNPs are 
represented by black spherical structures inside ECs (arrows). 
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5.2.2 SiNP Biodistribution within Tissues and Organs.  
The ICP results confirmed the internalisation of SiNPs within various tissues and organs 
after their injection in vivo (Figures 75). A small fraction of 6% of the SiNPs administered in 
vivo were localised into various tissues including; lungs, heart, aorta, mesentery, liver, 
spleen and kidney. The percentages for their distribution into different tissues as 
determined by ICP are illustrated in Figure 76. Despite the minimal concentration of SiNPs 
internalised into different tissues, the largest fraction of uptake was observed within the 
MA tissue with the latter accounting for nearly 5% of SiNPs injected in vivo (Figure 75). 
 
 
Figure 75. The mean normalised silicon oxide concentration (g) per 1 g of in vivo tissue. 
The pie chart illustrates how the 6% fraction of internalised SiNPs was distributed within 
tissues.  
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Figure 76. Mean percentage of SiNPs present in in vivo tissues. Expressed as a mean 
percentage of the actual dose injected (100%).  
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5.3 Discussion  
 
SiNPs injected in vivo, had no overall effect on Phe-induced contraction (at the higher 
doses) contrary to the results found after ex vivo infusion of SiNPs. This may be due to the 
corona formation after the SiNPs are injected into the blood (Tenzer et al., 2011), thus 
preventing their interaction with the α1-adrenergic receptors. Although SiNPs injected in 
vivo, induced a significant reduction in ACh dilator responses at the lower doses, there was 
no overall detrimental reduction in dilation at the high doses. Again, this may relate to 
corona formation. Whilst having no overall effect on SNP responses ex vivo, SiNPs injected 
in vivo, significantly reduced SNP-induced dilator responses at a lower dosage. Thus SiNPs 
may have an impact on the clinical use of NO donors in different settings including NO-
releasing NPs (Naghavi et al., 2013) and NO-releasing polymers for vascular stents (Seabra 
et al., 2008). The ability of PAPA to induce relaxation of VSMCs after the in vivo SiNPs 
injection (attributed to its direct action on the smooth muscle layer independent of the 
endothelium) suggests that SiNPs had no overall effect on the contractile machinery, or the 
integrity of VSMCs. Indeed, previous studies suggest the involvement of PAPA in the 
suppression of the L-type Ca2+ currents in VSMCs (Iguchi et al., 1992) through the blockage 
of voltage-dependent L-type Ca2+ channels (Bolton, 1979).  
 
The uptake of SiNPs by ECs was confirmed by TEMs and quantified by ICP, involving rigorous 
calculation, which took into account all factors including the presence of silica in natural 
tissues. TEM images may not account for all tissue cross-sections and hence may miss out 
SiNPs localised into any plane of the tissue and/or organ section. ICPs results suggest that 
SiNPs had largely accumulated in MAs in vivo. The mesentery represents the highest 
proportion of ECs, in comparison to other tissues e.g. the heart. Hence, the presence of 
larger proportion of ECs on small- and microvessels per surface area compared to other 
tissues may account for more uptake in vivo.   
 
Two batches of SiNPs were used for the in vivo study. These were used at the same dosage 
(NP/mL), but were of slightly different sizes 98 nm vs. 110 nm). The corresponding weight 
and surface area difference may have added a factor in the small variation observed 
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between the 3 different experiments. Since our group has previously demonstrated that it 
is NP number (hence surface area) rather than mass that affects vascular function. The 
results obtained in vivo need to be established with further experiments due to the limited 
n number (n=3). Also additional variable factors may be considered to account for extended 
SiNP exposure time of the rats, hence more circulatory time of NPs as well as real-time 
imaging of the fate of SiNPs, using the luminescent dye as a tracking material. A similar in 
vivo study by Borak et al. found that only 36% of the introduced SiNPs (150 nm) were 
excreted with urine after four days of iv injection (Borak et al., 2012). The remaining 
particles were accumulated in the lung air sacs and kidney glomerulus (Borak et al., 2012). 
Smaller size SiNPs (70 and 35 nm; but not 300 and 100 nm ones) were demonstrated to 
cross the placenta barrier in pregnant mice resulting in retarded uterus and foetus 
formation and caused pregnancy complications (Yamashita et al., 2011).  
 
Due to their predominant negative charge, SiNPs may have sequestered in the liver as 
indicated previously by Souris et al. (Souris et al., 2010). The neutralisation of the negative 
change or the possible change of surface charge to positive by corona formation in 
circulation, may have led to SiNP hepatobiliary excretion from the liver into the 
gastrointestinal tract (Souris et al., 2010). The corona formation of SiNPs are suggested to 
be charge-dependent and involve the adsorption of serum proteins facilitating 
hepatobiliary excretion (Souris et al., 2010). The excretion of SiNPs by the liver may explain 
the absence of SiNPs presence in the latter tissue in our present study.  
 
The fluorescent rhodamine B dye used to encapsulate our dye-encapsulated SiNPs, had 
previously demonstrated its ability to form a thiourea bond with thyroxine (T4) and 
triiodothyronine (T3) (Ermolenko et al., 1992). This phenomenon may have been implicated 
in the in vivo study, where dye molecules may have formed conjugates with plasma and/or 
serum proteins leading to blood corona formation and reducing the effects they have on 
blood vessels as in ex vivo.   
 
The presence of SiNPs in circulation may make them prone to corona formation and altered 
surface characteristics. The corona concept was previously demonstrated through a rapid 
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and extensive interaction between human serum albumin and SiNPs with a characteristic 
distributed adhesion of the protein and particle (Ang et al., 2014). The extent of NP damage 
was suggested to be related not only to the electrostatic effects of SiNPs and protein 
affinity but also to the hydrodynamic size of the latter NPs rather to than their 
concentration and/or protein size or charge (Tenzer et al., 2011). Although the effects of 
such phenomenon have not been tested in our study, further experiments using larger SiNP 
may provide some clues. Corona formation may lead to varied interaction with the 
surrounding tissues, proteins and receptors, improving their biocompatibility. However, 
the corona may also lead to a change in hydrodynamic size in the serum and/or their 
subsequent aggregation. This could possibly lead to the blockage or closure of microvessels 
such as arterioles and capillaries. The aggregation of NPs formed in the blood was 
previously suggested to cause obstruction in the capillaries of the lung, resulting in acute 
embolism (Muzykantov, 2005). A previous study by Yu et al. suggested a mechanical 
obstruction in the vasculature caused by the iv injection of 170 nm non-porous SiNPs at 
450 mg/Kg (Yu, Greish, et al., 2012). The latter resulted in congestion in major organs, lesion 
formation and subsequently organ failure (Yu, Greish, et al., 2012). This phenomenon is 
critical as applied to in vivo; as it indicates that the physical impact of SiNPs on the 
vasculature rather than their mediated cellular-toxicity effects and may limits their safety. 
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Chapter 6. 
 
The Molecular 
Mechanisms of SiNP-
induced Attenuated 
Dilation 
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Findings from the present study suggest that SiNPs have a detrimental effect on 
endothelial-dependent (ACh) dilator responses. In order to elucidate the mechanisms 
involved, a series of experiments were conducted including; the characterisation of the 
dilator component, the influence of superoxide dismutase and the analysis the cellular 
signalling pathway. We examined two theories; concerning 1) The involvement of ROS in 
mediating SiNPs-induced impairment to vascular function and 2) the role of inhibitors such 
as L-NNA, apamin, TRAM-34 and indomethacin in elucidating the pathways SiNPs may 
target to mediate their effects. Firstly, however, the dilator component within the rat MAs 
were elucidated using inhibitor studies.  
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6.1 Characterisation of the Dilator Component (Inhibition Studies)  
 
6.1.1 Influence of L-NNA 
The inhibition of NO synthesis via a NO synthase-inhibitor; L-NNA (at 100 µM) ex vivo 
caused a drastic reduction of ACh-induced dilator responses in KPSS pre-constricted 
vessels, with this being significant at all ACh concentrations tested (10-9 to 10-5 M). At the 
submaximal ACh concentration (100 nM) the mean percentage dilation was 74.25 ± 8.17% 
vs. 10.95 ± 6.44% after incubation in control and SiNPs respectively (n=4 and 5 respectively, 
unpaired t test, p<0.0001; Figure 77).   
 
 
Figure 77. The influence of incubation in L-NNA superfused in PSS and luminally-infused 
ex vivo on the ACh-induced relaxation in KPSS pre-constricted vessels. ‘n’ is number of 
vessels. **p<0.01, #p<0.001 and ##p<0.0001, error bars=SE. One-factor repeated 
measures ANOVA. P values correspond to comparisons between L-NNA-incubated vs. 
control ACh responses of MAs. 
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 In contrast to KPSS-reconstricted vessels, the 30 minutes inhibition of NO synthesis and 
release had no overall effect on the ACh-induced dilator responses in Phe pre-constricted 
vessels. This is despite a significant decrease in dilation to ACh at 10 nM; (At 10 nM ACh, 
the mean percentage dilation was 39.30 ± 11.25% vs. 8.78 ± 4.86% after incubation in 
control and LNNA respectively, n=6, paired t test, p<0.05; Figure 78), while the dilations to 
1 nM, submaximal (100 nM) and higher (1 µM and 10 µM) ACh concentrations were 
preserved.   
 
 
Figure 78. The influence of incubation in L-NNA on the ACh-induced relaxation in Phe pre-
constricted vessels. ‘n’ is number of vessels. *p<0.05, error bars=SE. One-factor repeated 
measures ANOVA. P values correspond to comparisons between L-NNA-incubated vs. 
control ACh responses of MAs. 
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6.1.2 Influence of Apamin and TRAM-34 
The vascular incubation in apamin (at 100 nM) and TRAM-34 (at 1 µM) alone for 30 minutes 
significantly decrease the dilator responses at specific ACh concentrations (1 nM, 10 nM 
and 100 nM). At 100 nM ACh, the mean percentage dilations were 78.77 ± 8.58% vs. 6.99 
± 5.71% and 12.17 ± 4.99%  after incubation in control, apamin and TRAM-34 respectively 
(n=6 and 4 respectively, unpaired t test, p<0.05; Figure 79). The dilatory responses were 
recovered at higher ACh concentrations (1 µM and 10 µM) (Figure 79). The co-incubation 
of MA in apamin and TRAM-34 however, significantly reduced and almost abolished the 
vasodilator responses to ACh in contrast to apamin or TRAM alone (Figure 79). At 100 nM 
ACh, the mean percentage dilation was 78.77 ± 8.58% vs. 17.09 ± 12.99% after incubation 
in control and apamin with TRAM-34 respectively, n=6 and 4 respectively, unpaired t test, 
p<0.05; Figure 79).   
 
 
Figure 79. The influence of co-incubation in apamin and TRAM-34 on the ACh-induced 
relaxation in Phe pre-constricted vessels. ‘n’ is number of vessels. *p<0.05, 
**p<0.01, #p<0.001 and ##p<0.0001, error bars=SE. Three-factor repeated measures 
ANOVA. P values correspond to comparisons between inhibitor-incubated vs. control 
ACh responses of MAs. 
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6.1.3 Influence of All Inhibitors (including indomethacin) 
The use of an inhibitor cocktail containing L-NNA, apamin and TRAM-34 attenuated the 
vasodilator responses to ACh despite a minimal degree of dilation of 7.96-10.98% that was 
sustained at the maximal ACh concentration of 1 µM and 10 µM, respectively (Figure 
80). To investigate whether a NO-independent pathway is involved in mediating the small 
degree of dilation that is present following the inhibition in L-NNA, apamin and TRAM-34, 
we have used a cyclooxygenase inhibitor; indomethacin (at 10 µM). The inhibition of the 
COX with indomethacin for 30 minutes had no overall effect on the ACh-induced dilator 
responses in Phe pre-constricted vessels; (At 100 nM ACh, the mean percentage dilation 
was 78.77 ± 8.58% vs. 84.41 ± 10.97%  after incubation in control and indomethacin 
respectively, n=6 and 4 respectively, unpaired t test, p<0.05; Figure 80). However, the use 
of all inhibitors including indomethacin abolished the vasodilator responses to ACh (Figure 
80).  
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Figure 80. The influence of the inhibitor cocktail of L-NNA, apamin and TRAM-34 as well 
as indomethacin on the ACh-induced relaxation in Phe pre-constricted vessels. ‘n’ is 
number of vessels. *p<0.05, **p<0.01, #p<0.001 and ##p<0.0001, error bars=SE. Multi-
variate repeated measures ANOVA. P values correspond to comparisons between 
inhibitor-incubated vs. control ACh responses of MAs. 
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102.30 ± 4.03% vs.  114.97 ± 5.28% after incubation in control and all inhibitors respectively, 
n=3, paired t test, NS).  
 
6.2 The Influence of Co-incubation of SiNPs with Inhibitors 
 
The co-incubation of SiNPs (5.32 x 1011 NP/mL) in the presence of L-NNA completely 
abolished the dilator responses to ACh at all concentrations tested (Figure 81). The most 
drastic effects were observed at the submaximal (100 nM), maximal (1 µM) and highest (10 
µM) ACh concentrations (At 100 nM ACh, the mean percentage dilation was 78.77 ± 8.58% 
vs. 3.09 ± 1.48% after incubation in control and SiNPs with L-NNA respectively, n=6 and 7 
respectively, unpaired t test, p<0.0001; Figure 81).   
 
 
Figure 81. The influence of co-incubation in SiNPs and L-NNA on the ACh-induced 
relaxation in Phe pre-constricted vessels. ‘n’ is number of vessels. *p<0.05, #p<0.001 
and ##p<0.0001, error bars=SE. Two-factor repeated measures ANOVA. P values 
correspond to comparisons between either SiNPs incubated ex vivo or with L-NNA vs. 
control ACh responses of MAs. 
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6.3 Influence of Superoxide Dismutase 
 
When the vessels were co-incubated in SiNPs (at 5.32 x 1011 NP/mL) and SOD dilation of 
Phe pre-constricted vessels was not restored but led to further reductions in the ACh dilator 
responses specially at higher ACh doses (10-5 to 10-3 M) (At 10 µM ACh, the mean 
percentage dilation was 96.68 ± 7.82% vs. 35.58 ± 3.51% after incubation in PSS and SiNPs 
with SOD respectively, n=6 and 5 respectively, unpaired t test, p<0.0001; Figure 82). 
 
 
Figure 82. The influence of co-incubation in SiNPs (at 5.32 x 1011 NP/mL) and SOD on the 
ACh-induced relaxation in Phe pre-constricted vessels. ‘n’ is number of vessels. 
**p<0.01, #p<0.001 and ##p<0.0001, error bars=SE. Two-factor repeated measures 
ANOVA. P values correspond to comparisons between either SiNPs incubated ex vivo or 
with SOD vs. control ACh responses of MAs. 
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6.4 Analysis of the Cellular Signalling Pathway  
 
The influence of SiNPs at the physiological level may translate into a change in the levels 
and/or the phosphorylation or de-phosphorylation pattern of certain proteins or regulatory 
proteins involved in mediating and/or facilitating vasodilation. These proteins may involve 
regulatory factors, adaptor proteins, enzymes and ion channels directly associated with the 
NO and/or EDHF-related pathways leading to the relaxation of small arteries. Hence, 
phosphorylated protein detection was carried out using the Proteomics Screening 
approach.   
 
100 MA segments (first-sixth order MAs) were collected per experimental condition, 
excluding the superior MA, and incubated in various conditions including: negative control 
(PSS only), positive control (ACh-stimulated), SiNPs control (NP only) and NPs with ACh-
stimulated vessels for the duration of 30 minutes. The latter tissues were processed as 
mentioned previously in the methodology. We examined whether SiNPs had an effect on 
the phosphorylated levels or form of key protein targets involved in the vasodilatory 
pathway in the rat MAs and arterioles. Initially a screening method was accomplished to 
screen over a number of protein targets within the vascular relaxation pathway using the 
Human Phospho-Kinase Antibody Array (Catalogue Number: #ARY003B, R&D Systems, 
Abingdon, UK) according to manufacturers’ instructions. The array was used for the 
detection of the relative phosphorylation levels of 46 intracellular kinases using a simple 
two-site sandwich assay principle. Proteins were visualised using chemiluminescence 
(Hyperfilm ECL; Amersham), scanned using a Syngene densitometer and analysed using the 
GeneSnap software (Syngene). The 5 minutes stimulation with 10 µM of ACh had led to the 
increase in the levels of phospho-ERK (p-ERK 1/2) and phospho-Akt (p-Akt 1/2/3) in isolated 
MAs compared to control (PSS only) (Figure 83). In contrast, the incubation in SiNPs for 
normal vessels (NPs only) or stimulated vessels (NP with ACh) had reduced the levels of p-
ERK and p-Akt compared to the levels detected in control vessels (Figure 83). The reduction 
in the phosphorylated pattern of ERK was more pronounced in the NP only-treated vessels 
as compared to stimulated ones (Figure 83). This gives an insight into the mechanism of 
attenuated vasodilation. Further molecular work is beyond the scope of the present study.    
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Figure 83. A) The effect of SiNPs on the phosphorylated levels of protein targets involved 
in mediating ACh-induced vasodilatation. A representative proteomics blot for the 
protein samples extracted from the pooled MAs from the Wistar Rat. The intensity of the 
dots shown above represent the quantity of the phosphorylated kinase present. B) A 
quantitative analysis of the p-ERK 1/2 blot shown in A. C) A quantitative analysis of the 
p-Akt 1/2/3 blot shown in A. 
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6.5 Discussion 
 
In order to elucidate the mechanisms by which SiNPs attenuate vasodilator responses, it 
was necessary first to determine what mediators were responsible for the dilator 
component in MAs. L-NNA is known as a competitive inhibitor of eNOS (Griffith and 
Kilbourn, 1996; Garvey et al., 1994), due to its ability to bind to enzyme pockets that in turn 
prevents other NO substrates from binding, thus blocking the NOS action and ultimately 
preventing NO generation (Clark et al.). The inhibition studies demonstrate that; 1) in 
depolarised vessels (KPSS preconstriction), NO was the major dilator component. 2) In Phe-
preconstricted vessels, the vasodilator response was influenced by all inhibitors tested (L-
NNA and potassium channel blockers), thus demonstrating that both NO and EDHF 
contribute to the vasodilator response in MAs. Therefore, the incubation of MAs in L-NNA 
may have partially compromised vasodilation because of reduced NO bioavailability (Joshi 
and Woodman, 2012). This suggests that NO may only partly contribute to the vasodilator 
component of MAs (Figure 77). The co-incubation of SiNPs in the presence of L-NNA 
completely abolished the dilator responses to ACh (Figure 80). This suggests that SiNPs may 
directly affect the EDHF pathway. Hence, EDHF act as an important dilator for MAs. This is 
further demonstrated by the use of the potassium channels inhibitors (apamin and TRAM-
34) alone and in combination. The results from the potassium channel inhibitors studies 
indicate the dependence of the mesenteric artery on both the SKCa and IKCa channels 
mediating the dilatory responses to ACh as previously suggested (Crane et al., 2003). 
Furthermore, there may be a cross-talk between the pathways leading to potassium 
channel activation within the endothelium such that the absence of the small potassium 
channels are compensated functionally by the intermediate channel partners. Our 
inhibition studies were previously supported by Jane and Langton who used apamin and 
TRAM-39 (at 50 nM) and demonstrated that the abolition of EDHF required the presence 
of both SKCa and IKCa channels using rat isolated MAs mounted on a wire myography system 
(Hinton and Langton, 2003). In rat mesenteric arteries, the stimulation of ECs results in the 
activation of endothelial calcium-sensitive potassium channels and leads to the generation 
of the hyperpolarising event. The resulting efflux of K+ from ECs via SKCa and IKCa channels 
(Edwards et al., 1998), regarded as the hyperpolarisation current, propagates or spreads 
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passively via myoendothelial gap junctions (Sandow and Hill, 2000; Sandow et al., 2002) to 
accumulate in the myoendothelial space where it stimulates the Na+/K+ ATPase pumps and 
voltage-gated potassium channels (Kv; e.g. Kv1.5 and Kv2.1 (Hald et al., 2012)) in VSMCs 
(Edwards et al., 1998). This results in the EDHF-attributed hyperpolarisation in VSMCs. 
Hence, the EC-VSMC electrical coupling (Little et al., 1995) is characterised by endothelial 
potassium channels that influence smooth muscle cell contractile activity by reducing Ca2+ 
influx via voltage-operated Ca2+ channels and by suppression of key enzymes involved in 
agonist-induced transduction pathways (Itoh et al., 1992). Thus it is logical to suggest that 
SKCa and IKCa channels are located and constitutively expressed in abundance on ECs in rat 
mesenteric arteries (Parkington et al., 2002), and their opening is voltage-independent but 
sensitive to a rise in endothelial Ca2+ (Gluais et al., 2005) (Figure 84). Previous studies 
determined the endothelium as being the specific site of action for apamin (Doughty et al., 
1999). Hence, we suggest that the SKCa channels affected here are related specifically to 
the action of apamin on ECs. The contribution of SKCa and IKCa channels to EDHF-mediated 
dilation as confirmed by our inhibition studies was also previously suggested to be more 
pronounced than the contribution made by other potassium channels such as Kv channels 
(Waldron and Garland, 1994). Taken together; with the fact that SiNPs uptake was only 
evident in ECs lining the blood vessels and that inhibitors were applied intravascularly 
inside the MA vessel lumen, we suggest that the SiNPs significantly affected dilation related 
to SKCa and IKCa  channels of endothelium origin. Our results from the inhibition studies 
provide further support to the belief that SKCa and IKCa channels are most abundant in 
endothelial cells, but not VSMCs from mesenteric arteries. 
 
It would be interesting to examine whether the incubation of 11,12-EET with MAs (Potente 
et al., 2003) will improve the dilator responses to ACh following SiNP incubation. This will 
determine the impact and contribution of an exogenously applied EDHF-derived precursor 
to the dilation responses of mesenteric vessels. The dilation of MAs in the presence of the 
inhibitor cocktail (L-NNA, apamin and TRAM-34) was not sufficient to completely abolish 
the dilator response of the MA and was able to maintain a very minimal dilation (the 
dilation of MAs were 8 and 11% at high ACh concentrations of 1 µM and 10 µM, 
respectively). This may suggest the presence of minimal degree of residual relaxation 
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despite the use of all inhibitors and the possible contribution from other pathway(s) in 
mediating vasodilation in second order rat MAs in particular, which may also be affected 
by SiNPs. Although the use of the cylcooxygenase inhibitor (indomethacin) did not have an 
overall effect on dilation, however its co-incubation with L-NNA, apamin and TRAM-34 
abolished the dilatory response of the MA. The latter suggests a minor additional 
contribution from prostanoids from the cyclooxygenase pathway to the dilator component 
of mesenteric arteries (Honing et al., 2000). Previous reports also suggest the participation 
of connexins (37, 40 and 43; reviewed in (Griffith et al., 2001)) from Chaytor paper 2005); 
in mediating the endothelial-dependent hyperpolarisation via myoendothelial gap 
junctions in different vascular beds (Taylor et al., 1998; Chaytor et al., 2005; de Wit and 
Griffith, 2010). These gap junctions may have alternative potassium channels to the 
apamin/TRAM-34-sensitive calcium-activated potassium ones and/or rely on other 
pathways that lead to vasodilation including cAMP (Chaytor et al., 2002).   
 
The rationale for using SOD as a ROS scavenger was an attempt to examine the involvement 
of ROS in mediating SiNPs damage as previously suggested (Fubini, 1997). Due to the 
dependence of the endothelium-derived NO factor in causing vasodilation, an elevation in 
ROS may quench NO, leading to impaired vasodilator responses (J. Kim et al., 2011). 
Furthermore; a study by Zhao et al. suggested the impairment of EDHF-related vasodilation 
in the MAs of the rat via ROS-dependent mechanism (Zhao et al., 2013). Hence, we have 
assumed that the attenuated vasodilatory function of the MAs upon the exposure to SiNPs 
may be mediated via the production of ROS. However, the data obtained show that SOD 
worsened dilation and no improvements were apparent when co-incubated with SiNPs. 
Hence, in light of results from vessels co-incubated in SiNPs and SOD (inability of SOD to 
restore vasodilation), we suggest that the mechanism for SiNPs impairment of vasodilation 
is ROS-independent and may involve alternative mechanisms. This finding contradicts other 
studies reporting the effects of SiNPs on inducing endothelial cells dysfunction through 
oxidative stress via JNK-, p53- and NF-κB-related pathways (Liu and Sun, 2010) or the 
induction of antioxidant enzymes (catalase, lutathione stransferase and thioredoxin 
reductase) by 100 nm SiNPs through ROS-dependent pathways (Passagne et al., 2012).  
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To determine whether SiNPs effects were on the basal phosphorylated forms of ERK and 
Akt and/or their expression levels, our findings suggest that under stimulated conditions 
there is a reduction (and/or down regulation in expression) of p-ERK and p-Akt levels 
following SiNPs uptake by first- to sixth order-MAs ex vivo. This highlights the critical role 
of phosphorylated ERK and Akt in mediating ACh-induced dilation of small arteries. The 
effect of SiNPs on MAs may be mediated through their effects on blocking the NO and 
EDHF-related signalling pathway at least in part via their ability to reduce the 
phosphorylated levels of both ERK and Akt. The latter may act independently or together 
to limit the action (if there are existing basal levels) and/or our expression of both eNOS 
and EDHF causing the compromise in the dilator responses of MAs to ACh ex vivo. Since 
EDHF is the principal dilator in MAs (Hilgers et al., 2006; Hilgers and Webb, 2007), we 
suggest that this is mostly affected by SiNPs, although the use of the whole mesentery 
(namely first to sixth order MAs) may reflect other components such as NO. The more 
pronounced role of EDHF in small MAs (specifically second to fourth order arteries) 
compared with medium sized and large conduit arteries such as the superior MA and the 
aorta is attributed to the action of IKCa and SKCa channels in ACh-induced relaxations (Chen 
and Cheung, 1997; Hilgers et al., 2006). However, the decrease of p-Akt levels also suggest 
an additional effect of SiNPs in preventing the backup role of NO to revert MA-dilator 
responses to normal levels or maintain the levels resulting from compromised EDHF 
action(s) following SiNPs infusion ex vivo. The actions of ERK are mediated via its action on 
regulating the activity of eNOS (Salerno et al., 2014) and EET-related signalling cascade 
(11,12- and 14,15-EETs CYP metabolites (Fleming, Fisslthaler, Michaelis, et al., 2001)) 
leading to eNOS-induced H2O2 production (that upregulates ERK) and subsequent 
hyperpolarisation of VSMCs. The decreased levels of p-ERK by SiNPs may thus be in part 
responsible for the impairment in the vasodilator function of MAs. Upon ACh stimulation, 
Akt is thought to be produced via two pathways; 1) the overproduction of EDHF and 2) 
when EDHF is compromised. When produced, Akt is involved in the upstream regulation of 
NO production via serine 1177 phosphorylation (Zhang et al., 2009) and promoting its 
action(s) on ECs (Dimmeler et al., 1999). The decreased levels of p-Akt by SiNPs may thus 
be in part responsible for the impairment in the vasodilator function of MAs through the 
blockage of NO production by eNOS. This is because NO acts as a backup to EDHF when the 
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latter is also compromised by SiNPs. The mechanism through which SiNPs decrease p-ERK 
and Akt may be due to their direct interaction with the latter proteins due to their 
abundance and role in mediating MA-dilation. The study by Yu et al. have reiterated this 
finding by suggesting the effect of SiNPs on lowering the haemoglobin levels in the blood 
of mice injected with  non-porous Stöber SiNPs (115 ± 13 nm; at 600 mg/kg) (Yu, Greish, et 
al., 2012). SiNPs may also induce irreversible conformational change (Turci et al., 2010) to 
the protein structures resulting in protein de-phosphorylation and/or misfolding. ERK can 
stimulate eNOS, calcium-dependent potassium channels and BKCa channels, and on the 
long-term, induce ECs and VSMCs proliferation. Due to the limitations in our study, there 
may be further SiNP disruptive, obstructive, blockade and/or inhibitory actions (if any) on 
MAs,  however these may have not been accounted for due to limitation in detecting all 
protein isoforms specific to the rat species and/or the difficulty in obtaining the more 
protein yield from more samples, hence sample size. Further investigation is required to 
account for other targets for SiNPs actions. This may include the specific CYP2C11 isoform 
associated with the rat MAs, as a different isoform was shown to be affected by SiNPs in a 
human liver and fibroblast cellular model (Christen and Fent, 2012).     
 
It is generally difficult to detect phospho-proteins in blood vessel lysates and the process 
may require incubation in the primary antibody for over a few days to obtain denser protein 
bands and/or the use of a stronger chemi-luminescent signal of Western blot detection. 
The main limitation of the proteomics study related to the fact that not all kinases cross-
reacted and/or were specific to the particular isoforms present in the rat MAs. 
Furthermore, the kit from R&D lacked a number of key targets such as cPLA2, PLCγ, CYP4A, 
and CYP2C11 involved in mediating MA-mediated vasodilation and hence these were not 
accounted for in the present studies and need to be further investigated in future studies.  
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7.1 Summary of Results 
 
7.1.1 The Synthesis and Characterisation of SiNPs 
Dye-encapsulated SiNPs were fabricated using the Stöber method and characterised by 
DLS, Zeta potential and TEM. Two batches of SiNPs (DA3 and A3) were monitored for 15 
months following their initial synthesis, in ethanol and water respectively. The results are 
summarised as follows:  
1. The presence of rhodamine dye was confirmed by fluorescence microscopy.  
 
2. The DLS technology using the ZetaSizer provided an overall SiNPs size of 124.1 nm 
with a stability of -34.5 mV (A3 sample). The size was confirmed by TEM analysis to 
be 98 nm in diameter.  
 
3. The SEM and TEM images of the synthesised DA3 SiNPs sample stored in ethanol 
demonstrate that the NPs have spherical morphology 15 months after their initial 
synthesis. The storage of the NPs over one year period did not affect the particle 
morphology, as the particle shape and size remained similar. In contrast, the A3 
SiNPs sample displayed more a granular appearance over time with some 
aggregation in morphology.  
 
4. There was a significant decrease in the Zeta potential of DA3 SiNPs sample following 
15 months of storage in ethanol. The potential for the A3 SiNPs displayed significant 
changes in PSS (only after 15 months) with slight fluctuations in Zeta potential when 
dispersed in water for the 15-month period. 
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7.1.2 Effects of SiNPs on MAs Ex Vivo 
Ex vivo vascular studies demonstrated that: 
1. The acute 30-minute exposure of MAs to SiNPs (at 5.32 x 1011 NP/mL) resulted in 
their uptake by ECs lining the vascular lumen and free localisation in the cytoplasm.  
 
2. SiNP uptake caused a significant reduction in contractile responses to Phe at specific 
concentrations without affecting the contractile machinery of MAs (high potassium 
solution).  
 
3. SiNPs uptake also attenuated the endothelium-dependent (ACh) vasodilator 
responses at specific concentrations (10-7 to 10-3 M).  
 
4. The dilator responses were improved when the vessels were incubated with a lower 
dose of SiNPs (1.01 x 1011 NP/mL). 
 
5. The endothelium-independent (SNP) vasodilator responses were unaffected by the 
incubation in SiNPs.  
 
7.1.3 Effects of SiNPs on MAs in Vivo 
In vivo vascular studies demonstrated that: 
1. A small fraction (approx. 6%) of the SiNPs administered in vivo were localised into 
various tissues including; lungs, heart, aorta, mesentery, liver, spleen and kidney. 
Despite the minimal concentration of SiNPs internalised into different tissues, the 
largest fraction of uptake was observed within the MA tissue with the latter 
accounting for approximately 5% of SiNPs injected in vivo 
 
2. SiNPs injected in vivo, had no overall effect on Phe-induced contraction contrary to 
the results found after ex vivo infusion of SiNPs. 
 
185 
 
 
3. Although SiNPs injected in vivo, induced a significant reduction in ACh dilator 
responses at specific concentrations (100 nM and 1 mM), there was no overall 
detrimental reduction in dilation at the high doses (1 µM – 100 µM).  
 
4. SiNPs injected in vivo, significantly reduced SNP-induced dilator responses at a 
lower dosage (10 and 100 nM). 
 
7.1.4 Mechanisms Mediating SiNPs Effects  
Molecular Studies involving the use of inhibitors, SOD and the analysis of signalling 
pathways demonstrated that:  
1. The vasodilator response of MAs was significantly reduced after vessels were 
incubated in L-NNA and potassium channel blockers, thus demonstrating that both 
NO and EDHF contribute to vasodilator response in MAs.  
 
2. The co-incubation of SiNPs in the presence of L-NNA completely abolished the 
dilator responses to ACh, suggesting the direct effect of SiNPs on the EDHF pathway.  
 
3. The co-incubation in SOD did not reverse the actions of the SiNPs, indicating that a 
reactive oxygen species (ROS)-independent mechanism may mediate SiNPs actions 
in MAs.  
 
4. SiNPs uptake in MAs caused a reduction in the phosphorylated levels of ERK and 
Akt.  
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7.2 General Discussion 
 
In the present study, RBITC dye-encapsulated monodispersed SiNPs were carefully 
fabricated and characterised, and their shelf life evaluated in various media (ethanol, water 
and PSS) over a 15-month period. SiNPs were selected as the nanomaterial of choice due 
to their ability to decompose into silicic acid which is a relatively harmless by-product, in 
comparison nanomaterials that are not metabolised such as gold NPs and CNTs (DIACONU 
et al., 2010). This property makes the silica an attractive metal of choice for NP fabrication 
and application. Our findings suggest that these SiNPs when stored in water, they show 
morphological changes over the 15-month time course. The granular appearance and 
rough outer surfaces of SiNPs in water, after the 15 month period, may have been caused 
by the silica seeds surrounding the individual SiNPs, generated by the water “dissolution-
effect” (Finsy, 2004) and/or silica decomposition into silicic acid (DIACONU et al., 2010), 
which promoted SiNP aggregation overtime. When dispersed in ethanol, no morphological 
changes were apparent as SiNPs maintained their smooth surface characteristics; however, 
SiNPs did not maintain stability (significant alteration in Zeta potential) over the 15-month 
period. SiNPs dispersed in PSS led to a significant increase in both hydrodynamic diameter 
and stability. Consequently, the long-term storage of SiNPs in water or ethanol is not 
recommended due to the change in their characteristics overtime. Incubating the SiNPs in 
blood resulted in an increase in the size of SiNPs and a greater decrease in Zeta potential 
(hence increased stability) after 8 hours of incubation. This may be due to corona formation 
and serum protein adsorption onto their surface (Gamucci et al., 2014).  
 
In addition to their application as contrast agents in medical imaging, SiNPs (in their 
mesoporous forms) can also be used as targeted delivery platforms for drugs, specific RNA 
and as gene carriers (Ferrari, 2008). This is due to their ability to accommodate thousands 
of luminescent molecules, protecting dye molecules from photodegradation (Roche et al., 
2006) and/or become functionalised or tagged by different receptor agonists and/or 
antibodies (Arruebo et al., 2009) directed towards specific sites in vivo for guided diagnostic 
and therapeutic interventions. Furthermore; due to their unique features, SiNPs are 
favoured over conventional diagnostic and therapeutic tools, for the delivery of drugs and 
cancer therapy. For instance; SiNPs are more stable than liposomes (which are composed 
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of lipid mixtures typical of cellular PMs), as drug nanocarriers (Mu et al., 2012). SiNPs have 
been shown to be superior in a number of diagnostic methods, in vitro. For example, in the 
study by Ekrami et al. on sputum specimens obtained from patients who were suspected 
to have pulmonary tuberculosis, the use of bioconjugated fluorescent SiNPs displayed 
higher diagnostic sensitivity and specificity in detecting Mycobacterium tuberculosis 
compared to conventional methods based on culture, microscopic analysis and polymerase 
chain reaction (PCR) (Ekrami et al., 2011). In vivo, the improved image contrast of 
ultrasound devices has been demonstrated due to the acoustic behaviour of SiNPs 
(Casciaro et al., 2010). It was suggested that SiNPs of 330 nm in size at 1-2 x 1011  NP/mL 
were ideal for ultrasound imaging being  detectable at high sensitivity at conventional 
diagnostic frequencies in vitro using with agarose phantoms (Casciaro et al., 2010). The 
ultrasound backscatter amplitude values increased as particle size increased from 160 nm 
to 330 nm (Casciaro et al., 2010). A further study by Lui et al. showed that systemically 
administering 100 nm SiNPs into mice could generate a detectable ultrasound response 
and regarded the latter size of SiNPs as being ideal for such purpose (Liu et al., 2006). The 
high contrast encountered by the use of SiNPs can overcome the limitation in visualising 
cancer cells, which are located beyond the capillary vasculature, undetected by 
encapsulated gas microbubbles (few µm in size) (Casciaro et al., 2010). An additional 
advantage of using SiNPs over commercial liposomal lipid/polymeric formulations as a 
contrast agent in ultrasound imaging is their slow degradation and potential for high in vivo 
stability makes them ideal for long-term imaging thereby overcoming the need for high 
dosages or volumes of traditional contrast agents (Liberman et al., 2014). In a very recent 
study by Gao et al., the use of rhodamine B dye-encapsulated SiNPs increased the 
absorption of acoustic energy by ultrasound devices (Gao et al., 2015). According to 
previous studies from our group, the acute exposure to SiNPs of 100 nm in size had no 
detrimental effects on the vasodilator responses of large conduit arteries (Akbar et al., 
2011). Therefore, our aim was to investigate the effects of SiNPs of approx. 100 nm on the 
small size arterial function ex vivo and in vivo using a rat model.  
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In the present study, we demonstrate the rapid uptake of SiNPs by ECs lining the mesenteric 
arteries. The neutralisation effect of PSS to SiNPs negative surfaces may have decreased 
their negative charge and facilitated their uptake into ECs. Incubation of SiNPs for longer 
periods may promote their uptake into the nucleus of ECs and/or VSMCs; hence, more 
functional and molecular consequences may become apparent as a consequence. Our 
findings contradict those from a previous study by Asefa and Tao, suggesting that SiNPs (in 
their mesoporous form) of less than 100 nm can avoid absorption by the 
reticuloendothelial system following their iv administration (Asefa and Tao, 2012). The 
latter may be due to the NP type that they used (mesoporous vs. non-porous SiNPs), hence 
the ability to accommodate and adsorb different ionic species and serum proteins within 
the blood in vivo. The localisation of our SiNPs in late endosomes indicates their processing 
to endocytotic pathways, however, a considerable number of particles seem to have used 
a different route of cellular entry and trafficking. While we cannot exclude that some SiNPs 
may have been shuttled back to the endothelial PM for extrusion, the majority of 
nanoparticles remained localised intracellularly and accumulated in the cytoplasm even 
after 3 hours of incubation.  
 
In the present study, we demonstrated that SiNP uptake by ECs ex vivo influences both 
constrictor and dilator responses. Phe contractile responses ex vivo were compromised at 
high Phe doses by SiNPs. This significant reduction in constriction seems to be specific to 
the pathways leading to stimulation of VSMCs via α1-adrenoceptors, since no significant 
effect of SiNPs were observed on AVP responses or KPSS. SiNPs significantly attenuated the 
vasodilator responses to endothelium-dependent agonist (ACh), while endothelium 
independent dilation by SNP was unaffected. This may be related to SiNP uptake being 
evidenced in ECs with no observed entry into VSMCs; hence, VSMCs’ sensitivity to NO 
remained intact.  
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In the present study, an attempt was made to elucidate the mechanisms leading to 
attenuated endothelial dependent dilator responses by SiNP uptake, using inhibition and 
molecular studies. The data obtained from our SOD studies suggest an alternative (ROS 
independent) mechanism of action of SiNPs characterised by the potential effect(s) of SiNPs 
interference (interaction, cross-linking, binding and/or cytotoxicity) on the vasodilatory 
pathway accompanying ACh-induced relaxations. Additional simple physical effects of SiNP 
presence within cells cannot be excluded. Since EDHF is an important contributor in the 
dilatory process of small vessels (Hinton and Langton, 2003), (also demonstrated here in), 
any effects of SiNPs could be mediated through their interference with and/or the block of 
EDHF action. These effects are hypothesised to be mediated via a direct interaction 
between SiNPs and cellular ions, organelles, proteins and/or DNA and/or the latter affinity 
to SiNPs. SiNPs may also affect the basal NO release thereby blocking the vasodilator 
function of NO and/or its EET-mediated EDHF-backup role (Simonsen et al., 1999). Likewise, 
SiNPs may impair basal protein levels (for both NO and EDHF pathways, as both contribute 
to small vessel dilation (Leo et al., 2011)) and/or mRNA and subsequent protein product 
and/or yield if the vessels are exposed to these NPs for longer periods. 
 
SiNPs may directly and/or indirectly interfere with, disrupt (leading to defective 
translocation) and/or block SKCa and IKCa channels involved in modulating the EDHF 
signalling and hence inhibit EDHF-mediated relaxation. The potential targets that may be 
affected by SiNPs are detailed in Table 5 and illustrated in Figure 84. Indirect effects of 
SiNPs may include physical and/or mechanical effect on the cell membranes of ECs leading 
to the disruption of the EC membranes as previously reported by Yu et al. (Yu et al., 2009) 
and altering membrane fluidity (Zhao et al., 2011). The latter membrane changes were 
previously suggested to have a significant impact on human red blood cells model using 
mesoporous SiNPs at a size range of 100-200 nm (Zhao et al., 2011). On the other hand, 
SiNPs adhesion to ECs may cause membrane bending and interaction (obstruct, 
accommodate, bind and/or block) with ECM, TJ proteins, ion channels and cell surface 
receptors in addition to being able to accumulate inside cells and deposit within organelles 
(e.g. endosomes as evident in the current study). Membrane bending of ECs and/or lipid 
vesicles in response to SiNPs adhesion and/or uptake may lead to mechanical or 
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morphological changes in lipid vesicles embedded in membranes and hence impaired 
cellular function(s). This can lead to disruption of the caveolin-rich lipid microdomains 
(and/or the caveolar caveolin-1) within ECs membranes thereby affecting potassium 
channels and connexins that reside within these structures and hence influence 
vasodilation. Caveolae microdomains consist of cholesterol and glycosphingolipids 
together with self-associating caveolins (Parton and Simons, 2007). The caveolae provide a 
matrix for compartmentation as they act as mechanotransducers by clamping enzymes 
such as eNOS and accommodating SKCa channels in close proximity on ECs membranes and 
myoendothelial TJs and spaces (Rath et al., 2009). They also promote the coupling between 
Ca2+ (TRPV4) and K+ (SKCa) channels to permit Ca2+ entry, which is required to open SKCa 
channels on ECs (when reaching Ca2+ threshold required), thereby facilitating the 
generation of PM hyperpolarisation (Rath et al., 2009). Additionally, SiNPs once taken up 
by ECs, may act indiscriminately in obstructing intracellular receptors and/or pathways 
leading to protein trafficking, protein misfolding, protein denaturation, protein de-
phosphorylation (ERK and Akt as demonstrated in our study) and protein modification 
defects rather than their direct targeted interaction with cellular compartments and/or 
molecules. SiNPs may also affect the basal EET or NO release thereby blocking the 
vasodilator function of EDHF and NO. The above scenarios may prevent the influx of ions 
such as potassium, disrupt cellular processes and protein trafficking and induce a 
conformational change to proteins and enzymes causing protein misfolding, cross-linking 
and/or dephosphorylate proteins leading to their denaturation.  
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Table 5. Potential targets that may be affected by SiNPs. 
SiNPs Target  Target Function(s) Localisation Reference 
Potassium 
channels (SKCa 
and IKCa) 
Mediate the downstream 
actions of EDHF and are 
involved in allowing K+ efflux  
SKCa 
channels reside 
within caveolae, 
whereas IKCa 
channels are 
present in cavelin-
1-independent 
EC fractions 
(Absi et al., 
2007) 
PLA2  Liberates AA from PM  EC PM (Graziani et 
al., 2004) 
CYP 2C11 
(inhibited by 
sulfaphenazole) 
EETs synthesis from AA 
precursors 
ECs’ cytosols  
Caveolae 
microdomains  
 
1. Accommodate SKCa channels 
on ECs PMs and TJs.   
2. Facilitate the generation of 
PM hyperpolarisation  
ECs PMs, 
myoendothelial 
TJs & VSMCs PMs 
(Rath et al., 
2009) 
Caveolin-1 
protein 
 
 
1. Act as regulatory scaffold for 
numerous signalling proteins 
2. Involved in endothelial 
connexins shuttling to the PM 
and myoendothelial gap-
junction formation. 
4. Spread of the electric current 
mediating the EDHF 
Within caveolae  (Saliez et al., 
2008) 
Connexins 
(Cx37, -40, and 
-43) 
Modulate EDHF-related 
pathway & interact with 
caveolin-1  
Lipid raft domains 
and caveolae  
(Schubert et 
al., 2002) 
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Thus, the physicochemical interaction of SiNPs with cellular organelles and molecular 
species such as proteins (in our case; ERK and Akt) need to be fully investigated to 
determine the underlying cause of the SiNP-mode of action observed ex vivo as well as in 
vivo at the physiological and molecular levels. Furthermore, SiNP adhesion to the vascular 
endothelium as well as their uptake in late endosomes (Figure 64F) may contribute to 
increased membrane bending of ECs and/or lipid vesicles. This may lead to mechanical or 
morphological changes in lipid vesicles and hence impaired cellular function(s).  
 
A comparison between the ex vivo and in vivo findings suggests that the functional effects 
of SiNPs are more pronounced ex vivo. Whilst in the ex vivo vessels there was a significant 
reduction in ACh dependent dilator responses at most concentrations, the attenuated 
dilation was only apparent at the lower ACh concentrations, in vivo. This was similar for 
Phe induced constrictor responses. This may be because, in vivo, the injected nanoparticles 
adsorb proteins from the serum (Ang et al., 2014). This leads to corona formation, 
evidenced in the present study by the altered SiNPs size, Zeta potential and morphology 
over time when the SiNPs were incubated in whole blood (Figures 39-41), and consequently 
altered surface characteristics of the nanoparticles such that they have less detrimental 
effect on vascular function. In contrast, for endothelial independent responses, the in vivo 
injected SiNPs induced a significant reduction in SNP induced dilation, as we have 
previously demonstrated for the QDs (Shukur et al., 2013). This has important medical 
implications, as SNP based drugs are used in heart disease patients. Hence, strategies 
would have to be developed to avoid such effects of SiNPs (Discussed in the future work 
section). 
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7.3 Conclusion  
 
This is a novel study implicating the influence of nanomaterials on small rat mesenteric 
arterial function. The experimental protocols implemented in the present study enabled 
the fabrication and characterisation of SiNPs and the assessment of vascular function in 
response to various agonists after acute exposure to luminescent SiNPs both ex vivo and in 
vivo. The main findings of this study indicate that rapid uptake of SiNPs by ECs lining the 
vasculature can alter the physiological function of rat mesenteric vessels, depending on 
their dosage. A schematic illustration summarising the effects of SiNPs on the vasodilator 
function of the mesenteric artery with the potential key targets within the vasodilatory 
mechanisms involved in mediating their behaviour ex vivo are outlined in figure 84. SiNPs 
may interfere with the EDHF and NO pathways leading to potassium channel inactivation 
(SKCa and IKCa, in particular) as well as decreased availability of NO and/or H2O2 (Figure 84). 
The mode of action of SiNPs may be mediated via their potential effects in altering cell 
surface receptors, enzymes and/or kinases, dephosphorylation of enzymes (Erk and Akt), 
interference with enzymatic substrate pockets and/or competition, interaction with the 
components of TJs ad well as simple physical effects (Figure 84).    
 
In addition to contributing to future medical diagnostics and therapeutics, NPs may also 
provide a useful tool to studying small arterial function at both the physiological and 
biochemical levels through their capacity to integrate and interfere with various molecular 
and cellular processes within the vasculature. Due to their promising role in biomedical 
applications, QDs, SiNP and CNTs biocompatibility and long-term safety and clearance must 
be carefully evaluated in preclinical studies before they could be translated for clinical use. 
This strategy will ensure the safe administration of these agents in vivo and guide their use 
in medical applications. 
 
Our findings highlight the importance of assessing the biosafety of NPs for use in imaging 
diagnostics and medical interventions such as therapeutics, in order to minimise their 
toxicological influence on vessel contractility and function. One approach may involve the 
use of SiNPs at a lower dosage, which in our study resulted in less detrimental impact of 
vascular function ex vivo.  
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Figure 84. A schematic illustration summarising the effect of SiNPs on the vasodilator 
function of ECs and VSMCs of the MA and the proposed and potential associated 
mechanisms involved mediating their behaviour ex vivo. EDHF; endothelial-derived 
hyperpolarising factor (EDHF), eNOS; endothelial-derived NO synthase, SiNPs; silica 
nanoparticles. SiNPs may directly interfere with the EDHF pathway by inactivating the 
SKCa and IKCa channels. Author originated.  
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SiNPs have potential use in imaging diagnostics. However, our study suggests that dye-
encapsulated SiNPs have detrimental effects on vascular function, attributed to their 
properties, including their chemical composition (dye molecules encapsulated within 
SiNPs), surface area and dosimetry. Furthermore, we have demonstrated that SiNPs 
influence vascular function by affecting the cascade of NO/EDHF production within the 
vascular endothelial cells through the down-regulation of ERK and Akt. Future work may 
involve a number of investigations, as follows:  
 
 
8.1 SiNPs 
 
In the current study SiNPs stability were characterised in water, ethanol, PSS and blood. 
Initial future work using SiNPs (with and without dye) will be needed to characterise their 
size, morphology and stability in blood, in real time as well as in cell media (to permit cell 
culture studies).   
 
 
8.2 Functional Studies 
 
8.2.1 In Vivo Studies  
More in vivo studies will need to be carried out to increase the n number of experiments 
and also account for the following;  
1. The effect of a range of SiNPs dosages on small MA function as well as large 
conduit arteries (aortic vessel) to determine the minimum dosage of SiNPs 
required for safe administration in vivo.  
2. The effects of SiNPs on ageing rats. This is relevant to older patients suffering 
from vascular disease, as they will require diagnostic and/or therapeutic 
interventions involving SiNPs.    
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8.2.2 Ex Vivo Studies  
More ex vivo studies will need to be carried out to examine for the following;  
1. SiNPs uptake and influence under flow and elevated pressure conditions: A 
preliminary experiment was carried out to determine the influence of SiNPs on 
mesenteric artery function under flow conditions and high intra-luminal 
pressure (100 mmHg) (Figures 85 and 66). The latter experiments provided a 
similar pattern to SiNPs effects as ex vivo under static conditions and at 60 
mmHg pressure in terms SiNPs uptake into ECs and attenuated vasodilator 
responses. Because increased uptake is suggested under elevated pressure, this 
is of important relevance for patients with hypertension and needs to be further 
investigated.  
2. A comparison between the effects of dye-encapsulated vs. bare SiNPs on 
vascular function: There is a need to assess the function of bare SiNPs without 
dye on mesenteric artery function ex vivo to exclude the role of the dye in 
mediating the effects of dye-encapsulated SiNPs on mesenteric function.   
3. The influence of SiNPs on signal transduction pathways: The proteomics 
experiment results obtained will need to be confirmed further using the 
Western blotting technique targeting the expression levels of both ERK and Akt. 
The proteomics results can also be confirmed by the use of antibodies to 
specifically target the level of phosphorylation of the protein isoforms related 
to the rat MAs and thought to be affected through the SiNPs injury to the 
vascular homeostasis. Table 6 lists the main receptors, enzymes, adapter 
proteins and transcription factors involved in mediating the contractile and 
dilator responses in MAs ex vivo. This further investigation may suggest the 
detailed molecular mechanism underlining SiNPs action(s) involving its effects 
on the upstream signalling cascade and downstream regulators of genetic 
regulation and expression (if any).    
4. The long-term or chronic influence of SiNPs on vascular function: Although the 
physiological effects of SiNPs uptake are apparent 30 minutes after incubation, 
however a change in the level of expression of the targets listed in Table 6, 
which may be affected by SiNPs may require longer incubation periods. Hence, 
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time-course experiments are needs with changes (if any) being accounted for 
using real-time PCR. Time-course experiments can also provide information on 
whether SiNPs can be translocated and deposited in VSMCs. This may 
determine whether that lack of effects of SiNPs on VSMCs was simply due 
insufficient time for SiNPs to penetrate the VSMC layer or whether there is a 
physical barrier to SiNPs entry.  
 
A 
 
B 
 
Figure 85. TEM images (A-D) illustrating the internalisation of SiNPs into the vascular 
endothelium of the MAs after 30 minute of incubation in SiNPs under flow conditions. 
The SiNPs are represented by black spherical structures inside ECs (arrows). 
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8.3 Cellular and Molecular Studies 
 
Due to time limitation and the length and effort required to perform the physiological 
studies, it did not permit the examination of SiNPs on isolated human cardiac microvascular 
endothelial cells (HCMECs), complicated by the difficulty of growing and expanding the 
latter cells in vitro. The purpose of using the HCMECs was to provide a model for translating 
the results obtained ex vivo into a human in vitro model using cell culture. The design for a 
series of experiments using the HCMECs is detailed in Appendix 7. Other cell types can also 
be used. These may include human aortic endothelial cells to provide a model for SiNPs 
interaction with large arteries. The effect of bare or dye-encapsulated SiNPs uptake on cell 
proliferation and apoptosis can then be determined. In addition, different concentrations 
of the RBITC dye on cell proliferation will be analysed. The influence of dosage and size of 
SiNPs as well as dye encapsulation of SiNPs can be established.  
 
8.3.1 To Determine the Influence of SiNPs Uptake on HCMECs Function (effect of 
SiNPs size and dosage)   
Cell-lines from HCMECs (obtained from PromoCell) from frozen will be cultured in 
Dulbecco’s Modified Eagles growth medium using standard cell culture techniques. SiNP 
suspensions of a range of concentrations (1 x 109-12 NP/mL) can be preprepared in cell 
culture medium. Cells seeded in a 24-well plate at a density of 5 x 104 cells per well can 
then be exposed to SiNPs for different time-points (10 minutes, 30 minutes, 1, 2, 6, 8, 15, 
24, 48 and 72 in hours) and following agonist stimulation. Cells can then be incubated in 
SiNPs while maintained at 37℃ in a 5% CO2 humidified environment. SiNPs uptake by 
HCMECs will be visualised using confocal fluorescence microscopy (Leica SP2 laser scanning 
confocal microscope). However, more detailed analysis of the localisation of SiNPs in 
relation to the morphology of the cells can be examined under TEM. For TEM analysis; SiNP 
suspensions containing the appropriate sizes and dosage of SiNPs can be  applied to the 
cells seeded in 6-well plates at a density of 2 × 105 cells per well, at 37℃ in a 5% CO2 
humidified environment for different time courses. Cells can then be trypsinised and then 
centrifuged to remove the trypsin. The pellets can be fixed in a Karnovsky's fixative 
containing phosphate buffered 2% glutaraldehyde and 2.5% paraformaldehyde. 
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Microwave fixation can be used with this primary fixative and the pellets washed in 
cacodylate buffer with no further additives. Samples can then be fixed and processed for 
TEM as previously described by Kim et al. (Kim et al., 2015). SiNP uptake into cells can also 
be quantified by ICP. The Influence of SiNPs on cell proliferation and viability can be 
assessed using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-
Aldrich, St Louis, MO) reduction. After exposure of cells to SiNPs of each size at the selected 
concentrations, the medium can be removed and the cells can be washed with PBS. The 
cells can then be incubated in fresh serum-free medium containing 0.5 mg/mL of MTT for 
4 hours 37℃. The resulting formazan product can then be dissolved in DMSO, and the 
collected samples cab be centrifuged at 12,000 rpm for 5 minutes to remove any remaining 
SiNPs. 100 µL of the supernatant can then be transferred to a fresh well of a 96-well plate 
and absorbance can be measured at 570 nm using a microplate reader (Synergy-HT, BioTek, 
Winooski, VT) (Kim et al., 2015). The lactate dehydrogenase (LDH) assay can also be 
performed to assess membrane disruption caused by SiNPs. The assay can be conducted 
using the CytoTox96® Non-Radioactive Cytotoxicity Assay kit (Promega, Madison, WI). 
Following the incubation in SiNPs, cells can be prepared for the LDH assay and the 
absorbance can be measured at 490 nm using a microplate reader (Synergy-HT, BioTek, 
Winooski, VT). This will examine the level of LDH release by cells following SiNPs incubation. 
 
8.3.2 To Investigate the Pathway for SiNP-dependent Uptake by HCMECs  
Inhibitor experiments can be conducted to identify the uptake route used by SiNPs using 
e.g. endocytic inhibitors that specifically block individual cellular uptake pathways 
(Qualmann et al., 2000). For instance, chlorpromazine is a cationic amphiphilic inhibitor 
which is known to block the clathrin-mediated pathway, where it reversibly translocases 
clathrin and its adapter proteins from the cell surface to intracellular vesicles (Vercauteren 
et al., 2010; Wang et al., 1993). Whereas, Cytochalasin D acts to disrupt the actin filaments 
within the cytoskeleton by inducing ATP hydrolysis in actin subunits, leading to an 
accumulation of ADP containing actin monomers and increasing the ratio of actin-
ADP/acting-ATP (Goddette and Frieden, 1986). Likewise, nocodazole is also involved in 
depolymerising the microtubule network by stimulating the hydrolysis of GTP in tubulin 
monomers and thereby leading to incorporation of GDP-tubulin into the filaments (Vasquez 
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et al., 1997). Markers for cathrin- and caveolin-mediated uptake such as glycoprotein 
transferrin and sphingolipid lactosylceramide respectively (Conner and Schmid, 2003; 
Vercauteren et al., 2010), can be used in investigating the path of NP-dependent entry to 
cellular compartments. We can also test whether the disruption of microtubules or actin 
network (Dausend et al., 2008; Raghu et al., 2009) by nocodazole or cytochalasin D 
respectively may influence the cellular uptake of SiNPs. 
 
8.3.3 To determine ROS Generation Induced by SiNPs Uptake 
The intracellular levels of ROS within the cultured cells following SiNPs uptake can be 
determined from cells exposed to various sizes and dosage of SiNPs using the cell-
permeable fluorogenic probe, 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA). DCFH-
DA can diffuse into cells, where it can react with ROS to form the highly fluorescent product 
2,7-dichlorodihydrofluorescein (DCF). Cells can be seeded into a 96-well plate at a density 
of 1.0 × 104 cells per well and pre-treated with DCFH-DA stock solution for 30 minutes 
before the administration of SiNPs. The fluorescence of oxidised DCF can be measured on 
a microplate reader (Synergy-HT, BioTek, Winooski, VT) at excitation and emission 
wavelengths of 480 nm and 530 nm, respectively (Kim et al., 2015).  
 
8.3.4 To Determine the Mechanism of Attenuated Dilation Induced by SiNPs 
There is no information on the mechanism of attenuated dilation in small arteries by the 
uptake of SiNPs, as far as we are aware. Hence, the future work will attempt to fulfil this 
gap and investigate further the molecular mechanisms underpinning the NP’s-physiological 
effects on the vasculature. The aim of the molecular study is to determine the molecular 
mechanisms of SiNP-associated effects on isolated arteries (aortic and mesenteric arterial 
segments) and cell cultures. In addition to their role in compromising vasodilation, SiNPs 
may trigger an immune response by the vascular ECs (Abbot et al., 1992; Scott and Bicknell, 
1993). The uptake of SiNPs may provoke an immunological response by ECs lining the 
vascular lumen causing EC dysfunction, damage and necrotic cell death through caspases 3 
and 7-dependent pathway (Bauer et al., 2011). Previous studies highlighted the release of 
IL-8 by ECs as a response to NP uptake (Hetland et al., 2001; Cho et al., 2007). NPs may 
further activate the EC-coagulation system thus switching the vessel wall into a pro-
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thrombotic and inflammatory surface (Wagner and Frenette, 2008), which can potentially 
trigger vascular disease due to the loss of the anti-thrombotic and anti-inflammatory 
properties of ECs (Spiel et al., 2008). Thus, mRNA extraction (Hilgers et al., 2006), real-time 
quantitative PCR array analysis and Western blotting techniques will be used to monitor 
the up- or down regulation in expression of potential target genes and the levels of proteins 
involved in the EDHF and NO-mediated pathways (Table 6).  These techniques will be 
performed on snap-frozen homogenised vessels (Saitoh et al., 2012) as well as the cell 
cultures. GenBank will be searched for the DNA sequences related to the gene targets list 
involved in mediating vascular dilation and inflammatory responses. The intracellular gene 
or protein candidates that are likely to be affected by SiNPs and will include inflammatory 
cytokine, receptors, adapter proteins, kinases and enzymes (Table 6). These targets are 
involved in mediating and facilitating vasodilator and inflammatory pathways that 
accompany vessel function. For the isolated arteries, the influence of uptake of SiNPs (at 
5.32 x 1011 NP/mL) on the gene and protein targets will be tested following the acute (30 
minutes) and longer term exposure to SiNPs following the stimulation by agonists.  
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Table 6. Potential protein or gene target list for the vasodilatory and inflammatory 
pathways in ECs including; potassium channels, receptors, kinases, enzymes, cytokines, 
cytokine receptors and inflammatory markers. 
Cytokines: IL-1, 4, 6 
and 15 
Cytokine Receptors: for IL-1, IL-6, IL-6 
signal transducer (IL-6ST), TNFα and γ-IFN. 
 
α1-adrenergic 
receptor and 
muscarinic M3 
receptor 
Kinases: PKG, PKG1α, 
CaMKKβ, PKA, PKC, 
MAPK (1,8 and 14), 
ERK and Akt 
 
Enzymes: eNOS, CaM, CaMKII, COX-2, 3MST, 
CBS, CSE, PLA2, PLC, Endothelial adenylyl 
cyclase, CYP epoxygenases  and 
monooxygenase, CYP4A, SOD1 and Catalytic, 
α-polypeptide (PIK3CA) 
 
TRPV4 channel 
Potassium Channels: 
KCa+, SKCa (SKCa2.3), 
IKCa (KCa 3.1) and BKCa 
Rat-specific voltage-gated potassium 
channels: rv-K IR6.1, rvKIR6.2, rvK IRSUR1 and 
rvSUR2B 
Transcription 
Factors: CREB, NF-κB, 
PPAR-α, PPAR-γ and 
FABPs 
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8.3.5 To investigate the Strategies to Enhance SiNPs Biocompatibility in vivo 
To enhance the biocompatibility of SiNPs a number of strategies can be adopted. One of 
which may involve the use of an inorganic core or shell of nanostructured magnetic iron 
oxide (Abbas et al., 2014), such as magnetite (Fe3O4), and maghemite (γ-Fe2O3) (Mahdavi 
et al., 2013) with SiNPs. Iron oxide NPs may be prone to clearance from the body, perhaps 
through iron processing in the spleen, hence SiNPs attachment or incorporation may 
bypass SiNPs effects in vivo (e.g. tissue deposition and bioaccumulation) as well as 
enhancing their chemical stability (Nidhin et al., 2008). Such superparamagnetic NPs may 
also enhance the use of the iron oxide-SiNPs hybrids in magnetic resonance imaging (MRI) 
as diagnostic probes (B. H. Kim et al., 2011). Another approach may involve the coating of 
SiNPs with micelles (Huo et al., 2006), peptides, polysaccharides or polymers of 
biocompatible nature such as dextran (Hong et al., 2008), chitosan (Li et al., 2008), 
poly(ethylenimine) (PEI) (Yiu et al., 2010) and PEG (Mukhopadhyay et al., 2012) to stabilise 
and safely process SiNPs in vivo. The coating of SiNPs with PEG lipids was previously 
suggested to increase their blood circulation lifetime and prevent SiNPs from aggregation, 
and hence the clogging of capillaries in the lung and liver of SiNP-injected mice (van 
Schooneveld et al., 2008). The conjugation of SiNPs with peptides or proteins such as 
antibodies (Tsagkogeorgas et al., 2006) may minimise their non-specific off-target 
interaction and enhance their selective targeting in vivo. Furthermore; a study by Ma et al. 
suggested the improvement of SiNPs compatibility, using HUVECs cell line, following the 
incorporation of the liposomal architecture into cerasomes made from SiNPs core 
structures (Ma et al., 2011). Hence, there is a need to further assess the biosafety of SiNPs 
and enable their safe administration in vivo. 
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Appendix 1. Conference Presentations 
 
Shukur, A., Whitehead, D. and Azzawi, M. 'The Influence of Silica Nanoparticles on Small 
Mesenteric Vessel Function and Contractility.'  
Poster presented at the Research Day conference – hosted by MMU, John Dalton Building, 
Manchester, held on the 20th April 2012. 
 
Shukur, A., Whitehead, D. and Azzawi, M. 'The Influence of Silica Nanoparticles on Small 
Mesenteric Vessel Function and Contractility.'  
Poster presented at the Manchester Life Sciences PhD Conference – hosted by the Faculty 
of Life Sciences, University of Manchester, The Manchester Place, Manchester, held on the 
11th May 2012. 
 
Shukur, A., Rizvi, S. B., Whitehead, D., Seifalian, A. and Azzawi, M. 13) 'The influence of 
Quantum dots on Small Mesenteric Vessel Function and Contractility.'  
Poster presented at joint meeting of the BMS and the Microcirculatory Society – hosted by 
Oxford University, Keble College, Oxford, held on the 4th – 6th July 2012. 
 
Shukur, A., Whitehead, D. and Azzawi, M. 'Infused Silica Nanoparticles Compromise Small 
Arterial Function, Ex vivo.'  
Poster presented at the International Cell Tracking Symposium (Nanoparticle-based 
Technologies for Cell Tracking) – hosted by the Department of Chemistry, University of 
Liverpool, Liverpool, held on the 1st – 2nd July 2013.   
 
Shukur, A., Whitehead, D. and Azzawi, M. 'Infused Silica Nanoparticles Compromise Small 
Arterial Function, Ex vivo.'  
Poster presented at the Northern Vascular Biology Forum (NVBF) – hosted by the University 
of Sheffield, North Campus Conference Centre, Sheffield, held on the 9th December 2013.    
 
Shukur, A., Whitehead, D. and Azzawi, M. 'Infused Silica Nanoparticles Compromise Small 
Arterial Function, Ex vivo.'  
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Poster presented at the NVBF – hosted by MMU, Geoffrey Manton Building, Rasamond 
Street West, Off Oxford Road, Manchester, M15 6LL, held on the 8th December 2014.    
 
Shukur, A., Whitehead, D., Wilkinson, F., Weston, R. Alexander, Y. and Azzawi, M. 'Infused 
Silica Nanoparticles Compromise Small Arterial Function.'  
Poster presented at the British Atherosclerosis Society (BAS)/British Society of 
Cardiovascular Research (BSCR) Joint Spring Meeting 2015 with the British Cardiovascular 
Society (BCS); New frontiers in Cardiovascular Science – hosted by The Education Hall, 
Manchester Central Conference Centre, Windmill Street, Manchester, M2 3GX, held on the 
8-9th June 2015.   
 
Shukur, A., Whitehead, D., Wilkinson, F., Weston, R. Alexander, Y. and Azzawi, M. 'Rapid 
Uptake of Silica Nanoparticles Attenuates Vasodilator Responses in Small Mesenteric 
Arteries.'  
Oral Presentation conducted for the Young Scientist Lecture competition at the 10th 
NANOSMAT Conference – hosted by the University of Manchester, held on the 13-16th 
September 2015. Also was a member of the organising team. 
 
Shukur, A., Whitehead, D. and Azzawi, M. Silica Nanoparticles Attenuate EDHF Pathway 
Dependent Vasodilator Responses in Small Mesenteric Arteries, ex vivo.'  
Poster Presentation conducted for the 3rd International Conference on Nanotechnology in 
Medicine (NANOMED) – hosted by NANOSMAT, Manchester Conference Centre, Sackville 
Street, Manchester, M1 3BB, held on the 23-25th November 2015. Also was a member of 
the organising team. 
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Appendix 2. Publications 
 
Peer-reviewed Scientific Journals.  
 
Shukur, A., Rizvi, S. B., Whitehead, D., Seifalian, A. and Azzawi, M. (2013) 'Altered sensitivity 
to nitric oxide donors, induced by intravascular infusion of quantum dots, in murine 
mesenteric arteries.' Nanomedicine, 9(4), May, pp. 532-539. 
 
Shukur, A., Whitehead, D., Seifalian, A. M., Alexander, Y., Wilkinson, F. and Azzawi, M. (2015) 
'Infused Silica Nanoparticles Compromise Vascular Function in Small Mesenteric Arteries.' Heart, 
101, Jun, pp. A98-A98. 
 
Shukur, A., Whitehead, D., and Azzawi, M. (2015) ''Rapid Uptake of Silica Nanoparticles 
Attenuates Vasodilator Responses in Small Mesenteric Arteries.' In submission. 
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Appendix 3. Calculations used for working out the number of 
nanoparticles per mL 
 
            𝑉𝑉=(4/3)𝜋𝜋𝑟𝑟3     [1] 
Equation 1: Calculates the volume of a sphere, where v is the volume of sphere, π is 3.14 
and r is the radius of the particle in cm. This equation was used to calculate the number of 
particles per mL.  
 
      𝑚𝑚=𝑉𝑉×𝐷𝐷      [2]  
Equation 2: Calculates the mass of a nanoparticles sphere, where M is mass of a particles 
sphere, v is volume of a sphere and d is the density of silica, which is 1.9.  
 
                    𝑁𝑁=𝑚𝑚/𝑉𝑉      [3]  
Equation 3: Calculates the number of particles within a given solution, where V is the 
volume of a sphere at a given diameter; m is the mass of dry NP product in 1 mL of SiNPs 
suspension. 
 
For example, the volume of sphere for the 98 nm sized A3 SiNPs was calculated as follows: 
4/3 x π x (half of nanoparticle size (49 nm) x 10-7)3 x 1.9 (silica density) 
 
To calculate NP/mL: Dry mass (0.0044 g)Volume of sphere (9.36 x 10−16) 
Thus = 4.70 x 1012 
 
C1xV1 = C2xV2 
4.70 x 1012 x V1 = 5.32 x 1011 x 1 mL  
 
Hence, the initial volume to take from the A3 SiNP suspension is 0.11 mL or 111 µL to 
achieve a final dosage of = 5.32 x 1011 NP/mL. 
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Appendix 4. The Hydrodynamic Diameter and Zeta Potential Outputs 
for SiNPs 
 
DA3 SiNPs in Ethanol  
A 
 
B 
 
Hydrodynamic diameter graph of DA3 SiNPs sample in ethanol over time, where A) month 
one and B) month fifteen. 
 
A 
 
B 
 
Zeta potential graph of sample DA3 SiNPs sample in ethanol over time, where A) month 
one and B) month fifteen.  
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A3 SiNPs in Water  
A 
 
B 
 
Hydrodynamic diameter graph of sample A3 SiNPs sample in water over time, where A) 
month one and B) month fifteen. 
 
A 
 
B 
 
Zeta potential graph of sample A3 SiNPs sample in water over time, where A) month one 
and B) month fifteen. 
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A3 SiNPs in PSS 
A 
 
B 
 
Hydrodynamic diameter graph of sample A3 SiNPs sample in PSS over time, where A) 
month one and B) month fifteen. 
 
A 
 
B 
 
Zeta potential graph of sample A3 SiNPs sample in PSS over time, where A) month one and 
B) month fifteen. 
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Appendix 5. Preparation of Solutions and chemicals 
 
General equations for Molar calculations 
Volume = Mass (g) x Density 
Number of Moles = [Mass (g)/molecular weight (g/mol)]/Volume (V) 
Concentration (C) (Molar; mol/L) = Moles/V 
 
TEM sample fixation and preservation  
The fixative for TEM was prepared by dissolving 4.28 g of sodium (Na) Cacodylate in 80 mL 
of dH2O. The mixture was then made to 100 mL with dH2O, stirred and adjusted to the 
desired pH with 0.1 M of HCl added in a drop-wise fashion to allow the sample to reach pH 
of 7.4. 100 µL of the gluteraldyde solution was added to 900 µL of the above mixture to 
make the fixative. The wash buffer for TEM was prepared by dissolving 4.28 g of Na 
Cacodylate and 0.025 calcium chloride (Ca2Cl) dihydrate in 80 mL of dH2O. The mixture was 
then made to 100 mL with dH2O, stirred and adjusted to the desired pH. 0.1 M of HCl was 
used in a drop-wise fashion to allow the sample to reach pH of 7.4. 
 
TRAM-34 Preparation  
TRAM-34 (molecular weight 344.84 g/mol; soluble at 2 mg/mL of DMSO) was prepared by 
dissolving 5 mg in DMSO, followed by water to give a final concentration of 5 mM.  
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Appendix 6. Preparation of the Protein Standard Dilutions 
 
7 x 0.5 mL Eppendorf tubes were prepared and labelled from 1 to 9 for the protein standard 
plot as in Figure 1. The protein standard concentration was 2 mg/mL Bovine calf albumin. 
The dilutions in each Eppendorf tube was prepared as shown in Table 1.  
 
Table 1. The dilutions used to make the protein standard plot. 
Eppendorf 
Tube 
 Dilutions (mg/mL) 
 
μL of Albumin 
Standard 
μL of Lysis 
Buffer 
1  2 40 0 
2  1.6 32 8 
3  1.2 24 16 
4  0.8 16 24 
5  0.4 8 32 
6  0.2 4 36 
7  0 0 40 
 
 
Figure 1. The standard linear regression blot used to create the line equation for the 
protein estimation study.  
 
 
y = 0.0005x + 0.1697
R² = 0.914
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 500 1000 1500 2000 2500
Ab
so
rb
an
ce
 4
50
 n
m
moll
252 
 
 
Appendix 7. The Characterisation of HCMECs Growth  
 
HCMECs Culture 
 
Passage 2 adult human-derived cardiac microvascular endothelial cells (HCMECs) were 
purchased from PromoCell (Heidelberg, Germany). The HCMECs were cultured in T-25 
flasks (Iwaki, Japan), or on 6-well plates at a seeding density of 10,000 to 20,000 cells/cm2 
as per our instruction manual and maintained in a growth medium at 37℃ in 5% CO2 in a 
humidified incubator. The medium was replaced initially after 16-24 hours when the cells 
were initially obtained then every 3-4 days. HCMECs were cultured in cell type-specific 
endothelial cell growth medium MV for microvascular endothelial cells (PromoCell; 
Heidelberg, Germany) supplemented with foetal calf serum (2%), epidermal growth factor 
(EGF) 10 ng/mL, heparin 90 μg/mL, and hydrocortisone 1 μg/mL. Cells were subcultured 
every 10-14 days (at ~70% confluence). Experiments can be conducted at passage 4-8, at 
which time cells demonstrated good growth rates without obvious loss of phenotype.  
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HCMECs Growth 
 
Healthy-looking HCMECs were observed as round with a characteristic oval-shape and a 
centralised nucleus in contract to unhealthy cells, which contained long processes, which 
are trying to communicate and reach other cells (Figure 1).  
 
A 
 
B 
 
C 
 
D 
 
Figure 1. Passage 2 HCMECs after 13 days of culture reaching 75-80% confluence. Images 
were obtained using the x10 (A and B) and x20 (C and D) objectives respectively of the 
Leica CTR000 microscope (Microsystems, UK). 
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